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Abstract 
 
 
Statement of Purpose   
 The purpose of this study is to examine the impact of preconception health on 
adverse pregnancy outcomes through the theoretical lens of reciprocal determinism.  
Thus, this study aims to develop a preconception health conceptual framework that 
accounts for the interactive relationships among behavior, the environment, and the 
person.   
Rationale for the Study   
Women may not recognize a pregnancy until the first or second missed 
menstrual cycle, a full four to eight weeks or more after conception.  Once a woman 
realizes the possibility of a pregnancy, it takes further time to confirm the pregnancy with 
a home pregnancy kit or a visit to the health care provider.  In that time period, the 
woman may have unknowingly exposed her embryo to nutritional deficiencies, over-the-
counter drugs, tobacco, alcohol, or other toxins.  Because nearly half of all pregnancies 
are unintended, yielding about three million unintended pregnancies in the U.S. annually, 
there is a need to shift care to an earlier period in a woman’s life cycle with greater 
potential to prevent birth defects and other adverse pregnancy outcomes, also known as 
preconception care. 
The preconception health movement began with the rationale that many adverse 
pregnancy outcomes are determined prior to prenatal care initiation.  Thus, in addition to 
prenatal care, the need for preconception health arose.  The empirical literature makes a 
strong case for the benefit of individual preconception health components and their 
effects on adverse pregnancy outcomes.  However, the actual effectiveness of collective 
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preconception health in reducing adverse pregnancy outcomes has not yet been 
demonstrated.  In an effort to evaluate the impact of preconception health on maternal 
morbidity, infant morbidity, and infant mortality, this study examined the reciprocal 
relationships between environmental, personal, and preconception behavioral factors 
and their associations with adverse pregnancy outcomes. 
Methods 
 A secondary data analysis was conducted using the Pregnancy Risk 
Assessment Monitoring System (PRAMS) data from 2005-2008 to test a 
preconception framework.  Project 1 examined all variables in the preconception 
framework among the following states:  Maine, New Jersey, Ohio, and Utah.  
Project 2 examined all variables except of two among all PRAMS-participating 
states.  All of the variables in the proposed framework were derived from 
questions in the PRAMS survey or from PRAMS-linked birth certificate data.  The 
research questions posed in this study were resolved through the path analyses 
of reduced and full iterations of the preconception framework in Projects 1 and 2.     
Results   
In Project 1, list-wise deletion of missing data resulted in a decrease from 
the original 27,933 participants to 12,239 participants.  In Project 2, this action 
resulted in a decrease from the original 200,008 participants to 128,551 
participants.  The analysis of the reduced frameworks for both projects revealed 
extremely low R-squared values (1.1% or less).  Subsequent analyses examining 
the full framework in Projects 1 and 2, as well as an additional post hoc analysis 
with supplementary PRAMS variables, resulted in R-squared values of 13.1%, 
11.4%, and 30.5%, respectively. 
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Implications   
This study examined the impact of preconception health behaviors on adverse 
pregnancy outcomes through the theoretical lens of reciprocal determinism.  
Preconception health behaviors alone accounted for a negligible portion of the variance 
associated with adverse pregnancy outcomes.  As hypothesized, preconception health 
behaviors work in concert with environmental factors, personal influences, prenatal and 
natal factors.  Significant predictors supported in the literature included lower 
socioeconomic status, pregnancy intention, pregnancy history, older maternal age, black 
maternal race, Hispanic ethnicity, overweight maternal BMI, tobacco use prior to 
pregnancy, maternal complications, hospitalization during pregnancy, later prenatal care 
initiation, fewer prenatal care visits, plurality, and cesarean section.  Even so, there is a 
large portion of the variance in adverse pregnancy outcomes that is not accounted for, 
and further examination is required.   
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Chapter 1:  Statement of the Problem 
 
 
Introduction 
 
Preconception care, or care prior to pregnancy, is an important aspect of 
women’s health care.  Preconception care may be defined as, “a set of interventions that 
aim to identify and modify biomedical, behavioral, and social risks to a woman’s health 
or pregnancy outcome through prevention and management, emphasizing those factors 
that must be acted on before conception or early in pregnancy to have maximal impact” 
(Posner, Johnson, Parker, Atrash, & Biermann, 2006, p. S198).  The goal of 
preconception care is to provide health promotion, screening, and interventions for the 
more than 62 million women of childbearing age in the United States (Johnson, 2006; 
U.S. Census Bureau, 2005).   
Ideologic Shift from Prenatal Care 
 
Prenatal care is generally described as the health care a woman receives during 
pregnancy (March of Dimes, 2009; U.S. Department of Health and Human Services 
[DHHS], 2009; Mayo Clinic, 2008).  Prenatal care may address maternal education, 
counseling, and the teaching of basic parenting skills (U.S. National Library of Medicine 
& National Institutes of Health, 2009), and it typically includes the monitoring of a 
pregnancy for potential maternal or fetal problems that may occur (Hood, Parker, & 
Atrash, 2007).  According to Healthy People 2010, about 74% of women obtain early 
and adequate prenatal care (U.S. Department of Health and Human Services [DHHS], 
2000).  However, prenatal care, even when initiated in early pregnancy, fails to prevent 
certain fetal development and maternal health risks.  During fetal development, the 
fourth through the tenth week after conception is the most critical window in which the 
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fetus is susceptible to potential health problems.  Usually, prenatal care begins in the 
eleventh or twelfth week of pregnancy, thus failing to prevent early embryonic 
developmental abnormalities and failing to reduce numerous health risks to the mother 
(CDC, 2006c).  Therefore, preventive care prior to the earliest days of a pregnancy, or 
preconception care, must pave the way for more effective prenatal care and healthier 
pregnancies in the future. 
Half of all infant deaths are attributed to four causes:  1) congenital 
malformations/birth defects; 2) disorders related to prematurity and low birth weight 
(LBW); 3) sudden infant death syndrome (SIDS); and 4) maternal complications of 
pregnancy (Arias, MacDorman, Strobino, & Guyer, 2003; Bennett & Kotelchuck, 2005).  
Research indicates that prenatal care alone is insufficient to effect necessary change in 
these contributors to infant mortality, and thus, other prevention strategies are needed, 
such as preconception care (U.S. Department of Health and Human Services [DHHS], 
2000; Korenbrot, Steinberg, Bender, & Newberry, 2002). 
Infant mortality is generally a primary focus, but mothers require attention, as 
well.  In the United States, maternal mortality rates decreased by 99% in the 20th 
century, with 11.5 maternal deaths per 100,000 live births reported in 1999 (Berg, et al., 
2003).  Black women, however, are over four times more likely to die due to maternal 
illness than are white women (Association of State and Territorial Health Officials 
[ASTHO], 2006).  Whereas maternal mortality is defined as the number of maternal 
deaths per 100,000 live births, maternal morbidity may be defined as illness or injury to 
the mother caused by, aggravated by, or associated with pregnancy, childbirth, or 
postpartum conditions within 42 days after giving birth (Reed, et al., 2000).  Conditions 
associated with maternal morbidity range from pregnancy-induced hypertension to 
sepsis to obstetric complications (Boulvain, 2008; Geller, et al., 2004).  In the United 
States, maternal morbidity affects nearly 1.7 million women annually, with 43% of 
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women experiencing some form of perinatal condition or complication (Danel, et al., 
2003).  Reducing maternal mortality and morbidity are national goals, and preconception 
care is one possible solution (ASTHO, 2006).  
A History of Preconception Health 
Ancient times.  Preconception care is not a novel idea.  The first known 
recorded history of preconception care was written in the 9th century B.C.  (Plutarch, 
trans. 1932).  Plutarch wrote of the ancient Spartans that their leader, Lycurgus, 
“ordered the maidens to exercise themselves with wrestling, running, and throwing the 
quoit and casting the dart, to the end that the fruit they conceived might, in strong and 
healthy bodies, take firmer root and find better growth” (Plutarch, trans. 1932, pp.59-60).  
Another ancient text is found in the Old Testament of the Bible, when an angel of the 
Lord appeared to Samson’s mother and said, “…You have never been able to have any 
children, but very soon you will be pregnant and have a son…And even before he is 
born, you must not drink any wine or beer or eat any food forbidden by God’s laws…” 
(Judges 13: 3-4; Contemporary English Version).  These texts highlight preconception 
health components, such as physical exercise and avoidance of alcohol, to improve 
pregnancy outcomes.  Written records about preconception care, from this point in time 
through the 18th century, are scarce. 
The 19th and early 20th centuries.  William Potts Dewees, an early American 
obstetrician and a pioneer in perinatal medicine, published several books about the 
medical conditions afflicting women and children.  In 1825, William Potts Dewees stated 
in the Treatise on the Physical and Medical Treatment of Children that, “…the physical 
treatment of children should begin, as far as may be practicable, with the earliest 
formation of the embryo: it will, therefore, necessarily involve the conduct of the female, 
even before her marriage, as well as during the period of pregnancy” (Dewees, preface 
page ix).  In 1902, the National Vital Statistics System was developed (Margolis, Cole, & 
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Kotch, 2005).  For the first time, a figure for infant mortality in the entire United States 
was established (Margolis, Cole, & Kotch, 2005).  In 1900, the infant mortality rate in the 
United States was 150 infant deaths per 1,000 live births (Margolis, Cole, & Kotch, 
2005). 
The 1970s.  In 1979, the U.S. Department of Health, Education, and Welfare 
(DHEW) published a federal position paper acknowledging the need for a national shift 
in its approach to prevention (DHEW, 1979).  This document proposed a comprehensive 
package of integrated services for women, including interconceptional care, prenatal 
care, perinatal care, child health care, services for handicapped children, and adolescent 
services (DHEW, 1979).  For definitional purposes, “preconceptional” refers to a 
woman’s health status prior to pregnancy, “periconceptional” refers to a woman’s health 
status from the time immediately prior to conception through the period of fetal organ 
development, and “interconceptional” typically addresses a woman’s health status 
between pregnancies, birth spacing, and intendedness of subsequent pregnancies 
(Freda, Moos, & Curtis, 2006). 
The 1980s.  The U.S. Surgeon General’s Conference in the early 1980s on infant 
mortality related that the United States’ ranking declined from 10th place in the 1960s to 
19th place among 39 industrialized nations (Institute of Medicine [IOM], 1985).   To 
improve pregnancy outcomes, leaders began to initiate several national programs 
(Atrash, et al., 2008; National Healthy Mothers Healthy Babies Coalition [HMHB], 2007).  
In 1981, the “Healthy Mothers Healthy Babies” coalition was formed by the American 
College of Obstetricians and Gynecologists (ACOG), the American Academy of 
Pediatrics (AAP), the March of Dimes (MOD), the American Nurses Association (ANA), 
the National Congress of Parents and Teachers, and the U.S. Public Health Service 
(HMHB, 2007).  The purpose of this coalition was to improve maternal and child health 
through education and collaborative partnerships (HMHB, 2007).  In 1985, the United 
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States Public Health Service included preconception care in the landmark publication, 
Preventing Low Birth Weight (IOM, 1985).  This report recognized that preconception 
opportunities were often overlooked in favor of prenatal care, and the IOM Committee 
recommended prepregnancy risk identification, counseling, risk reduction, and health 
education as part of a restructuring of the perinatal prevention paradigm (IOM, 1985).  
The AAP and the ACOG, in partnership with the MOD, published Guidelines for 
Perinatal Care in 1983 (AAP & ACOG, 1983).  These guidelines included preconception 
care in an appendix, stating, “Preparation for parenthood should begin prior to 
conception.  At the time of conception, the couple should be in optimal physical health 
and emotionally prepared for parenthood” (p. 257).  In 1989, the federally appointed 
Expert Panel on the Content of Prenatal Care endorsed the preconception health care 
visit as possibly the single most important health care visit in regards to its effect on 
pregnancy (U.S. Department of Health and Human Services [DHHS], 1989).  The Panel 
recommended health coverage and reimbursement for preconception visits during family 
planning as part of prenatal care (DHHS, 1989).  The Panel also iterated that optimal 
preconception care occurs when services are provided as part of general prevention 
care or during primary care visits for other medical needs (DHHS, 1989).  This approach 
integrates preconception care into opportunities provided by the existing health care 
system, and is therefore commonly known as “opportunistic care” (Freda, Moos, & 
Curtis, 2006).   
The 1990s.  Published in 1990, Healthy People 2000 recommended to increase 
the proportion of primary care clinicians who provide age-appropriate preconception care 
and counseling to at least 60%, an objective for which no previous baseline data was 
reported (U.S. Department of Health and Human Services [DHHS], 1991).  This 
recommendation was later omitted from Healthy People 2010 due to measurement 
issues (DHHS, 2000, Moos 2002).  Another national program began in 1991, the Healthy 
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Start Initiative (National Healthy Start Association [NHSA], 2008).  This program was 
implemented in urban and rural communities with infant mortality rates 1.5-2.5 times the 
national average, and it aimed to develop community-based approaches to reduce infant 
mortality rates and improve the health of women and their families (NHSA, 2008).  In 
1993, the MOD Birth Defects Foundation published Toward Improving the Outcome of 
Pregnancy: The 90s and Beyond (MOD, 1993).  This document introduced “reproductive 
awareness” as the primary health promotion strategy to improve pregnancy outcomes, 
and it addressed the need to include males as part of the preconceptional effort (MOD, 
1993).  The MOD also called for professional standards to address opportunistic health 
care to reach all women from menarche to menopause with preconceptional messages 
(MOD, 1993).  In 1995, the ACOG published its first technical bulletin regarding 
preconception care and recommended a thorough and systematic identification of risks, 
patient-oriented education, and the initiation of preconception interventions (ACOG, 
1995).  However, the organization cautioned against over-promising the benefits of 
preconception care to patients and providers, noting that preconceptional services do 
not guarantee positive pregnancy outcomes (ACOG, 1995).  
The 21st century.  By 2002, the infant mortality rate dramatically diminished to 7 
infant deaths per 1,000 live births; however, this infant mortality rate ranked the United 
States as 28th among 39 industrialized nations (Bennett & Kotelchuck, 2005).  The 
percentage of women who accessed early and adequate prenatal care increased from 
76% in 1980 to nearly 84% in 2004 (NCHS, 2007).  There was a corresponding drop in 
infant mortality from 12.6 deaths per 1,000 live births in 1980 to 6.8 deaths per 1,000 live 
births in 2004 (NCHS, 2007).  However, other countries made similar progress, and the 
United States dropped further in the worldwide infant mortality rankings to 29th among 39 
industrialized nations in 2004 (Martin, Hamilton, Sutton, Ventura, Menacker, & Kirmeyer, 
2006).   
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The AAP and ACOG recognized the growing importance of preconception care in 
their fifth edition of the Guidelines for Perinatal Care (AAP & ACOG, 2002).  In previous 
editions, preconception care shifted from an appendix item to part of the main text 
(Freda, Moos, & Curtis, 2006).  In the fifth edition, however, the guidelines highlighted 
the need for integration of preconception health promotion into all health encounters 
during a woman’s reproductive years (AAP & ACOG, 2002).  In 2004, the Preconception 
Health and Health Care Initiative was launched by the Centers for Disease Control and 
Prevention (CDC) Workgroup on Preconception Health and Health Care, representing 
22 CDC programs dealing with maternal and child health, as well as national experts 
and representatives of over 35 national, state, and local organizations (Atrash, 2008).  
As part of the Initiative, national experts on a Select Panel on Preconception Care 
developed Recommendations on Preconception Health and Health Care in 2005.  These 
recommendations aimed to achieve four goals:  1) improve preconceptional knowledge, 
attitudes, and behaviors of women and men; 2) assure that all women of reproductive 
age in the United States receive preconception health services enabling them to achieve 
optimal health prior to pregnancy; 3) reduce risks indicated by previous adverse 
pregnancies through interconceptional interventions; and 4) reduce disparities in 
adverse pregnancy outcomes (CDC, 2006).  In 2006, the Panel prompted the 
development of ongoing workgroups in the areas of clinical, public health, consumer, 
policy, and finance to develop the Initiative’s goals and the Panel’s recommendations 
further (Atrash, 2008).  The CDC convened national preconception care summits in 2005 
and 2007 to disseminate and share preconception care improvements and research 
developments.   
Indeed, preconception is not a novel concept.  However, even with all of this 
historical background, key players, and presumed grand ideas, the concept of 
preconception health has not been implemented in the mainstream population of the 
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United States.  Even with a vast amount of research on the individual components of 
preconception health, there is still no evidence of the effectiveness of collective 
preconception health on adverse pregnancy outcomes. 
Biologic Plausibility 
An understanding of human development is critical to understanding the 
importance of preconception care.  Pregnancy is typically discussed in terms of time, 
such as first, second, and third trimesters.  However, in terms of development, 
pregnancy is more commonly divided into germinal, embryonic, and fetal periods 
(Stassen Berger, 2005).  The germinal period takes place between fertilization and day 
14 of development (Stassen Berger, 2005).  At this stage, the developing human being, 
known as a zygote, is characterized by rapid cell division and the beginning stages of 
cell differentiation (Stassen Berger, 2005).  The embryonic period follows, from day 14 
through day 56, during which the developing embryo (previously known as the zygote) 
forms the basic structures of the body (Stassen Berger, 2005).  The neural tube 
develops by day 22, which becomes the central nervous system consisting of the brain 
and the spinal column (Greenberg, Bruess, & Conklin, 2007).  In the fourth week, the 
head begins to develop, and the formation of eyes, ears, nose, and mouth begins 
(Stassen Berger, 2005).  By day 23, the beginnings of a cardiovascular system are 
present and the rudimentary heart begins to beat (Greenburg, Bruess, & Conklin, 2007).  
Weeks five through seven mark the development of arms, distinct fingers, legs, and 
distinct toes with the beginnings of a skeletal structure (Stassen Berger, 2005).  By day 
56, the embryo weighs approximately one-thirtieth of an ounce, or about one gram, and 
it is about one inch in length (Stassen Berger, 2005).  At this time, facial features and 
organs have formed, and the embryo has all the body parts (except for sex organs) of a 
human being (Stassen Berger, 2005).  During the fetal period, the embryo (now known 
as the fetus) grows in size, as do the developing organs (Stassen Berger, 2005).   
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Cell organization, cell differentiation, and organogenesis, therefore, typically occur 
between days 15 and 56, introducing a critical window for embryonic development.  
During this time frame, the embryo is sensitive to teratogenic activity that gives rise to 
birth defects (Bennett & Kotelchuck, 1995).  Many nutritional, drug-related, or viral 
exposures may be detrimental to a developing embryo (Bennett & Kotelchuck, 1995). 
Major organ systems of the embryo may be affected by these external influences 
(Bennett & Kotelchuck, 1995). 
Women may not recognize a pregnancy until the first or second missed 
menstrual cycle, a full four to eight weeks or more after conception.  Once a woman 
realizes the possibility of a pregnancy, it takes further time to confirm the pregnancy with 
a home pregnancy kit or a visit to the health care provider.  In that time period, the 
woman may have unknowingly exposed her embryo to nutritional deficiencies, over-the-
counter drugs, tobacco, alcohol, or other toxins.  According to a study conducted in a 
family practice residency clinic, 52% of 136 women with a negative pregnancy test had a 
medical condition known to be a risk factor for adverse pregnancy outcomes (Jack, et 
al., 1995).  Because nearly half of all pregnancies are unintended, yielding about three 
million unintended pregnancies in the U.S. annually (DHHS, 2000), there is a need to 
shift care to an earlier period in a woman’s life cycle with greater potential to prevent 
birth defects and other adverse pregnancy outcomes, also known as preconception care 
(Bennett & Kotelchuck, 2005). 
Intent of the Proposed Study 
 Research indicates that prenatal care alone is insufficient to effect necessary 
change in infant mortality, thus explicating the need for other prevention strategies, such 
as preconception care (DHHS, 2000; Korenbrot, Steinberg, Bender, & Newberry, 2002).  
The idea of preconception health derives from ancient times and it is not a new idea to 
the United States.  Yet, preconception health is only now being considered as 
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supplemental prevention to prenatal care.  Preconception health, however, does not 
occur in a vacuum.  The literature fails to demonstrate the effectiveness of 
preconception health as a whole on reducing adverse pregnancy outcomes, especially in 
the context of environmental and personal influences.   
Pregnancy Risk Assessment Monitoring System.  The proposed study is 
based upon a secondary data analysis using Pregnancy Risk Assessment Monitoring 
System (PRAMS) surveillance data.  The PRAMS project, a product of the CDC, collects 
cross-sectional, population-based data from 37 states, one city (New York City), and an 
American Indian tribal territory regarding maternal experiences before, during, and 
shortly after pregnancy to inform the development of state health programs designed to 
improve maternal and infant health (CDC, 2009).  Some states do not participate in 
PRAMS (Table 3).  Most of these states have similar systems, and others may choose 
not to participate due to internal staffing or resource issues (D’Angelo, D.V., November 
13, 2009).  Several states expressed interest in applying for the next PRAMS funding 
cycle in 2011 (D’Angelo, D.V., November 13, 2009). 
The PRAMS survey aims to target all pregnancies resulting in a live-born infant in 
the United States with the following exclusions:   
1) out-of-state births to residents;  
2) in-state births to nonresidents;  
3) infants whose birth certificate lacks a maternal last name;  
4) those birth certificates processed more than six months after the birth;  
5) all but one infant associated with a multiple gestation;  
6) adopted infants; and  
7) surrogate births.   
The sampling frame consists of all mothers that represent the population eligible for 
study inclusion.  Due to inaccessibility of such a sampling frame list, the operational 
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sampling unit consists of all infants born alive within the specified state to resident 
mothers during a specific time frame, and birth certificates are used as the operational 
sampling frame, which automatically exclude stillbirths, fetal deaths, and induced 
abortions.  From the remaining eligible birth certificates, a stratified systematic 
probability sample of 100 to 250 mothers is drawn every month in each state.  States 
generally oversample for infants with low birth weight, and as the choice for dual 
stratification variables is limited to birth certificate information, many states opt to stratify 
by race or ethnicity.  
 The PRAMS questionnaire was first developed in 1987.  The instrument was then 
edited and revised by the CDC with state participation until April 2004 when the phase 
five questionnaire was developed that is in use today.  The PRAMS survey continuously 
undergoes assessment and evaluation to revise item material and to meet the public 
health needs of each state.  In the phase five PRAMS questionnaire, there are three 
types of questions:  core questions, standard state questions, and state-specific 
questions.  Core questions are used by every participating state.  Standard state 
questions are optional questions of interest for each state that were developed by the 
CDC with significant state and researcher input.  Currently, states may choose from 185 
standard questions for their surveys.  In addition, states may develop their own specific 
questions beyond the standard state questions that do not address topics of general 
interest.  Core questions remain fairly constant throughout the study periods, but the 
selection of standard questions and state-specific questions by individual states may 
vary from year to year. 
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 [Note:  All exogenous variables are allowed to covary.] 
 
Figure 1.  The preconception health framework. 
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 Purpose.  The purpose of this study is to examine the impact of preconception 
health on adverse pregnancy outcomes through the theoretical lens of reciprocal 
determinism.  Thus, this study aims to develop a preconception health conceptual 
framework that accounts for the interactive relationships among behavior, the 
environment, and the person (Figure 1).  All of the variables in the proposed framework 
are derived from questions in the PRAMS survey or from PRAMS-linked birth certificate 
data.  The framework and variations of the framework will be analyzed using structural 
equation modeling.   
Research Questions 
1. What is the relationship between preconception health behaviors and adverse 
pregnancy outcomes among women of reproductive age? 
a. To what extent do preconception health behaviors explain the variance 
associated with adverse pregnancy outcomes? 
b. Which factors are most strongly associated with adverse pregnancy 
outcomes? 
2.   What is the relationship among preconception health behaviors, prenatal factors, 
postnatal factors, personal influences, environmental factors, and adverse pregnancy 
outcomes among women of reproductive age? 
a. To what extent does the entire framework explain the variance associated 
with adverse pregnancy outcomes? 
b. Which factors are most strongly associated with adverse pregnancy 
outcomes? 
Null Hypotheses 
 HO1:  Preconception health behaviors are not predictive of adverse pregnancy  
  outcomes. 
 HO2:  The preconception health framework is not adequate to account for the  
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  variance associated with adverse pregnancy outcomes among women of  
  reproductive age. 
Alternative Hypotheses 
HA1a:  Preconception health behaviors alone explain about 10% of the variance   
           associated with adverse pregnancy outcomes. 
HA1b:  Normal BMI and contraceptive use are the strongest protective factors for  
            adverse pregnancy outcomes. 
HA2a:  The entire framework accounts for about 95% of the variance associated  
            with adverse pregnancy outcomes. 
HA2b:  Insurance status, income, and pregnancy intention are the strongest \  
           predictors of adverse pregnancy outcomes.  Early initiation of prenatal care,   
           normal BMI, and contraceptive use are the strongest protective factors  
           against adverse pregnancy outcomes. 
Delimitations 
 Delimitations of a study describe the population to which study results may be  
generalized (Locke, et al., 2000).  The delimitations for this study are as follows: 
1. Results are only generalizable to the mothers of live-born infants born 
between 2005 and 2008 who are part of the data set.  Therefore, this 
study does not represent all women who became pregnant during this 
time frame, but only those who delivered a live, viable infant. 
2. Results are only generalizable to the mothers of live-born infants born 
in one of the five states in Project 1 or one of the PRAMS-participating 
states in Project 2.  In Project 1, datasets from Maine, New Jersey, 
Ohio, Utah, and Vermont will be analyzed, as these are the only five 
states that address all of the variables included in the proposed 
preconception health framework.  Most of these states rank among the 
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lowest infant mortality in the United States.  Thus, to enhance 
generalizability, Project 2 involves the analysis of datasets from all 
PRAMS-participating states.  The Project 2 analyses eliminate two 
constructs of the preconception health framework due to 
instrumentation limitations:  obtaining oral care and obtaining medical 
care.  Due to the selection of these ten states, the results of this study 
are not generalizable to the entire nation.   
3. Results are only generalizable to mothers of live-born infants who are 
residents of the states included in the study and who gave birth within 
those states. 
4. Results are only generalizable to mothers of live-born infants who did 
not adopt or have a surrogate give birth to the baby. 
Limitations 
 Limitations of a study describe the restrictive conditions or inherent weaknesses of 
the study design (Locke, et al., 2000).  The limitations for this study are as follows: 
1.  This study relies on self-reported data, which may be subject to 
potential sources of error. 
2. This study uses data about preconception behaviors several months 
following delivery.  This extended time frame may introduce recall bias.  
A sub-analysis will be conducted to determine the effect of recall bias. 
3. This study is limited in the testing of validity and psychometric 
properties of the PRAMS questionnaire. 
4. The core section of this study limits the examination of domestic 
violence to physical violence, excluding the examination of emotional or 
sexual violence. 
5. This study is limited to the items and scaling inherent in the PRAMS 
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questionnaire, with noted exclusion of items regarding maternal 
narcotic/amphetamine/marijuana use, genetic testing, maternal sexually 
transmitted infections, birth defects, and postnatal insurance status. 
6. This study is limited to the core items of the PRAMS data, and it is also 
limited to the standard state items used by only certain states. 
7. This study may introduce social desirability bias, because some 
participants may be hesitant to report on behaviors perceived as 
unhealthy or harmful to a pregnancy. 
 
Definition of Terms 
Body Mass Index – weight in kilograms divided by the square of the height in meters 
Folic Acid – one of the water-soluble B vitamins, commonly found in leafy greens, 
legumes, and fortified cereal products, which aids in the synthesis of DNA and RNA; lack 
of adequate folic acid during pregnancy increases the risk of neural tube defects, such 
as spina bifida or anencephaly 
Interconception Health – a woman’s health status between pregnancies, birth spacing, 
and intendedness of subsequent pregnancies 
Periconception Health – a woman’s health status from the time immediately prior to 
conception through the period of fetal organ development 
Preconception Care – a set of interventions that aim to identify and modify biomedical, 
behavioral, and social risks to a woman’s health or pregnancy outcome through 
prevention and management, emphasizing those factors that must be acted on before 
conception or early in pregnancy to have maximal impact 
Preconception Health – a woman’s health status prior to pregnancy 
Opportunistic Care - integrating preconception care into opportunities provided by the 
existing health care system 
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Chapter 2:  Literature Review 
 
Review of Literature 
Preconception health encompasses many components, and yet it lacks focus 
and substance in the empirical literature.  This chapter provides background on 
preconception health components, the association of these components with adverse 
pregnancy outcomes, the theoretical underpinning of the proposed preconception health 
framework, and gaps in the literature. 
Preconception Health Components 
 In the past 30 years in the United States, lead organizations and agencies have 
discussed, researched, and attempted to implement preconception health (Atrash, 2008; 
Atrash, et al., 2008; National Healthy Start Association, 2008; National Healthy Mothers 
Healthy Babies Coalition, 2007; Centers for Disease Control and Prevention [CDC], 
2006; American Academy of Pediatrics [AAP] & American College of Obstetricians and 
Gynecologists, 2002; 1983; U.S. Department of Health and Human Services [DHHS], 
2000; 1991; 1989; Institute of Medicine, 1985; ACOG, 1995; March of Dimes [MOD], 
1993).  Even so, there are still no standardized guidelines for preconception health 
components today.  A search of the literature revealed varying preconception health 
components as promoted by the following organizations:  1) American Academy of 
Family Physicians (AAFP) (professional organization); 2) ACOG (professional specialist 
organization); 3) CDC (federal organization); and 4) MOD (not-for-profit organization) 
(Brundage, 2002; ACOG, 2007; CDC, 2006; CDC, 2006b; MOD, 2009a; MOD, 2009b; 
MOD, 2008).  These organizations promote preconception health to the general public, 
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professionals and researchers, or both, and these resources were combined for the 
purpose of comparison in this study (Table 1).   
 
Table 1.  Preconception health components promoted by different organizations. 
Preconception Health Components AAFP
a ACOGb CDCc MODd 
Folic acid supplementation X X X X 
Weight management     
          Obesity management X X X X 
          Underweight management X X  X 
          Nutrition   X  
                  Fruits/Vegetables  X  X 
                  Whole grains  X  X 
                  Low-fat dairy  X  X 
          Exercise: 
                  30 minutes most days a week 
 X  X 
Smoking cessation X X X X 
Avoidance of alcohol X X X X 
Avoidance of narcotics, amphetamines, and marijuana X X  X 
Oral health care   X X 
Medical health care X X X X 
          Diabetes management X X X X 
          Epilepsy management X X X  
          Hypertension management X X X X 
          Asthma management   X X 
          Thyroid management   X X 
          Maternal PKU screening   X X 
          Prescription medications X X X X 
          Over-the-counter medications  X X X 
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Preconception Health Components  AAFP
a ACOGb CDCc MODd 
          Sexually Transmitted Infection   
          (STI) screening 
X X X X 
          Immunizations X  X X 
          Family history X X  X 
                Genetic testing X X  X 
                Assessing previous pregnancy outcomes  X  X 
Avoidance of toxic substances X X X X 
          Cat litter X  X X 
          Garden soil X    
          Raw meat X   X 
          Occupational exposures X  X  
          Household chemicals X X X X 
          Excess fish consumption    X 
          High doses vitamin A X X   
          High doses vitamin D X    
          Caffeine X   X 
Avoidance of domestic violence X X X  
Avoidance of stress X   X 
Avoidance of hyperthermia (e.g., hot tubs) X   X 
Frequent handwashing X   X 
a = American Academy of Family Physicians; b = American College of Obstetricians and Gynecologists;  
c = Centers for Disease Control and Prevention; d = March of Dimes 
Compiled from the following sources:  (CDC, 2006; 2006b); (MOD, 2009a; 2009b; 2008); (ACOG, 2007); 
(Brundage, 2002). 
 
 
These preconception health components promoted by AAFP, ACOG, CDC, and MOD 
will be defined and addressed in relation to their effects on adverse pregnancy 
outcomes. 
Adverse pregnancy outcomes. A discussion of adverse pregnancy outcomes is 
essential to an understanding of this study.  Adverse pregnancy outcomes are 
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commonly categorized as maternal morbidity (complications, illness, or injury), maternal 
mortality (death), infant morbidity, and infant mortality.  In the PRAMS data collection, 
only live women were included in the survey process (CDC, 2009).  Therefore, maternal 
mortality will be excluded as an adverse pregnancy outcome in this study.  The following 
chapter will discuss fetal, infant, and maternal complications and infant mortality in 
relation to preconception characteristics.   
Prior to this discussion, it is important to understand the distinctions between low 
birth weight, preterm birth, and small for gestational age categorization.  Babies born 
weighing less than five pounds, eight ounces, or 2500 grams, are typically considered to 
be low birth weight (LBW), which affects one in fourteen babies born in the U.S. each 
year (MOD, 2009d).  Babies born weighing less than three pounds, five ounces, or 1,500 
grams, are usually considered to be very low birth weight (VLBW), and babies born less 
than two pounds, three ounces, or 1,000 grams, are considered to be extremely low birth 
weight (ELBW) (Stevens, Lynm, & Glass, 2002).  Immediate and long-term 
complications due to low birth weight may include the following conditions:   
• Respiratory dysfunction may occur, such as respiratory distress syndrome (RDS) 
due to surfactant deficiency (difficulty with breathing) or apnea of prematurity 
(short episodes without breathing). 
• Hypothermia due to a higher body surface area: body weight ratio and decreased 
body fat may result in hypoglycemia, apnea, increased oxygen consumption, or 
metabolic acidosis (excessive acidity of the blood). 
• Fluid and electrolyte imbalances due to insensible water loss or impaired renal 
function may result in dehydration, fluid overload, hypernatremia (elevated blood 
sodium level), hyponatremia (low blood sodium level), hyperkalemia (elevated 
blood potassium level), hypocalcemia (low blood calcium level), 
hypermagnesemia (elevated blood magnesium level); or impaired tolerance of 
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free water, bicarbonate resorption, potassium secretion, or urinary concentrating 
capacity. 
• Polycythemia (too many blood cells) or inadequate liver function may result in 
hyperbilirubinemia (elevated blood bilirubin levels).  Low levels of bilirubin are 
generally not a concern, but large amounts of bilirubin may cause seizures and 
brain damage, also known as a condition called kernicterus. 
• Anemia (too few red blood cells) may result from hemorrhage, phlebotomy, 
decreased red blood cell production, or hemolysis.  Treatment typically involves 
blood transfusions. 
• Impaired nutrition due to gut immaturity with decreased motility; enzyme 
deficiencies; increased risk of necrotizing enterocolitis (inflammation of the colon 
and small intestine); delayed enteric (tube) feeding due to respiratory disease or 
patent ductus arteriosus (heart problem increasing the risk of infection or 
inflammation of the arteries; and increased caloric needs may result in feeding 
difficulties or slow rates of weight gain.   
• Infection increases due to immunologic immaturity and prolonged invasive 
treatments (e.g. – increased use of endotracheal tubes, intravascular catheters, 
and prolonged and recurrent use of antibiotics).  
• Neurologic problems may occur, such as intraventricular hemorrhage (bleeding 
in the brain in the area where cerebrospinal fluid is produced), periventricular 
leukomalacia (death of white matter in the brain in an area heavily involved in 
motor control), and increased long term risk for cerebral palsy, developmental 
delay, or learning disabilities. 
•  Opthalmic complications may include retinopathy of prematurity (an eye disease 
that may result in retinal detachment) or strabismus (crossed eyes).   
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• Hearing deficits (University of California, San Francisco Children’s Hospital, 
2004).  
Low birth weight infants may be classified into two categories:  1) infants 
experiencing normal growth, but born too early, also known as preterm; or 2) infants with 
less growth than expected for a given age, whether born preterm or term, also known as 
small for gestational age (SGA) (McGuire & Fowlie, 2005). 
About two-thirds of all low birth weight infants are preterm (McGuire & Fowlie, 
2005).  Preterm delivery is characterized as labor beginning before 37 weeks of 
gestation, and about one out of every ten babies is born preterm in the United States 
each year (ACOG, 2009b).  Preterm birth is a leading cause of infant morbidity and 
mortality (Martin, et al., 2003), accounting for more than 70% of neonatal deaths and 
almost half of all long-term neurological disabilities (Mathews, Menacker, & MacDorman, 
2004).  Preterm labor complications of the fetus include sensory, respiratory, nervous 
system, and digestive problems (ACOG, 2009b).  Preterm delivery generally results in 
the need for infant resuscitation and ventilator support in neonatal intensive care units 
(NICUs), which dramatically increases health care costs (Lockwood, 2003).  In 2005 in 
the United States, preterm births resulted in medical care, lost household and labor 
market productivity, and early intervention service costs exceeding $26.2 billion (IOM, 
2007).  The causes of preterm birth are still unknown (Williamson, et al., 2008).  
Spontaneous preterm labor or spontaneous premature rupture of the membranes 
contribute to the majority of preterm births (McGuire & Fowlie, 2005).  However, 
increased rates of preterm delivery are also associated with multiple pregnancies, 
assisted reproduction, and maternal and fetal complications (McGuire & Fowlie, 2005).  
In the United States, the percentage of preterm births increased from 11.6% in 2000 to 
12.7% in 2005 in the United States (IOM, 2007).  Of these, 2.03% of births were 
classified as very preterm (less than 32 weeks of gestation), and 9.1% of births were 
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classified as infants born in the late preterm period (34-36 weeks of gestation) 
(MacDorman & Mathews, 2008).  Increases in the percentage of preterm births are 
evident among multiple and singleton births alike (Martin, et al., 2007).  Even though 
very preterm and late preterm births accounted for 2% and 9% of births in 2005 
respectively, very preterm births were associated with over one-half of all infant deaths 
and late preterm births were associated with three times the infant mortality rate for term 
births (those births between 37 and 41 weeks of gestation) (MacDorman & Mathews, 
2008).  Costs for early intervention services increase with decreasing gestational age 
(Clements, et al., 2007).  In 2003, mean cost per infant between 24 and 31 weeks 
gestational age was $5,393 compared with $1,578 for infants between 32 and 36 weeks 
gestation and $725 for infants born at term (Clements, et al., 2007).  In the same year, 
neonatal inpatient costs ranged from $11,000 to $18,000 per preterm birth compared 
with $1,300 to $1,900 per term birth (Schmitt, Sneed, & Phibbs, 2006; Gilbert, Nesbitt, & 
Danielsen, 2003).  
Small for gestational age infants, resulting from constitutional small stature or 
intrauterine growth restriction (IUGR), are commonly defined as preterm or term infants 
with a birth weight below the 10th percentile, or more than two standard deviations below 
the mean, for gestational age with abdominal circumference below the 2.5th percentile 
(Eichenwald, 2009; AAFP, 1998).  Infants below the third percentile for gestational age 
are at greatest risk of morbidity and mortality (Smith, 2005).  About 70% of SGA infants 
are etiologically small and are at less risk of complications than the remaining 30% of 
SGA infants who have pathologic causes resulting from genetic, metabolic, or 
environmental influences (Smith, 2005; Stevens, Lynm, & Glass, 2002; Ott, 1988).  
Maternal factors impairing fetal growth may include genetic size, extreme reproductive 
age, parity, race, socioeconomic status, malnutrition, chronic disease, exposures to 
teratogens, heart disease, renal disease, hypertension, pulmonary disease, 
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hemoglobinopathies (genetic red blood cell defects), collagen-vascular disease, 
diabetes, multiple gestation, uterine anomalies, thrombotic disease (blood clotting 
disorder), high altitude environment, smoking, and cocaine (Smith, 2005; Lee, et al., 
2003).  Fetal factors impairing growth may include constitution (genetic makeup), 
chromosomal abnormality, malformations of the central nervous system, skeletal 
malformations, gastroschisis (abdominal wall defect), and congenital infections, such as 
toxoplasmosis, cytomegalovirus, rubella, or herpesvirus (Smith, 2005).  IUGR fetuses 
may be classified as symmetric or asymmetric based upon morphologic characteristics 
(Hadlock, 2000).  Symmetric IUGR cases are proportionately small, and they generally 
result from chromosomal abnormalities or infection (Hadlock, 2000).  Asymetrical IUGR 
cases are thought to result from placental insufficiency, and therefore malnutrition, in the 
late second or early third trimester (Hadlock, 2000).  Placental risk factors for SGA may 
include vascular malformations, chorioangioma (vascular tumor of the placenta), 
infarction, abruption, previa, and abnormal trophoblast invasion (Smith, 2005).  With this 
type of IUGR, the head and long bones remain relatively normal in size, whereas the 
body is disproportionately smaller (Hadlock, 2000).  Neonatal complications of IUGR 
may include perinatal asphyxia (lack of oxygen), meconium aspiration (respiration of the 
first fetal feces), hypoglycemia (low blood sugar), thrombocytopenia (platelet disorder), 
altered immunity, abnormal temperature regulation, pulmonary hemorrhage, persistent 
pulmonary hypertension of the newborn (PPHN) (disorder of the fetal circulatory 
system), hypocalcemia (low serum calcium levels), and mortality (Kendig, 2007; Smith, 
2005).  Long-term effects of fetal growth restriction may include delayed growth in 
childhood, short stature, propensity for obesity, and an increased risk of hypertension 
and type-2 diabetes in adulthood (Eichenwald, 2009).  A triangulation of low birth weight, 
preterm delivery, and small for gestational age variables will be used in this study.  Other 
adverse pregnancy outcomes used in this study include length of maternal hospital stay, 
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length of infant hospital stay, use of the Neonatal Intensive Care Unit (NICU), and infant 
mortality. 
Folic acid supplementation.  Folate (naturally occurring folic acid) is a water-
soluble B vitamin that can be ingested in the diet from dark green leafy vegetables, 
beans and legumes, citrus fruits, whole grains, poultry, pork, shellfish, and liver (National 
Institutes of Health [NIH] & U.S. National Library of Medicine [NLM], 2009).  Folic acid 
works with vitamin B12 and vitamin C in the use and synthesis of protein, the formation of 
red blood cells, and the production of deoxyribonucleic acid, or DNA, which carries 
genetic information (NIH & NLM, 2009).   Because this vitamin is water-soluble, it is not 
stored in the fat deposits of the body and unused folate exits the body through the urine 
on a daily basis (NIH & NLM, 2009).  In 1998, the Food and Drug Administration (FDA) 
began requiring folic acid fortification of enriched cereal-grain products at a level of 140 
micrograms/100 grams to ensure adequate folic acid consumption (FDA, 1996).  This 
recommendation was intended to provide the average person in the United States with 
an additional 100 micrograms of folic acid per day (Yetley & Radar, 2004; Lewis, Crane, 
Wilson, & Yetley, 1999; FDA, 1993).  According to the National Health and Nutrition 
Examination Survey (NHANES), the adjusted geometric mean consumption of folic acid 
from fortified foods was 128 micrograms per day (95% CI:  123, 134 micrograms per 
day) among 1,685 nonpregnant women between 15 and 49 years of age (Quan-He, et 
al., 2007).  Other studies demonstrate that fortified foods may provide as much as 200 
micrograms of additional folic acid per day (Dietrich, Brown, & Block, 2005; Quinlivan & 
Gregory, 2003; Choumenkovitch, et al., 2002; Rader, Weaver, & Angyal, 2000).  
Regardless, the 1998 folic acid fortification of food resulted in increased average serum 
folate levels (Ganji & Kafai, 2006; Pfeiffer, et al., 2005; CDC, 2000) and a decreased 
prevalence of neural tube defects by 26%, which varied by race and ethnicity (Williams, 
et al., 2005; CDC, 2004c).  Folic acid levels typically range between 3 and 17 
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nanograms/milliliter (National Institutes of Health and U.S. National Library of Medicine, 
2009).  Among nonpregnant women between 15 and 44 years of age, median serum 
folate levels increased from 4.8 nanograms/milliliter during the 1988-1994 NHANES III 
study period to 13.0 nanograms/milliliter during the 1999-2000 NHANES study period 
(CDC, 2007e).  However, folate serum levels decreased to 11.4 and 10.6 
nanograms/milliliter in the 2001-2002 and 2003-2004 study periods, respectively (CDC, 
2007e).  The largest decrease was noted among non-Hispanic whites (16%), but in all 
study periods, the lowest median folate serum levels were detected among non-Hispanic 
blacks (CDC, 2007e).  Between 2005 and 2006, the prevalence of low blood folate levels 
(less than 3 nanograms/milliliter) was 0.5% among U.S. women of childbearing age 
(McDowell, et al., 2008).  For comparison, between 2003 and 2005, the prevalence of 
spina bifida (the most common neural tube defect) was 2.00 per 10,000 live births 
among infants with non-Hispanic white mothers, 1.96 per 10,000 live births among 
infants with Hispanic mothers, and 1.74 per 10,000 live births among infants with non-
Hispanic black mothers (Boulet, et al., 2009).  To ensure adequate folic acid 
consumption, folic acid supplements (man-made folate) are often recommended to 
supplement dietary intake (CDC, 2008).   
Numerous studies demonstrate the efficacy of folic acid in the reduction of neural 
tube defects (Czeizel & Dudas, 1992; Werler, Shapiro, & Mitchell, 1993; Shaw, et al., 
1995; Czeizel, Toth, & Rockenbauer, 1996; Czeizel, Dobo, & Vargha, 2004; Goh, 
Bollano, Einarson, & Koren, 2006; Thompson, et al., 2003; Vollset, et al., 2005).   The 
majority of these studies recommend the use of folic acid taken three months prior to 
conception for optimal benefit (Czeizel & Dudas, 1992; Werler, Shapiro, & Mitchell, 
1993; Shaw, et al., 1995; Czeizel, Toth, & Rockenbauer, 1996; Thompson, et al., 2003).  
The ACOG, the Institute of Medicine (IOM), the Department of Health and Human 
Services (DHHS), and the CDC have integrated the use of folic acid into their guidelines 
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for several decades (Lumley, Watson, Watson, & Bower, 2001).  Neural tube defects 
may be classified as major birth defects of the brain or spinal cord, which occur during 
the formation of the neural tube during the first few weeks of pregnancy (CDC, 2008).  
Neural tube defects account for 3,000 birth defects each year in the United States, and 
the two most common defects are spina bifida and anencephaly (CDC, 2008).  Spina 
bifida occurs when the fetal spinal column does not close completely during 
development, often causing nerve damage possibly resulting in partial paralysis (NIH & 
NLM, 2009).  Anencephaly occurs when a portion of the brain does not develop, 
generally leading to stillbirth or death shortly after birth (NIH & NLM, 2009).  These 
defects take an emotional and monetary toll on families, with lifetime costs ranging from 
$636,000 to $1 million (CDC, 2008).  Folic acid also reduces the risk of other congenital 
anomalies, such as defects of the urinary tract, cardiovascular defects, and orofacial 
clefts (Czeizel, Dobo, & Vargha, 2004).  The benefits of folic acid in the reduction of 
neural tube defects and other birth defects have been well documented. 
Weight management.  Maternal weight gain is a vital part of prenatal health, and 
the ACOG and the IOM provide guidelines to determine appropriate amounts of 
maternal weight gain based upon maternal prepregnancy weight, or that less total weight 
gain during pregnancy is recommended with higher prepregnancy weight and vice versa 
(Table 2) (ACOG, 2009; IOM, 2009).  Preconception health, on the other hand, focuses 
only on prepregnancy weight.   
 It is especially important to achieve and maintain a healthy weight prior to 
pregnancy, because dieting can be harmful during pregnancy (DHHS, 2009b).  The 
breakdown of fat during dieting yields byproducts known as ketones, which are toxic to a 
fetus and may impair mental and physical development (DHHS, 2009b).  The ACOG, 
MOD, AAFP, the National Institutes of Health (NIH), and the World Health Organization 
(WHO), state that individuals should be encouraged to maintain or work towards a 
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healthy body mass index (AAFP, 2009; ACOG, 2009; Massiah & Kumar, 2008; MOD, 
2005).  Body mass index (BMI) is a measure of weight relative to height, and it is a 
reliable indicator of total body fat (National Heart Lung and Blood Institute [NHLBI], 
2008).  BMI is calculated as weight in kilograms divided by height in meters squared.  
The resulting BMI number is then ranked on a scale:  underweight is below 18.5 BMI, 
normal weight is 18.5 to 24.9 BMI, overweight is 25-29.9 BMI, and obese is 30 BMI and 
above (Table 2).   
 
Table 2.  Institute of Medicine recommendations for maternal weight gain. 
Prepregnancy BMI BMI (kg/m2) Total Weight Gain 
Range (lbs) 
(singleton pregnancy) 
Rates of Weight 
Gain 2nd and 3rd 
Trimester (mean 
range in lbs/week) 
Underweight <18.5 28 – 40 1 
(1–1.3) 
Normal weight 18.5 – 24.9 25 – 35 1 
(0.8–1) 
Overweight 25.0 – 29.9 15 – 25 0.6 
(0.5-0.7) 
Obese (includes 
all classes) 
≥30.0 11 – 20  0.5 
(0.4-0.6) 
(Institute of Medicine, 2009) 
 
 
The BMI has certain limitations.  It is not a measure of body composition (AAFP, 
2000).  There is a strong correlation between BMI score and body fatness, but the 
correlation varies by sex and age (National Heart, Lung, and Blood Institute [NHLBI], 
2008).  For example, at the same BMI, women tend to have more body fat than men; at 
the same BMI, older adults tend to have more body fat than younger adults; and, 
athletes tend to have a higher BMI due to increased muscularity rather than increased 
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body fatness (NHLBI, 2008).  However, this study is comparing only the BMIs of women 
between 18 and 44 years of age, and according to the IOM, the BMI is the best available 
measure of prepregnancy weight (IOM, 2009). 
Obesity prior to pregnancy is a serious health concern.  Overweight individuals 
with a BMI 25.0 to 29.9 have a mildly increased risk of comorbidity, and obese 
individuals with a BMI of 30.0 to 34.9 (Class I), a BMI of 35.0 to 39.9 (Class II), and a 
BMI of 40 or more (Class III) have moderate, severe, and very severe risks of 
comorbidity respectively (AAFP, 2000).  In 2003, 19.6% of women in the United States 
between 18 and 44 years of age were obese (MOD, 2005).  In 2009, the IOM reported 
that eight percent of U.S. women of reproductive age were severely obese (AAFP, 
2009).   
Maternal health consequences of prepregnancy maternal obesity are numerous.  
Prior to conception, there is a higher prevalence of polycystic ovary syndrome among 
obese women, an endocrine condition characterized by amenorrhea (absence of 
menstruation) and infertility (Ehrmann, 2005).  Maternal obesity is also associated with a 
25-37% higher risk of miscarriage compared to non-obese women (Hamilton-Fairley, et 
al., 1992).  Once pregnant, certain maternal complications are more prevalent among 
obese women (Guelinckx, Devlieger, Beckers, & Vansant, 2008; Weiss, et al., 2004).  
Maternal obesity increases the risk of gestational diabetes, which is associated with an 
increased risk of fetal macrosomia (when the fetus is large [over the 90th percentile] for 
gestational age) and an increased risk of the development of diabetes later in life 
(Rudra, et al., 2007; Rode, Nilas, Wojdemann, & Tabor, 2005; Ehrenberg, Mercer, & 
Catalano, 2004; Sebire, et al., 2001).  Typically, 30% of women are at risk of developing 
diabetes within 15 years of delivery, but this risk increases to 70% among obese women 
(O’Sullivan, 1984).  Maternal obesity also increases the risk for pregnancy-induced 
hypertension and preeclampsia, conditions characterized by high blood pressure 
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(Doherty, 2006; Leeners, 2006; Rode, Nilas, Wojdemann, & Tabor, 2005).  Frederick 
and colleagues determined that for every unit increase in prepregnancy BMI, there is a 
resulting eight percent increase in the risk of preeclampsia (Frederick, et al., 2006).  
Another study determined that there were significant decreases in preeclampsia risk 
associated with BMI decreases (Villamor & Cnattingius, 2006).  Maternal obesity is also 
associated with deep venous thrombosis, in which blood clots can block blood flow, and 
pulmonary embolism, in which a clot travels to the blood supply of the lungs, possibly 
resulting in death (Sebire, et al., 2001).  Obese women are at higher risk of venous 
thromboembolism (adjusted OR 5.3 [95% CI 2.1, 13.5]) compared with normal weight 
women before and after birth (Larsen, Sorensen, Gislum, & Johnsen, 2007).  Research 
presents conflicting findings in relation to the association between maternal obesity and 
preterm delivery.  Varying studies find a decreased risk (Sebire, 2001; Cnattingius, 
Bergstrom, Lipworth, Kramer, 1998), an increased risk (Baeten, Bukusi, & Lambe, 
2001), or even no difference in preterm delivery when obese women are compared with 
women with a normal BMI (Jensen, et al., 2003; Galtier-Dereure, Boegner, & Bringer, 
2000).  With increasing prepregnancy BMI, there is an increased risk of caesarean 
section, either elective or unplanned (Barau, et al., 2006; Graves, DeJoy, Heath, & 
Pekow, 2006).  When obese women undergo delivery via caesarean section, there is 
increased risk for anesthetic complications (Saravanakumar, Rao, & Cooper, 2006), 
excessive bleeding, and post-partum infections (Sebire, 2001), which results in 
increased hospitalization, increased cost, and increased risk for deep vein thrombosis 
due to prolonged immobilization (Callaway, Prins, Chang, & McIntyre, 2006; Sebire, 
2001; Galtier-Dereure, Boegner, & Bringer, 2000).  Following delivery, certain maternal 
complications are more prevalent among overweight and obese women, such as 
hemorrhage, anemia, genital and urinary tract infections, endometritis, stress 
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incontinence, and depression (Lacoursiere, Baksh, Bloebaum, & Varner, 2006; Bodnar, 
Siega-Riz, & Cogswell, 2004; Sebire, 2001; Galtier-Dereure, Boegner, & Bringer, 2000).  
Fetal health consequences of prepregnancy maternal obesity are also multitudinous.  
Maternal obesity is more than twice as likely to result in a stillbirth or perinatal death 
when compared to women of normal weight (Kristensen, et al., 2005).  Macrosomia, 
defined previously with maternal complications, may lead to birth traumas, such as 
shoulder dystocia and possible brachial plexus injury (Dyachenko, 2006).  Maternal 
obesity is also associated with fetal birth defects, such as neural tube defects, abdominal 
wall defects, heart defects, and multiple congenital anomaly syndromes (Watkins, et al., 
2003).  Maternal obesity and gestational diabetes act synergistically to increase the risk 
of congenital defects (Moore, et al., 2000).  Due to these fetal complications, the 
percentage of infants admitted to intensive care is 3.5 times greater among infants born 
to obese women compared to infants born to women of normal weight (Galtier-Dereure, 
Boegner, & Bringer, 2000).   
Research often overlooks the other prepregnancy weight extreme, the 
underweight category.  This lack of emphasis may be due to its prevalence.  Whereas 
eight percent of women of reproductive age in the United States are severely obese, 
only three percent are underweight (less than 18.5 BMI) (AAFP, 2009).  Underweight 
class, in the empirical research, varies from the Institute of Medicine’s classification of 
less than 18.5 BMI (IOM, 2009) to a BMI of 19.8 kg/ms or less among other studies 
(Ehrenberg, Dierker, Milluzzi, & Mercer, 2003; Schieve, et al., 2000).  According to 
Ehrenberg and colleagues, among 15,196 subjects, the 13.2% of participants with BMI 
less than or equal to 19.8 kg/ms were at increased risk for maternal and fetal 
complications (2003).  In this study, underweight status was associated with preterm 
labor (RR 1.22; 95% CI 1.02, 1.46), intrauterine growth restriction (RR 1.67; 95% CI 1.2, 
2.39), and low birth weight (RR1.13; 95% CI 1.0, 1.27), and it was protective against 
   
32 
 
caesarean delivery (RR 0.8; 95% CI 0.71, 0.91) (Ehrenberg, Dierker, Milluzzi, & Mercer, 
2003).  These perinatal conditions may have serious consequences for the fetus as 
discussed previously.  In overweight and obese women, weight loss prior to pregnancy 
reduces perinatal risks, and vice versa for underweight women (Kramer, 2000; Nawaz & 
Katz, 2001).  
 Smoking cessation.  Among smokers, tobacco use is the leading cause of 
illness and death in the United States with 440,000 deaths per year (CDC, 2005b).  Even 
though smoking is the most preventable cause of all early death in the United States, 
women continue to use tobacco (American Cancer Society [ACS], 2007).  About 18% of 
women aged 18 years and older smoke cigarettes (ACS, 2007).  In the U.S. annually, 
almost 500,000 infants are born to the 11.4% of women who report smoking during 
pregnancy (CDC, 2004; Martin, et al., 2003).  
Numerous health risks related to pregnancy are associated with tobacco use.  
Tobacco use is associated with male impotence, conception delay, and infertility prior to 
conception (Rosenthal, Melvin, & Barker, 2006).  Complications during pregnancy 
associated with tobacco use include increased risk for spontaneous abortion, ectopic 
pregnancy, low birth weight, sudden infant death syndrome (SIDS), and premature birth 
(DHHS, 2001).  Maternal complications may also include increased risk of premature 
rupture of the membranes, placental abruption, and placenta previa (CDC, 2007).  Even 
environmental tobacco smoke, such as secondhand smoke, may increase fetal health 
risks, such as increased risk for low birth weight and intrauterine growth restriction 
compared to fetuses without environmental tobacco smoke exposure (DHHS, 2001).   
Smoking cessation is a difficult journey for most smokers.  About 70% of smokers are 
reported to want to quit smoking, and about 40% of those quit for at least one day every 
year (CDC, 2003).  Pregnancy increases the likelihood that women will stop smoking 
compared to other times (DHHS, 2001).  However, only 20% of women successfully quit 
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smoking during pregnancy (Hopkins, et al., 2001), and most women relapse within one 
year of giving birth (Carmichael & Abluwalia, 2000; Mullen, Richardson, Quinn, & 
Ershoff, 1997; Pollak & Mullen, 1997; McBride, Pirie, & Curry, 1992; O’Campo, Faden, 
Brown, & Gielen, 1992; Fingerhut, Kleinman, & Kendrick, 1990; McBride & Pirie, 1990).  
Further research is required to assess the determinants of perinatal smoking (Kahn, 
Certain, & Whitaker, 2002). 
 Avoidance of alcohol.  Human and animal studies have not demonstrated a 
safe threshold for alcohol consumption during pregnancy (Sood, et al., 2001; Shaw & 
Lammer, 1997; Lundsberg, Bracken, & Saftlas, 1997; Jacobson & Jacobson, 1994).  
Yet, in 2002, 54.9% of women of reproductive age and 10.1% of pregnant women admit 
to drinking alcohol (Tsai & Floyd, 2004).  Of these women, 12.5% of women of 
reproductive age and 1.9% of binge drinkers report binge drinking, which seems to be 
more detrimental to a developing fetus than low-level daily drinking (Tsai & Floyd, 2004; 
Maier & West, 2001; Stratton, Howe, & Battaglia, 1996).  The placental membrane 
separating the fetal and maternal circulatory systems is easily penetrated by alcohol, 
and thus, the blood alcohol of the fetus is typically consistent with maternal blood alcohol 
level (Little, & Vanbeveren, 1996; Stratton, Howe, & Battaglia, 1996).   
In the United States, about 1% to 3% of all live births are affected by fetal alcohol 
exposure (Mengel, Searight, & Cook, 2006).  Fetal exposure to alcohol may result in a 
range of complications and birth defects, also known as fetal alcohol spectrum disorders, 
(FASD) which negatively impact child development, cognition, physical appearance, and 
behavior throughout life (CDC, 2004; Sokol, Delaney-Black, & Nordstrom, 2003; 
Stratton, Howe, & Battaglia, 1996; Jones & Smith, 1973).   
The most serious disorder in this spectrum, fetal alcohol syndrome (FAS), is the leading 
preventable cause of mental retardation in the United States (Stratton, Howe, & 
Battaglia, 1996; Streissguth, 1994).  FAS typically occurs among children of women who 
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use alcohol heavily on a chronic basis (Abel, 1990), but further research demonstrates 
the adverse FAS outcomes among children of women who use low-level alcohol, with as 
few as four drinks per week (Moore, Khoury, & Liu, 1997; Windham, et al., 1997).  FAS 
is characterized by physical and mental disabilities, abnormal facial features, growth 
deficiencies, and central nervous system problems (CDC, 2006d).   
Another disorder, alcohol-related neurobehavioral disorder (ARND), impacts 
neurobehavioral effects and the central nervous system without displaying FAS 
characteristics (Mattson, et al., 1997).  With ARND, abnormalities include small head 
circumference (10% or less), learning disabilities, poor impulse control, seizures, deficits 
in language and math skills, and problems with memory, attention, and judgment 
(Mengel, Searight, & Cook, 2006; Mattson, et al., 1997).  Another set of outcomes may 
be classified as alcohol-related birth defects (ARBD), which is characterized by FAS 
features, low set ears, micrognathia (undersized jaw), epicanthal folds (skin folds of the 
upper eyelid), low nasal bridge, short upturned nose, strabismus (lack of eye 
coordination), clinodactyly (curvature of the fifth finger), “hockey stick” palmar crease 
(single crease in hand as opposed to two), radioulnar synostosis (fusion of the two 
forearm bones), renal anomalies (problems with kidneys), and cardiac defects (Mengel, 
Searight, & Cook, 2006).  Together, ARND and ARBD are four times more common than 
FAS (Hoyme, et al., 2005; May, et al., 2004; May & Gossage, 2001; Stratton, Howe, & 
Battaglia, 1996).  
Even though many organ systems may be affected by alcohol exposure in the 
fetus, the brain is especially sensitive (Riley, McGee, & Sowell, 2004; Mattson & Riley, 
1996; Clarren, 1986).  Complications of the fetal brain related to alcohol exposure 
include microcephaly (abnormal smallness of the head); migration anomalies 
(abnormality when neuronal cells migrate prior to differentiation); agenesis (failure to 
form) or thinning of the corpus callosum and anterior commissures; cerebellar, 
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brainstem, and basal ganglia anomalies; and neuroglial heterotopias (rare congenital cell 
masses of the brain) (Riley, McGee, & Sowell, 2004; Mattson & Riley, 1996; Clarren, 
1986).  Even low levels of alcohol may compromise normal fetal brain structure and 
function, resulting in impaired neurogenesis, cell proliferation, and cell migration 
(Mattson & Riley, 1996; Clarren, 1986).  These complications impact cellular 
connectivity, synaptosis (degeneration of cell synapses, or areas of communication), 
maturation, and apoptosis (programmed cell death), which are vital to healthy cellular life 
(Mattson & Riley, 1996; Clarren, 1986).  Conditions and complications resulting from 
fetal alcohol exposure are completely preventable if a woman abstains from alcohol 
consumption from the time of offspring conception through birth (Whitlock, Polen, Green, 
Orleans, & Klein, 2004). 
 Avoidance of narcotics, amphetamines, and marijuana.  Among pregnant 
women, nearly four percent use narcotics, amphetamines, or marijuana at some time 
during gestation (Substance Abuse and Mental Health Administration, 2006).  Drug 
effects on the fetus vary based upon how much drug was taken, how often, and the 
period during pregnancy in which it was used (ACOG, 2009c).  Different drugs taken 
together may act synergistically, and some drugs may be processed with impure 
substances that are harmful to a fetus (MOD, 2006).  The following drugs and their 
perinatal effects will be briefly discussed in this review:  cocaine, heroin, amphetamines, 
and marijuana.  Other drugs also may cause harmful perinatal effects, but the empirical 
literature is lacking in these areas.  Also, it is difficult to measure the impact of these 
types of drugs on the fetus, because detrimental effects from alcohol use, smoking, and 
poor nutrition often accompany drug use (MOD, 2006). 
 Cocaine is a vasoconstrictive substance, and when crossing the placental 
barrier, it restricts the necessary blood flow needed for healthy fetal development 
(Behnke, Eyler, Garvan, & Wobie, 2001).  Cocaine use increases the risk of miscarriage 
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in early pregnancy, and later fetal complications include increased risk for preterm labor, 
low birth weight, small head circumference, smaller than normal brain size, birth defects, 
and stroke (Bauer, et al., 2005; Vidaeff & Mastrobattista, 2003; Bateman & Chiriboga, 
2000).  Maternal complications associated with cocaine use include placental 
complications, such as placental abruption, in which the placental lining separates from 
the uterus (MOD, 2006).  Those infants exposed to cocaine in utero may experience 
mild behavioral disturbances, such as sensitivity to touch, irritability, or withdrawal from 
surrounding stimuli (Bauer, et al., 2005).   
 Perinatal complications associated with heroin use include premature rupture of 
the membranes (amniotic sac breaks too early leading to possible infection), preterm 
delivery, stillbirth, low birth weight, and birth defects (Briggs, Freeman & Yaffe, 2005).  
Fetal exposure to heroin often lead to withdrawal symptoms in infancy, such as fever, 
sneezing, trembling, irritability, diarrhea, vomiting, continual crying, and sometimes 
seizures (Briggs, Freeman, & Yaffe, 2005).   
 The fetal effects resulting from amphetamine use, including ecstasy and 
methamphetamines, are not well studied.  However, amphetamines have been 
associated with congenital heart defects, skeletal defects like clubfoot, other birth 
defects, low birth weight, small head circumference, preterm delivery, and placental 
complications (Smith, et al., 2006). 
 Marijuana, also known as cannabis, derives from the hemp plant, and it may 
contain up to 400 different chemicals (Organization of Teratology Information Specialists 
[OTIS], 2007).  Marijuana is the most prevalent illicit drug consumed among women of 
reproductive age, and estimates for marijuana use are almost three percent among 
pregnant women (Ebrahim & Gfroerer, 2003).  Marijuana use prior to pregnancy can 
hinder fertility in men and women and lower male sperm counts (MOD, 2006).  Among 
pregnant women using marijuana on a regular basis (six or more time per week), there is 
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a slightly increased risk of preterm delivery (OTIS, 2007).  A study involving 1,690 
mother/child pairs determined that there was statistically significant association between 
marijuana use during pregnancy and low birth weight, and users of marijuana were five 
times more likely than non-users to deliver infants with features similar to fetal alcohol 
syndrome (Lynn, et al., 1983; Hingson, et al., 1982).  Since the beginning of the 21st 
century, marijuana’s active ingredient, ∆-9-tetrahydrocannabinol (THC), has strongly 
increased in concentration, which may induce stronger fetal effects in the future (Pijlman, 
et al., 2005). 
Oral health care.  Oral health is an important and often overlooked part of 
preconception and prenatal care.  In the United States, however, only 22% to 34% of 
women preventively visited the dentist during pregnancy, and when a dental problem 
occurred, only half of all pregnant women sought dental care (Gaffield, Gilbert, Malvitz, & 
Romaguera, 2001).  There are currently no national guidelines for dealing with oral 
conditions during pregnancy (Silk, Douglass, Douglass, & Silk, 2008), and therefore, 
there is fear among the dental community of medicolegal action based on negligent or 
substandard treatment of oral conditions during pregnancy (Stefanac, 2001).  The 
American Dental Association (ADA) recommends, however, that pregnant women avoid 
elective dental care, if possible, during the first trimester and during the last one-half of 
the third trimester (ADA, 1995).  This narrow window of potential dental care is possibly 
recommended in part because of increased teratogenic risk, risk of spontaneous 
abortion in the first trimester, and an attempt to avoid causal association with dental 
procedures in either case (Pertl, et al., 2000; Sabatka, Bhattacharyya, Cohen, & Hunter, 
2000; Lee, McWilliams, & Janchar, 1999; Wasylko, et al., 1998).  The third trimester end 
of the narrow window for dental care is recommended because of the association 
between increased fetal sensitivity to external stimuli and increased risk of premature 
delivery (Lee, McWilliams, & Janchar, 1999; ADA, 1995). 
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 Maternal dental complications increase during the pregnancy period.  With 
varying levels of morning sickness, gastric acid may lead to tooth enamel erosion (ADA 
Council on Access, Prevention, and Interprofessional Relations, 2006).  This increased 
acidity, in combination with sugary dietary cravings, and lack of regular dental care 
increases the risk of tooth decay in pregnant women (Hey-Hadavi, 2002).  Gingival 
changes during pregnancy have been well documented (Mealey, 1996).  Increased 
progesterone due to pregnancy may induce temporary oral tumors (pyogenic 
granulomas) or loose teeth among pregnant women (Silk, Douglas, Douglas, & Silk, 
2008).  Pregnancy hormone fluctuations combined with changes to the oral flora and 
decreased immune response lead to the most common oral disease of pregnancy, 
gingivitis, which occurs among 60 to 75% of pregnant women (Silk, Douglas, Douglas, & 
Silk, 2008; ADA Council on Access, Prevention, and Interprofessional Relations, 2006).  
In preconception terms, about 30% of women of reproductive age experience 
periodontitis, a destructive bacterial inflammation of the periodontum akin to gingivitis 
(Kumar & Samelson, 2006).   
 The association between periodontitis and poor pregnancy outcomes is well 
documented (Silk, Douglas, Douglas, & Silk, 2008).  The causal mechanism is unclear 
for the periodontal relationship, but studies demonstrate that certain periodontopathic 
bacteria in pregnant women can cross the placental barrier (León, et al., 2007).  Such 
mirobacterial invasion of P. gingivalis, T. forsythensis, and E. corrodens, resulting from 
periodontal disease, has been associated with preeclampsia among pregnant women 
(Contreras, et al., 2006).  In a systematic review of empirical studies across 12 countries 
and involving approximately 15,000 women, 24 studies were identified as demonstrating 
a positive relationship between periodontitis and preterm birth, low birth weight, or both 
(Clothier, Stringer, & Jeffcoat, 2007).  Fourteen studies demonstrated no relationship 
between periodontitis and poor pregnancy outcomes (Clothier, Stringer, & Jeffcoat, 
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2007).  Another recent large randomized controlled trial conducted in the United States 
reported no association between periodontitis and preterm birth and low birth weight 
(Michalowicz, et al., 2006).  Treatment of periodontal disease in pregnant women during 
pregnancy improved oral disease outcomes, but it did not significantly change the 
prevalence of preterm birth, low birth weight, or fetal growth restriction (Michalowicz, et 
al., 2006).  Proper oral hygiene and routine periodontal care prior to pregnancy is 
recommended (American Academy of Periodontology, 2004). 
 Medical health care.  About 84% of women in the United States ages 18 to 44 
visited a medical provider in 2004, and 55% obtained preventive health services 
(Salganicoff, Ranji, & Wyn, 2005).  Thus, physicians, obstetrician/gynecologists and 
general practitioners alike, are poised to deliver effective preconception care and health 
education to the majority of women in the U.S.  According to one study of obstetrician-
gynecologists’ opinions, 87% of physicians thought preconception care was important, 
and 94% recommended such care to patients planning a pregnancy (Morgan, Hawks, 
Zinberg, & Schulkin, 2006).  However, nearly half (49%) of physicians said very few 
patients came in for preconception care (Morgan, Hawks, Zinberg, & Schulkin, 2006).  
Even though Frey and Files demonstrated that 95% of women surveyed prefer to obtain 
preconception care information from their primary care providers, only 39% recalled their 
physician ever discussing the topic (Frey & Files, 2006).  Physician participation is 
essential for the screening of some key preconception health components:  medication 
consultation (prescription and over-the-counter), screening and consultation for medical 
conditions [diabetes, epilepsy, hypertension, asthma, thyroid disorders, maternal 
phenylketonuria (PKU)], sexually transmitted infection (STI) testing, family history 
analysis, and immunizations.  Addressing preconception health components at a 
physician visit is important.  In addition, subcomponents of a preconception physician 
visit will be further discussed here, due to the individual preconception behaviors 
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required for disease management that a woman must perform, such as diabetes or 
hypertension management.  These subcomponents are initially recognized through 
screenings at the physician visit, but they are then maintained by ongoing individual 
behaviors. 
 Certain medical conditions may have adverse pregnancy outcomes, such as 
diabetes, epilepsy, hypertension, asthma, thyroid disorders, and maternal PKU.  These 
conditions, if not monitored appropriately during pregnancy, may lead to fetal and 
maternal complications.   
Diabetes mellitus, a metabolic condition characterized by abnormally high blood 
glucose levels, is defined as poorly controlled when glycosylated hemoglobin levels are 
higher than 8.4 percent (Brundage, 2002).  Uncontrolled diabetes mellitus may 
substantially increase the risk of birth defects (seven times that of women with controlled 
diabetes), miscarriage (32% increased risk), stillbirth, pre-eclampsia, preterm delivery, 
and large for gestation age fetuses compared to women with good control of their 
diabetes (Organization of Teratology Information Specialists [OTIS], 2008a; Brundage, 
2002).  Proper management of diabetes, whether type 1 or 2, through the monitoring of 
blood glucose levels substantially reduces these risks (Kitzmiller, Buchanan, Kjos, 
Combs, & Ratner, 1996; American Diabetes Association, 2004).   
Epilepsy, a chronic neurological disorder characterized by recurrent seizures, is 
associated with four to eight percent of birth defects (ACOG, 1997).  Women with 
epilepsy are also at increased risk for vaginal bleeding, placental abruption (premature 
separation of the placenta), preeclampsia, and premature birth.  Medications to treat 
epilepsy are associated with birth defects, but without such medication, seizures may 
pose other health risks for the fetus, like oxygen deprivation (Mayo Clinic, 2007).  As 
multiple anticonvulsants are to be avoided and no single drug of choice, the American 
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Academy of Family Physicians recommends the use of a single agent administered for 
the seizure type at the lowest protective level (Brundage, 2002).   
Chronic hypertension, defined as high blood pressure diagnosed prior to 
pregnancy or before 20 weeks’ gestation, occurs in one to five percent of all pregnancies 
(Agency for Healthcare Research and Quality [AHRQ], 2000).  This medical condition is 
most often associated with an uncomplicated pregnancy, but monitoring is necessary for 
the risks of preeclampsia, renal insufficiency, and intrauterine growth restriction 
(Brundage, 2002).  Certain hypertension medications, like angiotensin-converting 
enzyme inhibitors, angiotensin II receptor antagonists, and thiazide diuretics, are 
associated with an increased risk of birth defects (Brundage, 2002).  However, other 
drugs, like methyldopa and calcium channel blockers, are commonly used during 
pregnancy without such risk (Brundage, 2002).   
Asthma, a chronic disorder of the airways characterized by recurrent airflow 
obstruction, bronchial hyperresponsiveness, and inflammation, occurs in about eight 
percent of all pregnancies (Kwon, Triche, Belanger, & Bracken, 2006).  Asthma is 
associated with increased risks of preeclampsia, preterm birth, low birth weight, 
intrauterine growth restriction, birth defects, and perinatal death compared with women 
without a history of asthma (Schatz & Dombrowski, 2009).  With no clear understanding 
as to the underlying causal mechanisms, pregnancy may improve, worsen, or not affect 
maternal asthma (Schatz & Dombrowski, 2009).  The use of inhaled [beta]-agonists or 
inhaled corticosteroids has not been associated with perinatal risks (Martel, et al., 2007; 
Bakhireva, et al., 2005; Schatz, 2004).   
The thyroid is a part of the endocrine system, and thyroid disorders are 
characterized by reduced hormone production, hypothyroidism, or increased hormone 
production, hyperthyroidism (March of Dimes, 2009e).  Untreated hyperthyroidism has 
been associated with increase risk for fetal tachycardia (fast heart rate), small for 
   
42 
 
gestational age infants, premature birth, stillbirth, and birth defects (American Thyroid 
Association [ATA], 2005).  Graves’ disease causes 80-85% of maternal hyperthyroidism 
during pregnancy (ATA, 2005).  Treating maternal hyperthyroidism typically results in a 
healthy pregnancy, and usually anti-thyroid drug therapy, like methimazole or 
propylthiouracil (PTU), is administered (ATA, 2005).  Untreated hypothyroidism has been 
associated with increased risk of maternal anemia (low red blood cell count), myopathy 
(muscle pain and weakness), congestive heart failure, preeclampsia, placental 
abnormalities, low birth weight infants, postpartum hemorrhage (bleeding) (ATA, 2005).  
Levothyroxine medication, a synthetic thyroid hormone used to treat hypothyroidism, 
must be increased in early pregnancy for proper neurologic development of the fetus 
(American Association of Clinical Endocrinologists, 2002; ACOG, 2002).   
Maternal phenylketonuria (PKU), an autosomal recessive genetic disorder characterized 
by an enzyme deficiency, affects one in 25,000 babies (March of Dimes, 2009f).  
Untreated maternal PKU may increase the risk of low birth weight, mental retardation, 
heart defects, behavior problems, and characteristic facial features in infants (OTIS, 
2008b).  Women may avoid these adverse pregnancy outcomes by adhering to a low 
phenylalanine diet prior to and during pregnancy (ACOG, 2002).  All babies born in the 
United States are tested with a heel-stick for elevated levels of PKU in the blood, and 
preventive measures are then taken to reduce the effects associated with uncontrolled 
PKU (MOD, 2009f).   
 Prescription and over-the-counter drugs potentially affect fetal development, and 
it is important for women to discuss their medications with their physician or pharmacist.  
About 82% of women of reproductive age use some type of medication, and about 46% 
of these women use a prescription medication (Kaufman, Kelly, Rosenberg, et al., 2002).  
Certain drugs have been shown to be problematic for pregnancy, and three to six 
percent of birth defects may be attributed to drug or chemical exposure (Brundage, 
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2002).  Isotretinoins used to treat acne, may result in miscarriage and birth defects when 
taken during pregnancy (Perlman, Leach, Dominguez, Ruszkowski, & Rudy, 2001; 
Perlman, Rudy, Pinto, & Townsend-Akpan, 2001).  Anti-epileptic drugs, like valproic 
acid, are known to be teratogenic, and should be provided in lower doses to women of 
reproductive age (Morrell, 1998; Crawford, Appleton, Betts, Duncan, Guthrie, & Morrow; 
1999; Barrett & Richens, 2003).   Warfarin, an oral anticoagulant, is also a known 
teratogen, and non-teratogenic anticoagulants should be prescribed to women of 
reproductive age with certain blood disorders (Ressell, 2001; Hirsh, Fuster, Ansell, & 
Halperin, 2003).  Fetal defects resulting from a drug or chemical exposure vary 
depending with the time of exposure (Brundage, 2002).  Fetal exposure before day 17 of 
development may be lethal, as in exposure to anticancer drugs that inhibit cellular 
replication (Vallance, 1996).  Exposure between days 17 and 56 affects organogenesis, 
as in exposure to vitamin A drugs, like retinoids, that may cause structural anomalies 
(Cefalo & Moos, 1995) or physical and mental defects (Mitchell, Van Bennekom, & 
Louik, 1995).  Exposure after day 56 may cause a functional impairment (Cefalo & 
Moos, 1995), a general retardation of growth as in the use of beta blockers (Vallance, 
1996), or organ system maturation defects, as in the association between angiotensin-
converting enzyme inhibitors and abnormalities of renal function and skull development 
(Brent & Beckman, 1991).  One study demonstrated a lack of information regarding the 
risk and safety of more than 90% of medications, approved by the Food and Drug 
Administration between 1980 and 2000, when taken during pregnancy (Lo & Friedman, 
2002).  In addition, teratogenicity is unclear for many prescription and over-the-counter 
drugs, but at least these substances are subject to federal regulation and testing 
procedures.  Whereas dietary supplements, including herbal supplements, are not 
subject to strict regulation and also may be teratogenic (National Center for 
Complementary and Alternative Medicine, 2009).  Further research and testing is 
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needed to clearly determine the safety of many prescription drugs, over-the-counter 
drugs, and herbal supplements. 
Many sexually transmitted infections (STI) are associated with adverse 
pregnancy outcomes (Majeroni & Ukkadam, 2007).  In the United States each year, 
pregnant women are infected with the following STIs: 1,080,000 cases of bacterial 
vaginosis, 880,000 cases of genital herpes, 100,000 cases of chlamydia, 124,000 cases 
of trichomoniasis, 13,200 cases of gonorrhea, 16,000 cases of hepatitis B, and 6,400 
cases of HIV (CDC, 2008b).  Also, about 26.8% of women between 14 and 59 years of 
age are infected with human papillomavirus (HPV) (Dunne, et al., 2007).   
STI screening recommendations vary for nonpregnant and pregnant women.  The U.S. 
Preventive Services Task Force, the CDC, the AAFP, and the ACOG do not recommend 
routine STI screening for nonpregnant women not at increased risk for STIs (Meyers, et 
al., 2008).  Increased risk of STI transmission is determined by high-risk sexual behavior 
(e.g., having multiple current partners, having new partners, using condoms 
inconsistently) and age (U.S. Preventive Services Task Force, 2007, 2005a, 2005b; 
Calonge, 2004).  Women under the age of 25, are at increased risk of STI transmission 
due to increased sexual risk taking, immature immune systems, and the presence of 
columnar epithelium on the adolescent cervix (U.S. Preventive Services Task Force, 
2007, 2005a, 2005b; Calonge, 2004).  The aforementioned agencies recommend that 
nonpregnant women at increased risk for contracting STIs should be screened for 
syphilis, human immunodeficiency virus (HIV), chlamydia, and gonorrhea (Meyers, et al., 
2008).  These agencies also recommend STI screening for hepatitis B, HIV, and syphilis 
for all pregnant women, and additional screening for chlamydia and gonorrhea for 
pregnant women at increased risk for STIs (Meyers, et al., 2008).  Recommendations for 
pregnant or nonpregnant women for other STIs, such as hepatitis C, herpes simplex 
virus (HSV), human papillomavirus (HPV), and are excluded as either a 
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recommendation not to screen or a statement citing lack of specific recommendation 
(Meyers, et al., 2008).   
Sexually transmitted infections can be passed from mother to fetus or infant 
before, during, or after the baby’s birth.  Some STIs (e.g., syphilis) infect the fetus in 
utero via the placenta (CDC, 2008b).  Other STIs (e.g., gonorrhea, chlamydia, hepatitis 
B, HPV, and genital herpes) infect the infant during the birthing process as the baby is 
pushed through the birth canal (CDC, 2008b).  Cesarean deliveries may reduce this risk 
(ACOG, 2009d).  HIV can infect the fetus or infant by crossing the placenta, during 
delivery through the birth canal, and after birth during breastfeeding (CDC, 2008b).   
Untreated sexually transmitted infections during pregnancy may lead to fetal and 
maternal complications.  About five to fifteen percent of pregnant women are infected 
with Chlamydia trachomatis, or Chlamydia, which may result in fetal opthalmia 
neonatorum (bacterial conjunctivitis or eye infection), pneumonitis (inflammation of lung 
tissue), low birth weight, or preterm birth or maternal postpartum endometritis (infection 
of the lining of the uterus) (Andrews, et al., 2006).  The risk of perinatal transmission of 
Neisseria gonorrhea, or gonorrhea, is between 30% and 47%, which may result in 
opthalmia neonatorum, systemic neonatal infection, maternal endometritis, or pelvic 
infection (Brocklehurst, 2002).  Treponema pallidum, or syphilis, is highly transmissible 
with or without symptoms, and this infection is associated with hydroamnios (excessive 
amniotic fluid), spontaneous abortion, preterm delivery, fetal hydrops (abnormal 
accumulation of fluid), prematurity, fetal distress, stillbirth, congenital syphilis, and 
neonatal death (Apea-Kubi, et al., 2004; Wendel, et al., 2002).  Trichomonas vaginalis, 
or trichomoniasis, is a sexually transmitted vaginal infection that is associated with 
preterm delivery and low birth weight (Riggs & Klebanoff, 2004).  Bacterial vaginosis, a 
sexually related infection, may result in preterm birth, premature rupture of the 
membranes, and low birthweight (Majeroni & Ukkadam, 2007).  These five STIs and 
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sexually related infections may be treated and cured with antibiotics, even during 
pregnancy (CDC, 2008b).  Hepatitis B may be transmitted from mother to child, and it 
may lead to hepatic failure, liver carcinoma, cirrhosis, and even death (Arevalo, 1989).  
Routine screening for hepatitis B is recommended for all pregnant women, because 
immunoprophylaxis with hepatitis B vaccine and hepatitis immune globulin may be 
administered perinatally to reduce the probability of viral infection in exposed infants 
(Arevalo, 1989).  Human papillomavirus (HPV), a virus that may result in genital warts or 
cervical cancer, may resolve spontaneously (Majeroni & Ukkadam, 2007).  Perinatal 
transmission, though rare, may occur, possibly resulting in warts on the infant’s throat or 
voice box (U.S. DHHS, 2009).  Genital warts may be removed prior to pregnancy with 
medication or surgical removal (Majeroni & Ukkadam, 2007).  Trichloroacetic acid, 80-
90%, may be applied by a health care professional weekly to remove warts safely during 
pregnancy (Majeroni & Ukkadam, 2007).  Herpes simplex virus (HSV), a common viral 
STI, affects about one in four births (ACOG, 2007b), and third trimester maternal 
infection increases the risk of perinatal transmission between 30% and 50% (Majeroni & 
Ukkadam, 2007).  Herpes infections in newborns may affect the skin, mouth, eyes, brain, 
and internal organs, which may lead to mental retardation, cerebral palsy, seizures, and 
vision or hearing loss (ACOG, 2007b).  Antiviral medication reduces the rate of perinatal 
transmission significantly (Andrews, et al., 2006; Sheffield, et al., 2003; Watts, et al., 
2003).  Human immunodeficiency virus (HIV), a virus that may lead to acquired immune 
deficiency syndrome (AIDS), compromises the immune system allowing for opportunistic 
infection (ACOG, 2009d).  Without treatment, HIV perinatal transmission may occur in 
one of every four babies born to an HIV-infected mother (ACOG, 2009d).  However, with 
antiviral treatment and cesarean delivery, perinatal transmission of from infected 
mothers may be reduced by 99% (ACOG, 2009d).  
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 Vaccinations are an important part of primary prevention in the protection of 
maternal and fetal health.  Immunizations administered prior to pregnancy are optimal to 
prevent disease to potential offspring, but some vaccines may be administered during 
pregnancy (ACOG, 2003).  A concern of vaccination during pregnancy is the primarily 
theoretical risk of transmitting the virus to the developing fetus (AAFP, 2003).  Thus, live-
virus vaccines are contraindicated for pregnant women, such as LAIV influenza, 
measles, mumps, rubella, and varicella vaccines (CDC, 2007d).  At this time, there is no 
evidence of increased risk to the fetus when vaccinating pregnant women with 
inactivated virus (e.g., hepatitis A, inactivated influenza), bacterial vaccines (e.g., 
pertussis), or toxoids (e.g., tetanus and diphtheria) (CDC, 2007d).  Even in these 
instances, physicians may adhere to certain vaccination regimens based upon the 
gestational age of the fetus (AAFP, 2003).  To ensure maximal vaccination effectiveness 
without harm to potential offspring, preconceptional vaccination is key (ACOG, 2003).   
Immunization against hepatitis B, rubella (German measles), varicella, Tdap (tetanus, 
diphtheria, and pertussis), HPV, and influenza vaccines are recommended among 
women of reproductive age (Lu, 2007).  Preconceptional hepatitis B vaccination is 
recommended.  Hepatitis B, previously discussed and primarily considered a sexually 
transmitted infection, may also be transmitted via blood transfusions, infected wounds, 
or infected needles (Coonrod, et al., 2008).  Perinatal transmission associated with acute 
maternal hepatitis B infection ranges from 10% during the first trimester to 90% during 
the third trimester (ACOG, 1998).  And, hepatitis B infection in utero has an increased 
risk of low birthweight and prematurity (Shepard, 1998; Hieber, Dalton, Shorey, & 
Combes, 1977).  For those infants perinatally exposed to hepatitis B infection, immune 
globulin should be administered within 12 hours of delivery, followed by vaccinations at 
birth, one, and six months (Coonrod, et al., 2008).  This procedure offers 95% protective 
efficacy against hepatitis B infection; however, these costly procedures are extraneous if 
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a woman receives preconceptional vaccination against hepatitis B and avoids infection 
altogether (Coonrod, et al., 2008).  Rubella and varicella vaccines involve live-attenuated 
viruses, and therefore, are contraindicated for administration during pregnancy (CDC, 
2007d).  Therefore, preconceptional administration of these vaccines is essential (Lu, 
2007).  The rubella immunization is typically administered as part of the trivalent MMR 
vaccine – measles, mumps, and rubella.  This vaccine provides protective seronegativity 
for the mother, and it prevents congenital rubella syndrome, characterized by eye 
defects resulting in blindness, hearing impairment, heart abnormalities, and/or mental 
retardation (ACOG, 2003b).  Rubella infection during the first 16 weeks of pregnancy 
may also result in spontaneous abortion or stillbirth (MOD, 2007).  Varicella, or 
chickenpox, a highly contagious infection, results from a DNA herpes virus infection 
(Seidman, 1996).  Fetal varicella infection may result in stillbirth or congenital varicella 
syndrome, characterized by eye defects, limb hypoplasia, skin lesions, and central 
nervous system abnormalities (Seidman, 1996).  Preconceptional Tdap vaccination is 
recommended.  The Tdap vaccine immunizes against tetanus (infection of 
environmental Clostridium tetani spores through a skin-break leading to lockjaw and 
skeletal muscle rigidity), diphtheria (respiratory illness in which a grayish membrane 
covers the pharynx, palate, and nasal mucosa with possible airway obstruction), and 
pertussis (whooping cough) (Coonrod, et al., 2008).  Preconceptional Tdap vaccination 
infers passive immunity for infants, who may be at risk of death if contracting these 
illnesses (Coonrod, et al., 2008).  Preconceptional administration of the HPV vaccine, 
which is effective against certain strains of HPV that may lead to genital warts, cervical 
dysplasia, or cervical cancer, is important (Coonrod, et al., 2008).  Certain diagnostic 
tests for HPV, such as endocervical curettage, and certain treatment options are 
contraindicated during pregnancy (Coonrod, et al., 2008).  Reducing the risk of genital 
warts through vaccination prior to pregnancy potentially reduces perinatal transmission 
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and the incidence of laryngeal papillomatosis (tumors of the voicebox) in children of 
women infected with HPV (Saslow, et al., 2007).  Also, HPV vaccination may reduce the 
need for loop electrosurgical excision procedure and cone biopsy, procedures that 
remove abnormal cells of the cervix and may impact cervical competence and 
performance during pregnancy (Crane, Delaney, & Hutchens, 2006).  Preconceptional 
influenza vaccination is recommended.  About 200,000 hospitalizations and 36,000 
deaths may be attributed to influenza infection annually, and influenza during pregnancy 
increases the risk of morbidity and possible miscarriage (Harper, et al., 2005).  In a 
nested case-control study, fetal influenza exposure in the first trimester was associated 
with a potentially increased risk of schizophrenia (Neuzil, et al., 1998).  Preconceptional 
influenza immunization is recommended for women who will become pregnant during flu 
season and for women with increased risk for influenza-related complications, such as 
cardiopulmonary disease or metabolic disorders, prior to the beginning of flue season 
(Coonrod, et al., 2008).  In summary, preconceptional vaccination of against hepatitis B, 
rubella, varicella, Tdap, HPV, and influenza maintains a woman’s health and protects the 
health of her potential offspring.  
 Taking a thorough family medical history and an evaluation of the ethnic 
background of individuals may assist in screening for certain genetic conditions in 
potential offspring (Brundage, 2002).  Blood tests are used to determine carriers of 
specific genes that cause genetic diseases (MOD, 2008b).  If two genetic carriers of a 
disease conceive a child, there is a 25% chance that the child will inherit the disease 
(MOD, 2008b).  The ethnic background of either partner may indicate recommended 
carrier-screenings for sickle cell trait (a blood disorder common among African-
Americans), thalassemias (a blood disorder common among those of Mediterranean, 
African, and South Asian descent), and Tay-Sachs disease (a cause of fatal brain 
damage in those of Eastern European Jewish ancestry or non-Jewish individuals of 
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French-Canadian or Cajun ancestry) (Leuzzi & Scoles, 1996).  A family history review 
including cystic fibrosis (a disease of the secretory glands, lung, and digestive system) 
or congenital hearing loss also may indicate carrier-screening tests (Cefalo & Moos, 
1995).  Preconceptional knowledge of genetic carrier status allows carriers an 
opportunity to understand the risk involved with potential pregnancies and to discuss 
their medical and childbearing options (MOD, 2008b).   
As part of the family history, it is also important to note previous pregnancy 
outcomes (ACOG, 2007).  Reviewing past experiences of miscarriage, complications, 
fetal birth defects, or stillbirth allows for potential interventions to prevent recurrence in 
future pregnancies (ACOG, 2007).  Interventions may include specific medical tests to 
determine the cause of previous adverse pregnancy outcomes, and a preventive future 
approach to pregnancy can then be recommended (MOD, 2008b).  For example, if a 
woman experienced a previous preterm delivery, her health provider may recommend 
lifestyle changes, such as quitting smoking, or subsequent treatment with the hormone 
progesterone may be recommended to assist in gestational maintenance (MOD, 2008b).  
Thus, a review of family history and previous pregnancy outcomes may lead to 
interventions resulting in improved future pregnancy outcomes. 
Avoidance of toxic substances.  A range of substances may be harmful to a 
fetus, and therefore, preconception health promotes limitations or avoidances of such 
toxic substances (Brundage, 2002).  Common substances that are toxic to a developing 
fetus include cat feces, garden soil, raw meat, workplace/household chemicals, fish-
related mercury, pesticides, high doses of vitamins A and D, and caffeine. 
Cat litter, garden soil, and raw or undercooked meat are all associated with 
toxoplasmosis, a parasitic infection caused by Toxoplasma gondii.  The toxoplasmosis 
parasite may cross the placenta if infection occurs during pregnancy, and fetal infection 
occurs in about 40% of maternal infection cases (Organization of Teratology Information 
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Specialists [OTIS], 2007b).  Fetal infection may include problems with the brain, eyes, 
heart, kidneys, blood, liver, or spleen, and long-term effects may include seizures, 
mental retardation, cerebral palsy, deafness, and blindness (OTIS, 2007b).  It is 
recommended that all women of reproductive age wear gloves when handling cat litter to 
avoid exposure to cat feces, wear gloves when gardening, and avoid eating raw or 
undercooked meat (Piper & Wen, 1999).  Chemicals, household or in the workplace, 
may be harmful.  Women should be made aware of hazardous materials in the 
workplace as a result of Occupational Safety and Health Administration’s guidelines, and 
exposure to these substances should be avoided among women of reproductive age 
(Brundage, 2002). Hazardous over-the-counter chemicals found at home in cleaning 
products, certain foods, and pesticides may be inhaled, ingested, or even absorbed into 
the skin (Gjerdingen & Fontaine, 1991).  Solvents may be teratogenic and harmful to 
pregnancy, such as those found in paint thinners, varnish remover, and oven cleaners 
(Gjerdingen & Fontaine, 1991).  Extra strength cleansers should be avoided, and natural 
products may be substituted for most cleaning needs, such as baking soda and vinegar 
(MOD, 2003).  Fish-related mercury may be harmful.  Women can also be exposed to 
methylmercury by eating contaminated fish (OTIS, 2007c).  Large fish have the highest 
levels of mercury, such as shark, swordfish, king mackerel, and tilefish (U.S. 
Environmental Protection Agency [EPA], 2008).  The FDA and EPA advise that 
preconceptional women avoid such fish, as well as canned albacore tuna and fresh tuna 
steaks that typically have higher levels of mercury than canned light tuna (EPA, 2008).  
Women of reproductive age should limit cooked fish consumption to 12 ounces per week 
or less of fish low in mercury, such as salmon, catfish, pollock, canned light tuna, or 
shrimp (EPA, 2008).  Women should also avoid pesticides whenever possible.  Fetal risk 
has not been proven with pesticides at consumer household levels, but pesticides are 
poisonous and high levels have been associated with miscarriage, preterm delivery, and 
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birth defects (MOD, 2003).  Women of childbearing age may use less toxic products, 
such as boric acid, for pest problems, as well as having others apply chemicals, avoiding 
pesticide use in and around the kitchen, reducing the use of insect repellents containing 
DEET, and wearing rubber gloves when gardening to avoid skin exposure to pesticides 
(MOD, 2003).  Women of reproductive age may also choose to consume organically 
grown produce to avoid pesticide-contaminated fruits and vegetables (ACOG, 2009).  
Large quantities of vitamins A and D may be harmful.  Fat-soluble vitamins A and D are 
also considered toxic when ingested in large quantities (Brundage, 2002).  Vitamin A, 
when taken in doses of more than 10,000 international units per day, is teratogenic 
(ACOG, 2007).  The FDA recommends a limit of 3,000 international units of vitamin A 
per day for preconceptional women (Brundage, 2002).  Vitamin D, when taken in doses 
of 1,600 international units per day, may cause fetal hypercalcemia and growth 
retardation (Cephalo & Moos, 1995).  Women of reproductive age should limit vitamin D 
intake to 400 international units per day alone or combined in calcium supplements or 
multiple vitamins (Brundage, 2002).  Large quanitites of caffeine may be harmful.  High 
doses of caffeine have been associated with increased risk of spontaneous abortion and 
low birth weight (Klebanoff, et al., 1999).  Most authorities consider daily caffeine 
consumption of 300 mg safe, which is equivalent to two cups of coffee or six glasses of 
tea or soda (Klebanoff, et al., 1999).  All of these are common substances in the United 
States, and limitations and avoidance recommendations are in place to protect the 
safety of women and their potential offspring (ACOG, 2007). 
 Domestic violence.  Physical, emotional, and sexual abuse is dangerous for a 
mother and her fetus.  Domestic violence, interpersonal violence, or intimate partner 
violence may be defined as threats or acts of physical, sexual, and/or emotional abuse 
between two person in a close relationship, such as current and former spouses or 
dating partners (CDC, 2008c).  About 4.8 million intimate partner rapes and physical 
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assaults occur each year in the United States (Tjaden & Thoennes, 2000).  According to 
the 2005 Behavioral Risk Factor Surveillance System, 23.6% of women over the age of 
18 experienced interpersonal violence at some point in their lives and were more likely to 
report adverse health conditions and health risk behaviors (CDC, 2008d).  Physical, 
sexual, and emotional abuse prior to pregnancy may put a woman at risk for abuse 
during the pregnancy (Klerman, et al., 2008).  Martin and colleagues determined that 
59% of women who were physically abused in the year prior to pregnancy continued to 
suffer physical abuse during pregnancy (Martin, et al., 2001).  Interpersonal violence is 
also associated with adverse health conditions that my affect pregnancy, such as 
inconsistent contraception use, unplanned pregnancy, sexually transmitted infections, 
depression, and posttraumatic stress disorder (Coker, 2007; Kendall-Tackett, 2007).  
Some evidence indicates that intimate partner violence may lead to poor pregnancy 
outcomes, such as low birthweight and preterm delivery (Sharps, Laughon, & 
Giangrande, 2007; Silver, Decker, Reed, & Raj, 2006).  The emotional and psychological 
impact associated with intimate partner violence may also interfere with a healthy 
pregnancy (Klerman, et al., 2008).  Pregnant victims of sexual violence, within or outside 
of a domestic situation, may experience severe depression and use cigarettes, alcohol, 
or illegal drugs to cope during the pregnancy (McMahon, Goodwin, & Stringer, 2000).  
The severity of sexual violence may increase the risk of poor reproductive health 
outcomes (McMahon, Goodwin, & Stringer, 2000).  However, preconception 
identification of those women in previous abusive relationships and current abusive 
relationships can instigate treatment and minimize potential adverse pregnancy 
outcomes (Klerman, et al., 2008).  McFarlane and colleagues determined that 
interpersonal violence might be reduced through the use of abuse assessment, the 
provision of information about sources of assistance, the provision of safety plans, and a 
nurse case management protocol (McFarlane, Groff, O’Brien, & Watson, 2006). 
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 Avoidance of stress.  Stress is detrimental to health and a potential pregnancy.  
Allostasis is the body’s capacity to maintain stability through change (Klerman, et al., 
2008).  Psychosocial stress may alter allostasis, and repeated and chronic stress may 
lead to allostatic system deterioration (Klerman, et al., 2008).  Examples of allostatic 
systems include the inhibition of the hypothalamic-pituitary-adrenal (HPA) axis that 
keeps the body’s stress response in check and modulates the inflammatory response 
(Chrousos, 2000; McEwen, 1998).  An impaired allostatic system at the onset of 
pregnancy may be associated with pregnancy complications, such as preterm delivery 
(Klerman, et al., 2008).  Therefore, preconception control of perceived stress is 
important to optimize pregnancy outcomes (Klerman, et al., 2008).   
Inadequate financial resources are common stressors among women of reproductive 
age (Klerman, et al., 2008).  About 13% of women between 18 and 64 years of age have 
incomes that place them below the federal poverty level (U.S. Census Bureau, 2007).  
Poverty increases among women of reproductive age (U.S. Census Bureau, 2007).  
Between 18 and 24 years of age, 21% and 42% of women have incomes that place 
them below the federal poverty level and of low-income status (below 200% of the 
poverty level), respectively (U.S. Census Bureau, 2007).  Between 25 and 44 years of 
age, 15% and 34% of women have incomes that place them below the federal poverty 
level and of low-income status (below 200% of the poverty level), respectively (U.S. 
Census Bureau, 2007).  Women living in poverty or with low-income status may find it 
difficult to obtain food, shelter, and other necessities, which may lead to physical stress, 
psychosocial stress, and poor pregnancy outcomes (Huynh, et al., 2005; Haas, 
Meneses, & McCormick, 1999). 
Another common stressor among women of reproductive age is the inability to 
easily access healthcare.  Access issues may include lack of insurance, an inadequate 
number of providers, an inadequate number of providers who accept Medicaid, and 
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transportation issues (Klerman, et al., 2008).  Of the 94.7 million women in the United 
States between 18 and 64 years of age in 2007, 18% were uninsured and 10 were on 
Medicaid (Kaiser Family Foundation [KFF], 2008).  Eligibility for Medicaid is reserved for 
low-income women who are either pregnant, mothers of children 18 years of age or 
younger, disabled, or over 65 (KFF, 2008).  Women without children and disabilities are 
usually ineligible regardless of poverty status, and women over 65 years of age are 
typically eligible to receive Medicare (KFF, 2008).  Medicaid finances 41% of all births in 
the U.S., and it accounts for 71% of all publicly funded planning services (Sonfield, 
Alrich, & Gold, 2009).  Many women, however, lose their Medicaid status by 60 days 
after delivery, leaving them uninsured unless they qualify for further federal or state 
assistance (Klerman, et al., 2008).  Women without insurance are more likely to 
postpone care, forgo filling prescriptions, and eliminate preventive care, such as Pap 
smears (KFF, 2008).  Compared to women with private or public insurance, uninsured 
women are less likely to have visited a healthcare provider within the last year and more 
likely to experience poor health outcomes (Salganicoff, Ranji, & Wyn, 2005).   
Avoidance of hyperthermia.  Hyperthermia may be dangerous to a developing 
fetus.  Typically, normal human body temperature averages about 98.6 degrees 
Farenheit (OTIS, 2006).  During pregnancy, 101 degrees Farenheit may be cause for 
concern (OTIS, 2006).  The effects of elevated body temperature during pregnancy 
depend upon the extent of elevation, the duration, and the stage of fetal development in 
which it occurs (Edwards, 2006).  Most studies regarding hyperthermia and pregnancy 
delineate hyperthermia exposure as a body temperature of 102 degrees Farenheit for an 
extended period of time (OTIS, 2006).  Hyperthermia results most often from fever 
during an illness, but very heavy exercise or prolonged exposure (more than ten 
minutes) to heat sources such as hot tubs, very hot baths, or saunas can also elevate 
body temperature (OTIS, 2006).  Prenatal death and abortion may result from mild 
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exposure prior to implantation or severe exposures during embryonic and fetal 
develoment (Edwards, 2006).  Central nervous system defects may occur including 
neural tube defects, microphthalmia (abnormal smallness of the eye), cataracts, 
microencephaly (abnormal smallness of the head), and other structural and functional 
defects may include defects of craniofacial development, the bones, the teeth, and the 
heart (Edwards, 2006).  Prior to and during pregnancy, prolonged exposure to elevated 
body temperatures should be avoided (OTIS, 2006). 
 Frequent handwashing.  The powerful impact of handwashing is often 
overlooked in the public arena, but this simple habit is extremely effective in reducing the 
spread of infectious disease (Mayo Clinic, 2007).  Frequent handwashing prevents the 
hand-to-hand or hand-to-infected surface spread of germs related to the common cold, 
flu, gastrointestinal disorders, and food-related illnesses such as salmonella and E. coli 
infection (Mayo Clinic, 2007).  This review has expounded on the potential harmful fetal 
effects that may result from infection (e.g., common cold, flu, E. coli) and toxic 
substances (e.g., garden soil, cat or rodent feces) (MOD, 2008; Mayo Clinic, 2007).  
Frequent handwashing diminishes the resulting risk of infection or contamination and is 
essential among women of reproductive age (MOD, 2008).  
 Lack of consensus.  In summary, there are numerous preconception health 
components that impact pregnancy outcomes.  However, leading public health agencies 
poised to develop and implement preconception health education and policies have 
failed to come to a consensus regarding the necessary components for inclusion in 
preconception health.  This inconsistency hinders further development of the 
preconception health movement.  The aim of preconception health is to reduce infant 
morbidity and mortality above and beyond the preventive impact of prenatal care.    
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Prenatal Care 
 
Prenatal care is generally described as the health care a woman receives during 
pregnancy (March of Dimes, 2009; U.S. Department of Health and Human Services 
[DHHS], 2009; Mayo Clinic, 2008).  Prenatal care may address maternal education, 
counseling, and the teaching of basic parenting skills (U.S. National Library of Medicine 
& National Institutes of Health, 2009), and it typically includes the monitoring of a 
pregnancy for potential maternal or fetal problems that may occur (Hood, Parker, & 
Atrash, 2007).  According to Healthy People 2010, about 74% of women obtain early 
and adequate prenatal care (DHHS, 2000).  Inadequate prenatal care is associated with 
higher infant mortality rates, with a 1.8-fold increase among black women and a 1.6-fold 
increase among white women (Vintileos, et al., 2002).  In addition, prenatal care is 
associated with infant morbidity (Wilson, et al., 1992).  Inadequate prenatal care (no 
prenatal care, late prenatal care initiation [only third trimester], or less than five of the 
recommended 13 minimum prenatal visits) is significantly associated with increased 
Neonatal Intensive Care Unit (NICU) admission rates (5.1% with inadequate prenatal 
care vs. 2.9% with adequate prenatal care; p <.001) (Wilson, et al., 1992). 
Prenatal care alone, however, fails to prevent certain fetal development and maternal 
health risks.  During fetal development, the fourth through the tenth week after 
conception is the most critical window in which the fetus is susceptible to potential health 
problems.  Usually, prenatal care begins in the eleventh or twelfth week of pregnancy, 
thus failing to prevent early embryonic developmental abnormalities and failing to reduce 
numerous health risks to the mother (CDC, 2006c).  Half of all infant deaths are 
attributed to four causes:  1) congenital malformations/birth defects; 2) disorders related 
to prematurity and low birth weight (LBW); 3) sudden infant death syndrome (SIDS); and 
4) maternal complications of pregnancy (Arias, MacDorman, Strobino, & Guyer, 2003; 
Bennett & Kotelchuck, 2005).  Research indicates that prenatal care alone is insufficient 
   
58 
 
to effect necessary change in these contributors to infant mortality, thus explicating the 
need for other prevention strategies, such as preconception care (DHHS, 2000; 
Korenbrot, Steinberg, Bender, & Newberry, 2002).  Due to the impact of prenatal care on 
adverse pregnancy outcomes, prenatal care factors (initiation of prenatal care, prenatal 
education, maternal complications, and tobacco and alcohol use during pregnancy) will 
be integrated into the conceptual framework of this study.  
Postnatal Care 
 Postnatal care is less defined than prenatal care, but certain postnatal practices 
are known to reduce the risk of infant mortality.  Infant mortality is defined as the number 
of infant deaths per 1,000 live births, and an infant is defined as one year of age or 
younger (MacDorman & Mathews, 2008).  The ten leading causes of death for infants in 
2005 in the United States (CDC, 2007f) are as follows:   
1) Congenital malformations/birth defects 
2) Disorders related to short gestation and low birthweight 
3) Sudden infant death syndrome (SIDS) 
4) Newborn affected by maternal complications of pregnancy 
5) Newborn affected by complications of placenta, cord, and membranes 
6) Unintentional injuries 
7) Respiratory distress of newborn 
8) Bacterial sepsis of newborn 
9) Neonatal hemorrhage 
10) Necrotizing enterocolitis of newborn 
Infant mortality may be divided into two categories:  1) neonatal mortality and 2) 
postneonatal mortality.   
Neonatal mortality refers to the number of deaths among infants less than 28 
days of age per 1,000 live births (Health Resources and Services Administration 
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[HRSA], 2009).  In this study, it is possible that variables for neonatal intensive care unit 
use and length of hospital stay may serve as a proxy for neonatal complications 
contributing to neonatal death, such as respiratory distress, bacterial sepsis, 
hemorrhage, and necrotizing enterocolitis.  Other risk factors for neonatal death, such as 
low birthweight, preterm delivery, small for gestational age, and maternal complications 
will be included in the framework, as well.  
Postneonatal mortality, or the number deaths among infants between 28 days of 
age and one year of age per 1,000 live births, may include those deaths attributed to 
SIDS, unintentional injury, and possibly birth defects (HRSA, 2009).  SIDS cases may be 
defined as sudden deaths of infants under one year of age, which remain unexplained 
after autopsy, death scene investigation, and a review of the clinical history (AAP, 2005).  
SIDS is the leading cause of death in children between one month and one year of age 
(NIH & NLM, 2009b).  In 1992, the AAP recommended that infants be placed in a 
nonprone (back or side) position for sleep to reduce the incidence of SIDS (Kattwinkel, 
et al., 1992).  In 2000, with new evidence about SIDS risks, this recommendation was 
revised to state that placing an infant on its back was the preferred sleep position (AAP, 
2005).  The rate of SIDS decreased from 1.20 deaths per 1,000 live births in 1992 to 
0.56 deaths per 1,000 live births in 2001 (CDC, 2005c).  This reduction in SIDS 
incidence is controversial, with some researchers citing that the reduction is the direct 
result of changes in the coding of SIDS deaths (AAP, 2005).  Regardless, sleep position, 
low birth weight, race, overheating, birth in the fall or winter months, maternal tobacco 
use after delivery, and exposure to environmental tobacco smoke are known risk factors 
for SIDS (Mayo Clinic, 2009; AAP, 2005).   
Postnatal infant feeding practices may also impact adverse pregnancy outcomes.  
Breastfeeding is associated with a decreased risk of neonatal and postneonatal mortality 
(AHRQ, 2009; Chen & Rogan, 2004).  A history of breastfeeding is associated with 
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reduced risk of otitis media, non-specific, gastroenteritis, severe lower respiratory tract 
infections, atopic dermatitis, asthma, obesity, type 1 and 2 diabetes, childhood leukemia, 
SIDS, and necrotizing enterocolitis (Ip, et al., 2007).  An increase in infant mortality is 
also associated with a delay in breastfeeding initiation and with an increased degree of 
supplementary (formula) feeding (Edmond, 2006; Guttmacher Institute, 2006).  Due to 
the possible impact of postnatal care on infant mortality, postnatal care factors (infant 
sleep position, infant feeding practices, infant medical care, postnatal tobacco use, and 
infant smoke exposure) will be integrated into the conceptual framework of this study.  
Factors impacting unintentional injury and birth defects are not included in the PRAMS 
dataset, and therefore, will be excluded from the framework. 
Identifying the Gaps 
 The empirical literature clearly demonstrates the impact of independent 
preconception health behaviors on adverse pregnancy outcomes.  However, 
preconception health does not occur in a vacuum.  There is a gap in the literature 
demonstrating the effectiveness of preconception health as a whole on reducing adverse 
pregnancy outcomes, especially in the context of extenuating environmental and 
personal influences.  This study examines the impact of preconception health on 
adverse pregnancy outcomes through the lens of reciprocal determinism, thereby 
developing a preconception health conceptual framework that accounts for the 
interactive relationships between behavior, the environment, and the person. 
Reciprocal Determinism 
History.  In the early 20th century, the theoretical perspective of behaviorism 
began to gain ground in the field of psychology (Van Wagner, 2005).  During this time 
period, Pavlov discovered classical conditioning, or that conditioned associations could 
facilitate the learning of behaviors (Van Wagner, 2005).  Watson further delineated the 
effects of behavioral conditioning, and Skinner then introduced the concept of operant 
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conditioning, or the impact of a system of rewards and punishment on behavior (Van 
Wagner, 2005).  In the middle of the 20th century, Albert Bandura critiqued the concept 
of behavioral conditioning because of its sole reliance on environmental influence 
(Bandura, 1986).  Bandura stated that the basis for human behavior is neither instinctual 
as posited by Plato and Aristotle, nor a response to external stimuli as posited by 
Skinner (Bandura, 1986).  Rather, behavior is influenced by the interaction of multiple 
determinants that exist in the environment and within the individual (Bandura, 1986).  
Bandura determined that environmental factors and personal factors interact with 
behavior in a dynamic, triadic model of reciprocity, or reciprocal determinism (Figure 2) 
(Bandura, 1986).  
 
Figure 2.  A graphic representation of reciprocal determinism - Bandura (1986). 
 
 
  
 
 
  
 Within this model, behavior may be characterized as observable, intentional, and 
goal-directed actions or as the required skills for behavior performance (Bandura, 1986).  
Environmental factors may include physical surroundings or social influences (Bandura, 
1986).  Personal factors may include cognition, affect, and constitutional makeup 
(Bandura, 1986).  The reciprocal nature of the model intimates bidirectional influences 
between these determinants (Bandura, 1977; 1986; 1989).  For example, in relation to 
the person-behavior relationship, an individual’s actions may be influenced by his or her 
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biological properties, such as sex, ethnicity, temperament, and genetic makeup, as well 
as self-perceptions, emotions, and thoughts (Bandura, 1977; 1986; 1989).  In a 
reciprocal fashion, performance of a behavior may influence an individual’s emotions or 
thoughts (Bandura, 1977; 1986; 1989).  When dealing with the environment-person 
relationship, an individual’s beliefs and expectations may be influenced by his or her 
social circumstances (Bandura, 1977; 1986; 1989).  Reciprocally, the physical 
characteristics of an individual, such as age, size, race, sex, physical attractiveness, 
may influence his or her social environment (Bandura, 1977; 1986; 1989).  With regard 
to the environment-behavior relationship, an individual determines his or her 
environmental exposure, and the environment then modifies his or her behavior 
(Bandura, 1977; 1986; 1989).  Thus, an individual is a product of the environment that 
he or she produces (Bandura, 1977; 1986; 1989).  In a reciprocal fashion, behavior may 
impact the environment, such as the creation of a hostile environment by an aggressive 
individual (Bandura, 1977; 1986; 1989).  Reciprocal determinism is consistent with the 
principle of a system in that a change in one determinant yields a change in another 
determinant (Bandura, 1986).  However, these interactive influences are not necessarily 
equal in strength, as some interactions exert more influence than others (Bandura, 
1989).  And, these interactions are not necessarily simultaneous, but most often occur 
sequentially over time (Bandura, 1989).  Reciprocal determinism is a principle, or 
postulate, that is commonly recognized as a central tenet of the Social Cognitive Theory 
(formerly known as the Social Learning Theory) (Baranowski, Perry, & Parcel, 1997).  
Applications in public health.  Though not widely used on its own, several 
studies have used the principle of reciprocal determinism to provide a structural basis for 
the conceptual organization of the empirical literature or the development of a 
conceptual framework (Perrin & Swerissen, 2008; Reddan, Wahlstrom, & Reicks, 2002).  
A conceptual framework may be defined as a visual diagram consisting of a set of key 
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factors, concepts, or variables, a given outcome, and the presumed associations therein 
(Bertrand, 2006; Miles & Huberman, 1994).  Conceptual frameworks, attempt to explain 
what is happening and why (Maxwell, 2004).  The development of conceptual 
frameworks relies on the use of theory, empirical evidence, and experiential knowledge 
to assimilate knowledge, to explain causal associations, and to generate hypotheses 
(Bertrand, 2006).   
Perrin and Swerissen (2008) used the reciprocal determinism postulate to 
develop a model of behavioral and psychological influences and interactions regarding 
people at risk for diabetes-related foot complications.  In this study, the researchers 
conducted a literature review and organized the numerous studies found according to 
the principle of reciprocal determinism (Perrin & Swerissen, 2008).  This allowed the 
researchers to include multiple contributing factors, and the researchers determined that 
demographic variables predispose persons to certain beliefs, attitudes, and knowledge, 
which influence foot monitoring and protective actions (Perrin & Swerissen, 2008).  The 
environment and social situations also immediately impacted behavior and the 
cognitions that followed (Perrin & Swerissen, 2008).  This study did not evaluate the 
developing framework from a statistical perspective, but the framework cohesively 
synthesized a large number of studies to identify factors that shape appropriate foot care 
behavior.   
Other researchers used the reciprocal determinism principle to identify benefits 
and barriers related to breakfast consumption by children (Reddan, Wahlstrom, & 
Reicks, 2002).  Reddan et al. (2002) built upon previous studies associated with 
influential factors of children’s eating behavior, and then used the reciprocal determinism 
construct in combination with student interviews to develop a comprehensive framework.  
Chi-square tests were performed to analyze statistical differences between 
determinants.  Statistically significant perceived benefits were determined to be 
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increased energy and ability to pay attention in school and significant perceived barriers 
included the lack of time to eat and lack of student hunger in the morning.  These results 
reiterated the findings found in the empirical literature.  However, the interactions of the 
environmental and psychological influences on behavior indicate that adjustments may 
be made to improve breakfast consumption in this population.  The researchers 
recommended further use of the reciprocal determinism postulate to develop practical 
strategies to address the determined barriers to breakfast consumption among children 
(Reddan, et al., 2002).  Several other studies support the use of the principle of 
reciprocal determinism to enhance the understanding of relationships among multiple 
influential factors and their associations with a given outcome (Read, Wood, & Capone, 
2005; Pakenham, Dadds, & Lennon, 2002; Makoul, 1998; Pakenham, Dadds, & Terry, 
1995). 
 Application in this study.  In this study, preconception health will be addressed 
according to the theoretical principle of reciprocal determinism via behavioral, 
environmental, and personal influences on adverse pregnancy outcomes.  Behavioral 
influences will include those behaviors that can be performed prior to pregnancy to 
reduce adverse pregnancy outcomes, also known as preconception health behaviors:  
weight management (measured via BMI), folic acid use, avoidance of tobacco, 
avoidance of alcohol, obtaining oral care, obtaining medical care, and contraceptive use.  
Personal influences will include cognitive and constitutional factors that may impact 
adverse pregnancy outcomes:  pregnancy intention, maternal age, race/ethnicity, and 
previous pregnancy outcomes.  Environmental influences will include preconceptional 
factors beyond a woman’s volitional control and socioeconomic factors that may impact 
adverse pregnancy outcomes:  income status, health insurance status (with the 
exception of Medicaid), Medicaid status, education level, external stress, and physical 
abuse.  Among these groups, several factors have not been previously discussed, such 
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as pregnancy intention, demographic characteristics, and contraceptive use.  According 
to the principle of reciprocal determinism and their empirical effects on adverse 
pregnancy outcomes, they will be included in this study.   
Pregnancy intention.  In the United States, about half of all pregnancies are 
unintended (Finer, 2006).  An unintended pregnancy may be categorized as either 
mistimed or unwanted at the time of conception (Santelli, et al., 2003; Klerman, 2000).  A 
mistimed pregnancy occurs sooner than planned, and an unwanted pregnancy is not 
wanted at the time of pregnancy or at any time in the future (Keeton & Hayward, 2007). 
Due to small sample size and failure to account for strong cofounders, there is an 
inconsistency among studies linking unintended pregnancies with adverse pregnancy 
outcomes, such as low birth weight and preterm delivery (D’Angelo, et al., 2004; Pulley, 
et al., 2002; Eggleston, 2000; Gazmararian, et al., 2000; Orr, et al., 2000; Kost, Landry, 
& Darroch, 1998a; Sharma, et al., 1994; De Muylder, et al., 1992; Cartwright, 1988).  
According to a study conducted using data from the Maternal and Infant Health Survey 
and the National Survey of Family Growth, adverse pregnancy outcomes were not 
associated with mistimed pregnancies when controlling for selected maternal 
sociodemographic characteristics, but unwanted pregnancies increased the likelihood of 
adverse pregnancy outcomes in the same controlling conditions (Kost, Landry, & 
Darroch, 1998a).  However, this association between unwanted pregnancies and 
adverse pregnancy outcomes was no longer significant when accounting for selected 
maternal prenatal behaviors, such as smoking during pregnancy (Kost, Landry, & 
Darroch, 1998a).  In another study, Pregnancy Risk Assessment Monitoring System 
data were used to determine the associations between pregnancy intention and adverse 
birth outcomes among 87,087 women (Mohllajee, Curtis, Morrow, & Marchbanks, 2007).  
These researchers, after controlling for selected demographic and prenatal behavioral 
factors, demonstrated that women with unwanted pregnancies were more likely to 
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experience a preterm delivery (adjusted OR 1.16 [95% CI 1.01, 1.33]) and women with 
mistimed pregnancies were less likely to experience a preterm delivery (adjusted OR 
0.92 [95% CI 0.86, 0.97]) than women with intended pregnancies (Mohllajee, Curtis, 
Morrow, & Marchbanks, 2007).  
Pregnancy intention varies with maternal behavior (Keeton & Hayward, 2007).  
Regarding preconception maternal behaviors, women with unintended pregnancies were 
more likely to report cigarette smoking (adjusted OR 1.50 [95%CI 1.28, 1.75]) and less 
likely to report daily vitamin supplement use (adjusted OR 0.66 [95%CI 0.58, 0.76]) 
when compared to women with intended pregnancies (Hellerstedt, et al., 1998).  
Regarding prenatal maternal behaviors, women with unintended pregnancies were more 
likely to report smoking (OR 1.4 [95% CI 1.2, 1.7]), illicit drug use (OR 3.4 [95% CI 1.9, 
6.4]), not taking daily vitamin supplements (OR 1.4 [95% CI 1.2, 1.7]), and alcohol use 
(OR 1.2 [95% CI 0.99, 1.4]) than women with intended pregnancies (Than, et al., 2005).  
Women with intended pregnancies are also more likely than those with unintended 
pregnancies to recognize the early signs of pregnancy and seek out early prenatal care 
(Kost, Landry, & Darroch, 1998b).   
Pregnancy intention also varies among demographic subgroups (Keeton & 
Hayward, 2007).  There is an increased risk of unintended pregnancy among women 
with less than a high school education, among adolescents, and among black women 
(Chandra, et al., 2005; Than, et al., 2005).  According to an older study conducted with 
data from 1988 National Survey of Family Growth, increased risk of unintended 
pregnancy status was also associated with never being married, women living below the 
federal poverty level, and women with more than two children, in addition to the 
aforementioned risk factors, when compared to women with intended pregnancies (Kost 
& Forrest, 1995).  Overall, pregnancy intention is associated with preconception 
behavioral and environmental factors, and it may also relate to adverse pregnancy 
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outcomes.  Pregnancy intention will be included in the conceptual framework of this 
study. 
Demographic characteristics.  Adverse pregnancy outcomes may have a direct 
or an indirect relationship with selected demographic characteristics.  Low birth weight 
(LBW) rates may vary by race or ethnic status (Shiao, Andrews, & Helmreich, 2005).  In 
2001, the low birth weight rate for black women was 10.4% (Shi, et al., 2004).  Black 
women of low socioeconomic status (SES) demonstrated a LBW rate 5.8% higher 
compared to white women in the same SES group and 6.2% higher compared to the 
total U.S. population (Shi, et al., 2004).  Also in 2001, the infant mortality rate decreased 
from 7.2 to 6.8 deaths per 1,000 live births; however, the infant mortality rate for black 
infants was 13.5 deaths per 1,000 live births, the highest of any racial group (Beato, 
2003).  In another study, increasing maternal age (among women 15 to 34 years of age) 
of black women was associated with increased rates of low birth weight and very low 
birth weight infants, whereas white women did not experience this association 
(Geronimus, 1996).  Black women in low-income areas that were 34 years of age were 
three times as likely to have a low birth weight infant and four times as likely to have a 
very low birth weight infant than low-income black women that were 15 years of age 
(Geronimus, 1996).  Geronimus explains this as a weathering hypothesis among the 
African-American population, or that the effects of social inequality on health may 
compound with maternal age, thus impacting fetal health (Geronimus, 1992).  Low birth 
weight and other adverse pregnancy outcomes also may vary by maternal age (Shiao, 
Andrews, & Helmreich, 2005).  On the maternal reproductive age spectrum, the 
youngest and oldest mothers exhibit the highest rates of LBW (Jolly, et al., 2000a, 
2000b; Martin, et al., 2003).  Low birth weight rates were significantly higher among 
nulliparous young women (17 years of age or less) than those born to women between 
20 and 24 years of age (Abu-Heija, Ali, & Al-Dakheil, 2002).  Those women 35 years of 
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age or older are associated with an increased risk of preterm delivery, cesarean delivery, 
low birth weight, fetal distress, and infant admission to the NICU compared to younger 
women (Ziedeh, 2002; Yuksel, et al., 1996).  Low birth weight rates were also 
significantly associated with lower gestational age and lack of adequate health insurance 
(Hunter & Taslimi, 2008).  The possible effects associated with income status and health 
insurance on pregnancy outcomes were also previously mentioned in the discussion of 
environmental stressors.   
Maternal age is also associated with adverse maternal behaviors (Weisman, et 
al., 2006).  Among preconceptional and interconceptional women, women between 18 
and 34 years of age experienced binge drinking, nutritional deficits, physical inactivity, 
increased gynecologic infections, and more psychosocial stress than older women 
(Weisman, et al., 2006).  Women between 35 and 45 years of age also experienced 
binge drinking, nutritional deficits, and physical inactivity, but they also were more likely 
to have chronic conditions like hypertension and high cholesterol compared to younger 
women (Weisman, et al., 2006).  Overall, demographic characteristics are associated 
with preconception behavioral and personal factors, and they may relate to adverse 
pregnancy outcomes.  Maternal age, race/ethnicity, education, insurance status, and 
income status will be included in the conceptual framework of this study. 
 Use of contraception.  A discussion of contraceptive use logically ensues a 
discussion related to the high rates of unintended pregnancy in the United States, and 
there is a vast body of research devoted to the use of contraceptives.  However, in the 
preconception health literature, discussion of contraception is minimal.  Despite the 
Center for Disease Control and Prevention’s vast amount of work dedicated to 
preconception health in the last decade, contraception is only briefly mentioned in 
reference to the development of a reproductive life plan (CDC, 2006).  Other 
preconception promotion materials never mention the use of contraception ((MOD, 
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2009a, 2009b, 2008; ACOG, 2007; Brundage, 2002).  Some preconception advocates 
may view contraceptive use as independent of preconception health promotion, and 
therefore, that additional discussion of contraceptives in relation to preconception health 
is not warranted.  Due to possible contraceptive failure, contraceptive use does not 
negate the need for preconception health promotion.  Of the approximately 62 million 
women of reproductive age, about 43 million are sexually active and do not want to 
become pregnant (Guttmacher Institute, 2008).  The average woman in the United 
States desires to have only two children, and therefore, must rely on contraceptive use 
for the majority of nearly three decades of her life to prevent unintended pregnancy 
(Guttmacher, 2008).  Whereas preconception health addresses preventive behaviors 
that may be performed in case of pregnancy, regardless of intention, contraception 
addresses the only the prevention of pregnancy.  Contraceptive use will be included in 
the conceptual framework of this study.  Note that not all of the preconception health 
components and subcomponents previously discussed are included in this study due to 
limitations with the Pregnancy Risk Assessment Monitoring System dataset. 
Pregnancy Risk Assessment Monitoring System Survey  
The Pregnancy Risk Assessment Monitoring System (PRAMS) surveillance 
project of the CDC will be used in this analysis.  The PRAMS project collects population-
based data from 37 states, one city, and an American Indian tribal territory regarding 
maternal experiences before, during, and shortly after pregnancy to inform the 
development of state health programs designed to improve maternal and infant health 
(CDC, 2009).  Surveys, like the PRAMS questionnaire, are useful tools in the 
examination of characteristics of a large population, and they provide a relatively quick, 
standardized method of data collection (Creswell, 2003).   
 PRAMS development.  The CDC first developed the topics and questions 
comprising the PRAMS questionnaire in 1988 (CDC, 2008f).  Focus groups and in-depth 
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interviews were used to pretest the questionnaire.  Interviews were based on the 
cognitive techniques developed by Jobe and Mingay (1989).  Cognitive interviewing 
aims to enhance questionnaire validity by improving item structure according to the way 
respondents structure information in their memory (CDC, 2008f).  In cognitive 
interviewing, the respondent reads each survey question aloud, paraphrases it, states 
her answer, reads the response options aloud, marks her choice, and explains her 
thinking (Adams, et al., 1991).  This process allows the researcher to detect readability 
issues.  The PRAMS survey demonstrated about an eighth-grade reading level.  After 
1,000 questionnaires were completed, responses were systematically reviewed for 
greater than 10% of item nonresponse, greater than 90% of similar item responses, or 
items with a high number of written answers.  Items were modified accordingly.   
Since then, the items of the PRAMS questionnaire undergo continuous revision, with 
major revisions in 1990, 1995, 1999, 2001 (mini-revision), and 2004.  These revisions 
delineate the five phases of PRAMS.  Content areas of PRAMS are developed based 
upon the following criteria (CDC, 2008f):  
1.  Usefulness of information to develop specific interventions aimed at reducing 
infant morbidity and mortality. 
2. The likelihood that valid and sensitive information can be collected from the 
mother shortly after delivery. 
3. Estimated prevalence of behavior, attitude, or experience. 
4. Strength of associations between behavior, attitude, or experience and infant 
morbidity and mortality. 
5. Importance of covariation of information for the association between 
behavior, attitude, or experience and infant morbidity and mortality. 
6. Availability of state-level information from other data sources. 
7. State need for information for 2010 health objectives or other program needs. 
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The CDC provides basic advice to participating states about item wording and structure, 
and the CDC and states pretest newly developed and modified questions.  Cognitive 
interviewing techniques are used by the National Center for Health Statistics 
Questionnaire Design Research Laboratory to evaluate core and standard-state 
questions and by the states to evaluate the state-developed questions.  All cognitive 
interviewing revisions made at the CDC or state-level are subsequently subjected to field 
testing to ensure appropriateness.  Samples for both types of pretesting are carried out 
by mail and telephone, in English and Spanish, among 20 to 25 women of varying 
sociodemographic backgrounds.  Due to the variation in state PRAMS questionnaires, 
the final step in the pretesting process is to conduct a flow assessment in each state of 
the final state-specific questionnaire.  To do this, mail and telephone surveys in English 
and Spanish are tested via a convenience sample of coworkers, friends, and family to 
ensure smooth flow of the questionnaire.  All state pretesting procedures are outlined 
and approved by the CDC prior to implementation.  Due to the inclusion of over 200 
indicators, validation of the PRAMS survey relies on pretesting and evaluation of 
individual questions (D’Angelo, D.V., November 13, 2009). 
PRAMS data collection.  Due to the large number of states administering the 
PRAMS survey, a standardized data collection methodology was developed.  Some 
portions of the required protocol are customizable to tailor the procedures to state-based 
needs.  Sources of data for PRAMS surveillance are obtained from birth certificate data, 
operational data, and questionnaire data.  Birth certificates are used as a sampling 
frame, to weight survey data for population representativeness, and to obtain 
demographic information about the survey participants.  PRAMTrac, a software system 
developed by the CDC to assist with PRAMS data collection, generates operational 
data.  This operational data is used to calculate response rates and monitor the quality 
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of data collection.  Questionnaire data includes self-reported data collected using 
Dillman’s Tailored Design Method (Dillman, 2000). 
 Dillman’s Tailored Design Method is used in survey research as a tested approach 
to increasing response rates for mail surveys by contacting participants in numerous and 
varied ways (Dillman, 2000).  Using this method, PRAMS surveillance includes the 
following sequential contacts with sampled mothers: 
1.  Preletter (Day 1):  An introductory letter explaining PRAMS and the 
subsequent arrival of the questionnaire. 
2.  Initial Mail Questionnaire Packet (3-7 days later):  Contains a multipurpose 
cover letter describing PRAMS, its purpose, and an explanation of how and 
why the participant was selected.  It also elicits participant cooperation, 
describes procedures of response, explains incentives and rewards, and 
provides a telephone number for additional information.  In 2004, the letter 
was divided into two parts:  an introductory letter and an informed consent 
information sheet.  Following the multipurpose cover letter, a questionnaire 
booklet is included in the packet.  Each state may customize the colorful 
cover art of the booklet.  The booklet is no more than 14 pages in length and 
is slightly smaller than 8 ½” X 11”.  An extra page is attached at the end for 
any participant comments.  The packet also includes a self-addressed 
postage-paid return envelope for easy return of the questionnaire, an 
informational PRAMS brochure with answers to frequently asked questions, a 
three-year calendar for a memory aid, and some type of incentive or reward 
selected by the state.  Examples of incentives and rewards include coupons 
for certified birth certificates, a raffle card for a possible cash reward, postage 
stamps, bibs, a one-dollar bill, and magnetic picture frames. 
3. Tickler (7-10 days later):  A thank you and reminder note. 
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4.  Second Mail Questionnaire Packet (7-14 days later):  Sent if no response.  
Same as the initial mail questionnaire packet, with an additional appeal for 
response in the cover letter. 
5.  Third Mail Questionnaire Packet (7-14 days later):  Sent if no response.  
Same as the second mail questionnaire packet. 
6.  Telephone Follow-up (7-14 days later):  Call made if no response.  
Telephone numbers are identified through a variety of sources varying by 
state.  To increase possible participant availability, calls made over a period 
of two to three weeks are staggered throughout the day on varying days of 
the week.  Up to 15 calls are made in an attempt to reach a participant, and 
telephone interviewers often schedule call-back times to fit the mother’s 
schedule.  By September 2006, all states used Computer Assisted Telephone 
Interviewing (CATI) software for telephone follow-up. 
Each month in each state, a systematic stratified sample of eligible birth certificates is 
drawn from the birth certificate file, and the above sequence of contacts is made with 
each selected participant.  The total data collection cycle from the pre-letter mailing to 
the follow-up telephone call lasts between 60 to 95 days.  PRAMTrac software is used to 
assist with mail and telephone call scheduling, letter preparation, and tracking of 
responses.  PRAMS response rates of 70% from each state are required for each 
sampling stratum.  In 2005, 26 out of 28 PRAMS projects achieved a response rate of 
70% or higher, and six of these states met or exceeded an 80% response rate.  Higher 
response rates minimize nonrandom or systematic error from response bias.  In addition, 
PRAMS uses larger sample sizes than those needed to obtain a given precision level in 
epidemiologic measurements.  These larger samples sizes help reduce the amount of 
random error associated with the estimates obtained from PRAMS data.  Also, 
demographic characteristics and some medical information for nonrespondents may be 
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obtained from the birth certificates used to locate them.  The CDC calculates weights 
after data collection to adjust for possible error in sampling, nonresponse, and frame 
noncoverage.  Sampling and instrumentation will be discussed in further detail in the 
next chapter.  In 1991, the cost of data collection and management for PRAMS varied 
from $75,000 to $94,000 per state (Adams, et al., 1991).  These costs vary based upon 
sample size, staff salaries, and processing costs.  These figures do not account for one-
time costs related to the development of study protocol, the questionnaire, the 
PRAMTrac software, or data analysis. 
 Since the early 1990s, over 70 journal articles and numerous surveillance reports 
have been generated using PRAMS data (CDC, 2008e).  The CDC monitors the multi-
state use of all PRAMS research data, and generated output primarily involves 
correlational studies and prevalence estimates (CDC, 2008e).  Research involving 
PRAMS data incorporates topics ranging from breastfeeding trends to the perinatal 
impact of smoking to maternal depression.  Two CDC-based reports used PRAMS data 
to assess the prevalence of preconception and interconception indicators in 1999 (Beck, 
et al., 2002) and 2004 (D’Angelo, et al., 2007).  In the 2004 surveillance summary, 18 
behaviors and conditions were deemed relevant to preconception health and health care 
(D’Angelo, et al., 2007).  In relation to preconception maternal behaviors and 
experiences, mean overall prevalence was 23% for tobacco use, 50% for alcohol use, 
53% for nonuse of contraception among women not trying to become pregnant, 35% for 
multivitamin use at least four times a week, 78% for ever having a dental visit prior to 
pregnancy, 30% for receiving preconception health counseling, 3.6% for experiencing 
physical abuse, and 19% for experiencing at least four stressors prior to pregnancy.  
Regarding preconception maternal conditions, mean overall prevalence was 13% for 
women being underweight, 13% for women being overweight, and 22% for women being 
obese; 1.8% for diabetes; 6.9% for asthma; 2.2% for hypertension; 1.2% for heart 
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problems; and 10% for anemia.  Previous pregnancy outcomes exhibited mean overall 
prevalence of 12% for having a previous low birth weight infant and 12% for having a 
previous preterm infant (D’Angelo, et al., 2007).  As indicated in this study, whereas 
preconception maternal behaviors and conditions may be improved upon among women 
in the United States, it also may be determined that the PRAMS represents a 
conditionally optimal dataset to examine such behaviors and conditions in relation to 
adverse pregnancy outcomes.  The condition that prevents the PRAMS data from 
achieving optimal status is the variability of optional standard state and state-specific 
questions.  This hindrance will be evident in the distinction between Projects 1 and 2 of 
the proposed study.  Project 2 requires the exclusion of two variables, obtaining oral 
care and obtaining medical care, due to limitations of standard state questions.  Both 
projects of this study also require exclusion of certain preconception maternal conditions, 
such as diabetes, asthma, hypertension, heart problems, and anemia due to 
instrumentation limitations.   
Summary 
The preconception health movement began with the rationale that many adverse 
pregnancy outcomes are determined prior to prenatal care initiation (Moos, 2006).  Thus, 
in addition to prenatal care, the need for preconception health arose.  The empirical 
literature makes a strong case for the benefit of individual preconception health 
components and their effects on adverse pregnancy outcomes.  However, the actual 
effectiveness of collective preconception health in reducing adverse pregnancy 
outcomes has not yet been demonstrated.  In an effort to evaluate the impact of 
preconception health on maternal morbidity, infant morbidity, and infant mortality, this 
study will examine the reciprocal relationships between environmental, personal, and 
preconception behavioral factors and their associations with adverse pregnancy 
outcomes. 
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Chapter 3:  Methods 
 
Purpose 
 According to Healthy People 2010, about 74% of women obtain early and 
adequate prenatal care (U.S. Department of Health and Human Services [DHHS], 2000).  
Yet, prenatal care, even when initiated in early pregnancy, fails to prevent certain fetal 
development and maternal health risks.  Half of all infant deaths are attributed to four 
causes:  1) congenital malformations/birth defects; 2) disorders related to prematurity 
and low birth weight (LBW); 3) sudden infant death syndrome (SIDS); and 4) maternal 
complications of pregnancy (Arias, MacDorman, Strobino, & Guyer, 2003; Bennett & 
Kotelchuck, 2005).  Research indicates that prenatal care alone is insufficient to effect 
necessary change in these contributors to infant mortality, thus explicating the need for 
other prevention strategies, such as preconception care (DHHS, 2000; Korenbrot, 
Steinberg, Bender, & Newberry, 2002).  The idea of preconception health derives from 
ancient times, and it has been addressed in the United States for the last thirty years.  
Yet, preconception health is only now being considered as an alternative to prenatal 
care, and its collective effectiveness has not been demonstrated.  The literature 
demonstrates the impact of independent preconception health behaviors on adverse 
pregnancy outcomes.  However, preconception health does not occur in a vacuum.  The 
literature fails to demonstrate the effectiveness of preconception health as a whole on 
reducing adverse pregnancy outcomes, especially in the context of environmental and 
personal influences.  This study examines the impact of preconception health on 
adverse pregnancy outcomes through the lens of reciprocal determinism, thereby 
developing a preconception health conceptual framework that accounts for the 
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interactive relationships between behavior, the environment, and the person (see Figure 
3). 
Research Questions 
1.  What is the relationship between preconception health behaviors and adverse 
pregnancy outcomes among women of reproductive age?  
2.  What is the relationship among preconception health behaviors, prenatal 
factors, postnatal factors, personal influences, environmental factors, and 
adverse pregnancy outcomes among women of reproductive age? 
Null Hypotheses 
HO1:  Preconception health behaviors are not predictive of adverse pregnancy 
outcomes. 
HO2:  The preconception health framework is not adequate to account for the 
variance associated with adverse pregnancy outcomes among women of 
reproductive age. 
Study Design 
 This secondary data analysis employs a non-experimental study design using 
cross-sectional data collection.  The design is appropriate for this study because cross-
sectional studies aim to describe the relationship between variables of interest in a 
specific population at one point in time.  Due to the time frame of data collection, cross 
sectional studies are limited by their inability to examine causal relationships between 
variables (Kelsey, Whittemore, Evans, & Thompson, 1996).   
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 [Note:  Covariance is allowed among all exogenous variables.] 
Figure 3.  Preconception health framework – Project 1. 
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 Phase five data, collected annually from 2005 to 2008, of the Pregnancy Risk 
Assessment Monitoring System (PRAMS) surveillance project of the CDC will be used in 
this analysis.  A conceptual framework will be developed and analyzed to address the 
proposed research questions (Figure 3).  For ease of discussion, this framework will be 
addressed as the preconception health framework.  For enhanced generalizability of the 
study results, the study will be divided into two parts.  First, the preconception health 
framework will be analyzed among the following five states:  Maine, New Jersey, Ohio, 
Utah, and Vermont.  These five states are the only PRAMS-participating states that 
address all of the variables included in the framework.  This will be addressed as Project 
1.  Four of the five states in project one rank among the twelve states with the lowest 
infant mortality in the nation (Table 3) (Kaiser Family Foundation [KFF], 2009).  As infant 
mortality is an outcome of interest, a second analysis will be conducted with all PRAMS-
participating states pending an acceptable fit of the reduced framework based on the 
fixed parameters of entire framework (Table 3).  The reduced framework lacks two 
constructs eliminated from the framework due to instrumentation limitations:  obtaining 
oral care and obtaining medical care (Figure 4).  This will be addressed as Project 2.    
Study Sample   
 In 2006, over four million births occurred in the United States (KFF, 2009).  In the 
same year, 340,352 births were attributed to the five states that will be included in 
Project 1:  Maine, New Jersey, Ohio, Utah, and Vermont (see Table 4) (KFF, 2009).  
These states, as demonstrated in Tables 3 and 4, are not necessarily representative of 
all states in relation to race/ethnicity and infant mortality rates.  The PRAMS survey aims 
to target all pregnancies resulting in a live-born infant in the United States with the 
following exclusions:  1) out-of-state births to residents; 2) in-state births to nonresidents; 
3) infants whose birth certificate lacks a maternal last name; 4) those birth certificates 
processed more than six months after the birth; 5) all but one infant associated with a 
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multiple gestation; 6) adopted infants; and 7) surrogate births.  The sampling frame 
consists of all mothers that represent the population eligible for study inclusion.  Due to 
inaccessibility of such a sampling frame list, the operational sampling unit consists of all 
infants born alive within the specified state to resident mothers during a specific time 
frame, and birth certificates are used as the operational sampling frame, which 
automatically exclude stillbirths, fetal deaths, and induced abortions.  From the 
remaining eligible birth certificates, a stratified systematic sample of 100 to 250 mothers 
is drawn every month in each state.  States generally oversample for infants with low 
birth weight, and as the choice for dual stratification variables is limited to birth certificate 
information, many states opt to stratify by race or ethnicity.  Stratification of the sample 
instills the ability to make inferences about subgroups of public health interest, and it 
allows for comparisons to be made across groups.  A probability sample was surveyed, 
or in other words, the sample was selected so that within each stratum there was an 
equal probability of selecting each record.  Within each stratum, systematic sampling 
was employed to select the sample.  The sampling fraction (1/f), or the probability of 
selection, was calculated based upon the estimated sampling frame size for the stratum 
and the desired sample size for that stratum.  Then, a number between one and f was 
chosen at random, that record was selected, and every fth record following was also 
selected.  Sampling for PRAMS surveillance occurs on a monthly basis within two and 
six months following delivery, although the ideal time frame is two to four months 
following delivery.  The two-month mark is designated to allow for an examination of 
factors occurring in early infancy, and the four- or six-month mark is designated to 
minimize recall bias, to increase the probability of locating the mother, and for 
comparison among respondents.  Each participating state samples approximately 1,000 
to 3,400 mothers annually. 
 
   
81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 [Note:  Covariance is allowed among all exogenous variables.] 
Figure 4.  Preconception health framework – Project 2. 
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Table 3.  State rankings according to infant mortality rates (deaths per 1,000 live births), 
2003-2005, and current PRAMS participation. 
 
State Ranking 
(1 = low; 51 = high) 
Infant 
Mortality PRAMS 
State Ranking 
(continued) 
Infant 
Mortality PRAMS 
1.  Minnesota 4.8 * 25.  Hawaii 6.7 * 
2.  Massachusetts 4.9 * 27.  Kentucky 6.8  
2.  Utah 4.9 * 28.  Wyoming 7.0 * 
4.  New Hampshire 5.0  29.  Kansas 7.1  
5.  California 5.2 **** 30.  Florida 7.2 * 
6.  Iowa 5.4  30.  South Dakota 7.2 * 
6.  New Jersey 5.4 * 32.  Pennsylvania 7.3 * 
6.  Vermont 5.4 * 33.  Illinois 7.5 * 
6.  Washington 5.4 * 33.  Virginia 7.5 * 
10.  Connecticut 5.5  35.  Missouri 7.6 * 
11.  Oregon 5.7 * 36.  West Virginia 7.7  
12.  Maine 5.9 * 37.  Ohio 7.8 * 
12.  Nebraska 5.9 * 38.  Indiana 7.9 **** 
12.  Nevada 5.9  38.  Oklahoma 7.9 * 
15.  New York 6.0 * 40.  Maryland 8.0 * 
16.  Idaho 6.1  40.  Michigan 8.0 * 
16.  New Mexico 6.1 * 42.  Arkansas 8.3 * 
18.  Rhode Island 6.2 * 43.  Georgia 8.4 * 
19.  Colorado 6.3 * 44.  North Carolina 8.6 * 
19.  Wisconsin 6.3 * 45.  Tennessee 8.9 * 
21.  Alaska 6.4 * 46.  Alabama 9.0 * 
21.  Montana 6.4 **** 46.  Delaware 9.0 * 
21.  North Dakota 6.4 **** 46.  South Carolina 9.0 * 
21.  Texas 6.4 * 49.  Louisiana 9.8 * 
25.  Arizona 6.7  50.  Mississippi 10.7 * 
   51. Washington D.C. 12.2 **** 
Note:  * = state currently participating in PRAMS; **** = state previously participating in PRAMS 
(Adapted from Kaiser Family Foundation, 2009) 
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Table 4.  Selected state demographic and birth data characteristics – Project 1. 
Selected Characteristics United 
States 
Maine New 
Jersey 
Ohio Utah Vermont 
Number of births, 2006 4,265,555 14,151 115,593 150,593 53,504 6,511 
Number of births per 1,000 
population 
14.2 10.7 13.2 13.1 21.0 10.4 
Percentage of live births by race/ethnicity, 2006 
     Non-Hispanic White 54.1 94.0 49.5 77.0 78.9 95.2 
     Non-Hispanic Black 14.5 2.1 15.2 15.8 0.9 1.1 
     Non-Hispanic   
     Asian/Pacific Islander 
5.3 1.6 9.6 2.0 3.0 1.7 
     Hispanic 24.4 1.5 25.4 4.5 15.4 1.1 
Number of infant deaths, 
2006 
28,527 89 632 1,170 273 36 
Infant mortality rate, 2003-
2005 
6.8 5.9 5.4 7.8 4.9 5.4 
Infant mortality rate by race/ethnicity, 2003-2005 
     Non-Hispanic White 5.7 5.8 3.7 6.4 4.5 5.3 
     Non-Hispanic Black 13.6 X 11.9 15.6 X X 
     Hispanic 5.6 X 5.2 6.5 5.8 X 
Median annual household 
income, 2005-2007  ($) 49,901 47,160 65,933 47,750 55,974 51,566 
Health insurance coverage of nonelderly women, 0-64  (%) 
     Medicaid 9.6 17.1 6.5 10.3 6.4 15.5 
     Uninsured 17.7 9.9 16.8 13.2 16.5 12.2 
Percentage of mothers in 
prenatal care in the first 
trimester, 2006 
83.2 87.7 77.6 72.9 80.2 83.8 
(Adapted from Kaiser Family Foundation, 2009)  
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Analysis weights.  Analysis weights are calculated by the CDC for each state to 
adjust for sample size, nonresponse, and omissions in the sampling frame.   
A. Adjustment for sample size:  Sampling weight is defined as the reciprocal of 
the sampling fraction, or selection probability for a particular stratum.  For 
example, if one out of every 100 mothers is sampled, the sampling frame 
would be 1/100.  The reciprocal of the sampling frame would be 100, and 
each mother in the sample, therefore, represents 100 mothers in the 
population.   
B. Adjustment for nonresponse:  When a mother in the sample fails to complete 
the questionnaire, nonresponse bias may be introduced.  To adjust for 
incompletion, the unit nonresponse weight is calculated.  Factors associated 
with response to PRAMS include maternal age, education, marital status, 
trimester of first visit to prenatal care, race, Hispanic ethnicity, and unknown 
birthweight.  The unit nonresponse weight is derived as the ratio of the 
number of sampled mothers in the response category to the number of 
respondent mothers in the response category.   
C. Adjustment for noncoverage:  Sometimes mothers may not be included in the 
sampling frame.  Adjustment for such omission is defined as a sampling 
frame noncoverage weight.  Examples of factors associated with 
noncoverage include stratum, maternal county of residence, and hospital of 
delivery.  This type of weight is computed as the ratio of the number of 
mothers on the “corrected frame” (sum of original sampling frame and the 
missed mothers) in the noncoverage category to the number of mothers in 
the original frame in the noncoverage category.   
An analysis weight is subsequently calculated as the product of the sampling weight, the 
unit nonresponse weight, and the sampling frame noncoverage weight.  And, therefore, 
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the sum of the analysis weights for respondents should equal the number of mothers 
eligible for PRAMS in the state.  These weights are applied by the CDC to state data and 
will be used in this study.   
 Sub-analyses.  Recall bias may result from an extend time period between the 
date of the infant’s birth and the date of the PRAMS questionnaire completion.  A sub-
analysis will be conducted to determine the effect of recall bias in the PRAMS 
population.  Also, there may be differences between early and late responders in this 
study.  The statistical weights applied by the CDC account for response differences to 
some extent.  For further analysis, a sub-analysis will be conducted to determine the 
effect of response waves within the PRAMS population.  The CDC does not release 
these dates for public use (Morrow, B., February 1, 2010).  Therefore, the sub-analysis 
will be conducted via a rough proxy examining the differences between mail and 
telephone respondents. 
 Geographic location.  Geographic location may influence the incidence of 
adverse pregnancy outcomes in this study.  Only one-half to two-thirds of all PRAMS 
participating states collect geographic information about respondents (D’Angelo, D.V., 
December 18, 2009).  Each state uses its own algorithm to calculate this information 
based upon county of residence, and therefore, the degree of interstate consistency is 
unknown (D’Angelo, D.V., December 18, 2009).  This is a limitation of the PRAMS 
dataset. 
 Missing data.  Through repeated contacts using the modified Dillman method, 
the CDC attempts to reduce the amount of missing data in PRAMS.  When items from 
the written survey are missing, the item is coded as missing.  The survey is not 
discarded and the item is not imputed.  Item non-response varies widely depending on 
the item, and those items skipped most frequently include height, weight, and dates 
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(D’Angelo, D.V., December 17, 2009).  Even so, this item non-response occurs 
infrequently, or less than 10% of the time.  This is a limitation of the PRAMS dataset. 
Sample size.  This study will analyze the data using confirmatory factor analysis 
and path analysis with latent variables, methods used in structural equation modeling 
(SEM).  With regard to sample size in SEM, some references suggest that a sample 
larger than 100 subjects or five times the number of study variables should be used 
(Hatcher, 1994).  The greatest number of variables used in any model of this study is 24, 
so the minimum number needed in the sample would be 120.  However, other 
references suggest that models reach stability with larger sample sizes, such as 800 to 
1,200 subjects (MacCallum, et al., 1992).  These larger sample sizes are recommended 
for studies in which many model modifications are anticipated (MacCallum, et al., 1992).  
With data collected over a four-year period with 1,000 to 3,400 subjects annually per 
state, the minimum number of subjects available for any part of this study will be about 
20,000 subjects.  This increases the power of the study and exceeds the size limitations 
associated with structural equation modeling procedures. 
 Instrumentation.  The PRAMS questionnaire was first developed in 1987.  The 
instrument was then edited and revised by the CDC with state participation until April 
2004 when the phase five questionnaire was developed that is in use today.  PRAMS 
undergoes continuous assessment and evaluation to revise item material and to meet 
the public health needs of each state.  In the phase five PRAMS questionnaire, there are 
three types of questions:  core questions, standard state questions, state-specific 
questions.  Core questions are used by every participating state.  Standard state 
questions are optional questions of interest for each state that were developed by the 
CDC with significant state and researcher input.  Currently, states may choose from 185 
standard questions for their surveys.  In addition, states may develop their own specific 
questions beyond the standard state questions that do not address topics of general 
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interest.  Two types of questionnaires are used with PRAMS surveillance, as discussed 
previously:  a self-administered mail questionnaire or an interviewer-administered 
telephone questionnaire.  Both questionnaire types contain the same research 
questions, but formatting is slightly altered for ease with telephone use.  The 
questionnaires are available in English and Spanish languages.  The range of the 
number of questions for the PRAMS questionnaire varies per state and per year.  On 
average, each questionnaire contains between 75 and 80 questions (D’Angelo, D.V., 
December 17, 2009).  Since 2000, the shortest survey contained 60 questions and the 
longest survey contained 90 questions, but these survey lengths are not the norm for 
PRAMS questionnaires (D’Angelo, D.V., December 17, 2009). 
 IRB approval.  This study involves research with human subjects, but it meets the 
criteria for Institution Review Board (IRB) exemption.  According to exemption category 
45 CFR 46.101(b)(4), “Research involving the collection or study of existing data, 
documents, records, pathological specimens, or diagnostic specimens, if these sources 
are publicly available or if the information is recorded by the investigator in such a 
manner that participants cannot be identified, directly or through identifiers linked to the 
participants” (University of South Florida Office of Research, Division of Research 
Integrity and Compliance, 2008, pp. 4).  PRAMS data is publicly available, and the data 
requested for this study would be de-identified by the CDC prior to data release.  
Therefore, this study should be acceptable for exemption status by the IRB.  An 
application for IRB exemption will be submitted prior to work with the PRAMS data. 
 Data acquisition.  In previous years, the CDC has provided PRAMS data to 
individuals through an application proposal process.  The application process (CDC, 
2008f) includes submission of a four to eight page research proposal from which the 
CDC PRAMS team will ascertain the suitability of PRAMS data for the proposed analysis 
and the appropriateness of the analysis plan given the PRAMS survey design.  Once 
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approved, the CDC will send the proposal for state review, and potential state-specific 
paperwork may follow.  Researchers listed on the proposal (in this case, one researcher) 
will then be required to complete a data sharing agreement form, in which specific 
guidelines are outlined.  These guidelines include statements requiring 
acknowledgement of the PRAMS Working Group and the CDC for any oral or written 
presentation.  They also state that all oral or written presentation of the study results 
must be submitted to the CDC and all PRAMS-participating states for review prior to 
submission for publication or presentation at a meeting.  In addition, the guidelines 
require that all copies of data must be destroyed and confirmed in writing, or returned to 
the CDC upon completion of the proposed analyses. 
 Currently, the CDC is in the process of negotiating data sharing agreements with 
all PRAMS-participating states.  There is a hold on the release of data to outside 
researchers, and completion of this process is projected for January of 2010 (D’Angelo, 
D.V., July 31, 2009; November 3, 2009).  It is possible to contact each state individually 
to complete each state’s application process for obtaining state-level PRAMS data.  
However, based upon preliminary investigation, it would be difficult to obtain the needed 
information in a cohesively formatted dataset without cost.  Thus, I have come to an 
arrangement with the CDC to facilitate the implementation of this study (D’Angelo, D.V., 
November 3, 2009).  During the CDC’s holding period, each of the five states in Project 
1 of this study will be contacted directly to obtain only permission for use of their 
respective state data.  Repeated e-mails, letters, or telephone calls will be made as 
needed in an attempt to obtain permission from all five states included in Project 1.  
Once permission is obtained, the CDC will provide the state data pending approval of 
the CDC’s application proposal process.  Once the hold is removed, a separate 
application will be submitted to the CDC to obtain the data required for the analysis of all 
PRAMS-participating states in Project 2. 
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 Variables and constructs.  The variables and constructs of the preconception 
health framework were directly measured or inferred from birth certificate data and the 
PRAMS questionnaire.  Selected variables from birth certificate data include 
race/ethnicity, education level, and birth weight (used to designate low birth weight 
status and to calculate small for gestational age status).  Selected variables from the 
core portion of the PRAMS questionnaire include health insurance status (excluding 
Medicaid), Medicaid status, income level, external stress, physical abuse, pregnancy 
intention, maternal age, previous pregnancy outcomes, contraceptive use, folic acid use, 
avoidance of tobacco, avoidance of alcohol, initiation of prenatal care, prenatal 
education, maternal complications, alcohol use during pregnancy, tobacco use during 
pregnancy, infant sleep position, infant feeding practices, infant medical care, postnatal 
tobacco use, infant smoke exposure, length of maternal hospital stay, preterm delivery, 
use of the Neonatal Intensive Care Unit (NICU), length of infant hospital stay, and infant 
mortality.  BMI will be calculated from core PRAMS questions ascertaining maternal 
weight and height, and small for gestational age (SGA) status will be calculated via an 
algorithm based on birth weight (birth certificate data) and gestational age (PRAMS 
data).  To identify the framework, the measured outcome variable adverse pregnancy 
outcomes will be defined as a Z-score composite of the following indicator variables:  
length of maternal hospital stay, preterm delivery, use of the NICU, length of infant 
hospital stay, and infant mortality.  Due to the variability in scale of these variables, Z-
scores are used to provide standardization for the composite.  In addition, selected 
variables from standard state questions include obtaining oral care and obtaining 
medical care, and these variables will be included in Project 1.  All of the variables in the 
preconception framework, and their associated survey items, are identified in Table 5. 
 To reiterate, in Project 1 of this study, the preconception health framework (Figure 
1) will be analyzed for the following five states:  Maine, New Jersey, Ohio, Utah, and 
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Vermont.  Four of these five states are among the twelve states with the lowest infant 
mortality rate.  These five states are also not racially and ethnically diverse, so a second 
set of states will be analyzed, pending acceptable fit of the reduced framework, to 
evaluate the reliability of the framework in Project 2.  However, the state-specific items in 
the framework (obtaining oral care and obtaining medical care) were not chosen by any 
other states for survey inclusion and are, therefore, not available for inclusion in Project 
2.  Thus, Project 2 of this study will rely on core questions only, discarding the state-
specific items related to the variables of obtaining oral care and obtaining medical care.  
The fit of the reduced framework, based on the fixed parameters of the entire framework, 
will be determined prior to implementation of Project 2.  This will determine the effect of 
the two state-specific items, and whether or not the study should proceed without the 
inclusion of these variables.  Pending an acceptable fit, the framework (Figure 4) will be 
analyzed among all PRAMS-participating states.   
 
Table 5.  Operationalization of the variables of the preconception health framework. 
 
VARIABLE OR 
CONSTRUCT 
# SURVEY ITEMS AND RESPONSE OPTIONS SCALE 
ENVIRONMENTAL FACTORS 
Income 54 During the 12 months before your new baby 
was born, what was your total household 
income before taxes?  (Include your income, 
your husband’s or partner’s income, and any other 
income you may have used.) 
A. Less than $10,000 
B. $10,000 to $14,999 
C. $15,000 to $19,999 
D. $20,000 to $24,999 
E. $25,000 to $34,999 
F. $35,000 to $49,999 
G. $50,000 or more 
Ordinal 
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Health Insurance 
Status 
1 
 
Just before you got pregnant, did you have 
health insurance? (Do not count Medicaid) 
     A.  No 
     B.  Yes 
Ordinal 
Medicaid Status 2 Just before you got pregnant, were you on 
Medicaid? 
     A.  No 
     B.  Yes 
Ordinal 
Education Level 
 
From birth certificate data Nominal 
External Stress 31 
 
 
 
 
 
31a 
 
 
 31b 
 
 
31c 
 
31d 
 
31e 
 
31f 
 
 
31g 
 
 
31h 
 
 
31i 
 
31j 
 
31k 
 
31l 
 
 
31m 
This question is about things that may have 
happened during the 12 months before your 
new baby was born.   (For each item, circle Yes 
if it happened to you or circle No if it did not.) 
 
A close family member was very sick and had to 
go into the hospital. 
 
I got separated or divorced from my husband or 
partner. 
 
I moved to a new address. 
 
I was homeless. 
 
My husband or partner lost his job.   
 
I lost my job even though I wanted to go on 
working. 
 
I argued with my husband or partner more than 
usual. 
 
My husband or partner said he didn’t want me to 
be pregnant. 
 
I had a lot of bills I couldn’t pay. 
 
I was in a physical fight. 
 
My husband or partner or I went to jail. 
 
Someone very close to me had a bad problem 
with drinking or drugs. 
 
Someone very close to me died. 
 
Ordinal 
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Physical Abuse 32a 
 
 
 
 
 
 
32b 
During the 12 months before you got 
pregnant, did an ex-husband or ex-partner 
push, hit, slap, kick, choke, or physically hurt 
you in any other way? 
A. No 
B. Yes 
 
During the 12 months before you got 
pregnant, were you physically hurt in any way 
by your husband or partner? 
A. No 
B. Yes 
Ordinal 
 
 
 
 
 
 
Ordinal 
PERSONAL INFLUENCES 
Pregnancy Intention 10 
 
 
 
 
 
 
 
 
11 
Thinking back to just before you got pregnant 
with your new baby, how did you feel about 
becoming pregnant? 
A. I wanted to be pregnant sooner 
B. I wanted to be pregnant later 
C. I wanted to be pregnant then 
D. I didn’t want to be pregnant then or any 
time in the future 
 
When you got pregnant with your new baby, 
were you trying to get pregnant? 
A. No 
B. Yes 
Nominal 
 
 
 
 
 
 
 
 
Ordinal 
Maternal Age 4 Age derived from the following question: 
What is your date of birth? 
Ratio 
Race/Ethnicity 
 
From birth certificate data  Nominal 
Previous Pregnancy 
Outcomes 
8 
 
 
 
 
 
9 
 
Did the baby born just before your new one 
weight 5 pounds, 8 ounces (2.5 kilos) or less 
at birth? 
A. No 
B. Yes 
 
Was the baby just before your new one born 
more than 3 weeks before its due date? 
A. No 
B. Yes 
Ordinal 
 
 
 
 
 
Ordinal 
PRECONCEPTION HEALTH BEHAVIORS 
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Contraceptive Use 12 When you got pregnant with your new baby, 
were you or your husband or partner doing 
anything to keep from getting pregnant?  
(Some things people do to keep from getting 
pregnant include not having sex at certain times 
[rhythm] or withdrawal, and using birth control 
methods such as the pill, condoms, cervical ring, 
IUD, having their tubes tied, or their partner 
having a vasectomy.) 
A. No 
B. Yes 
Ordinal 
Weight Management 
 
 
 
5 
 
 
6 
BMI derived from the following questions: 
 
Just before you got pregnant with your new 
baby, how much did you weigh? 
 
How tall are you without shoes? 
Interval 
Folic Acid Use 3 During the month before you got pregnant 
with your new baby, how many times a week 
did you take a multivitamin or a prenatal 
vitamin?  (These are pills that contain many 
different vitamins and minerals.) 
A. I didn’t take a multivitamin or a prenatal 
vitamin at all. 
B. 1 to 3 times a week 
C. 4 to 6 times a week 
D. Every day of the week 
Ordinal 
Avoidance of 
Tobacco 
24 
 
 
 
 
25 
Have you smoked at least 100 cigarettes in the 
past 2 years?  (A pack has 20 cigarettes.) 
A. No  (skip 25) 
B. Yes 
 
In the 3 months before you got pregnant, how 
many cigarettes did you smoke on an average 
day?  (A pack has 20 cigarettes.) 
A. 41 cigarettes or more 
B. 21 to 40 cigarettes 
C. 11 to 20 cigarettes 
D. 6 to 10 cigarettes 
E. 1 to 5 cigarettes 
F. Less than 1 cigarette 
G. None (0 cigarettes) 
Ordinal 
 
 
 
 
Ordinal 
Avoidance of 
Alcohol 
28 
 
 
 
Have you had any alcoholic drinks in the past 
2 years?  (A drink is 1 glass of wine, wine cooler, 
can or bottle of beer, shot of liquor, or mixed 
drink.) 
Ordinal 
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29a 
 
 
 
 
 
 
 
 
 
29b 
A. No  (skip 29a and 29b) 
B. Yes 
 
During the 3 months before you got pregnant, 
how many alcoholic drinks did you have in an 
average week? 
A. 14 drinks or more a week 
B. 7 to 13 drinks a week 
C. 4 to 6 drinks a week 
D. 1 to 3 drinks a week 
E. Less than 1 drink a week 
F. I didn’t drink then 
 
During the 3 months before you got pregnant, 
how many times did you drink 5 alcoholic 
drinks or more in one sitting? 
A. 6 or more times 
B. 4 to 5 times 
C. 2 to 3 times 
D. 1 time 
E. I didn’t have 5 drinks or more in 1 sitting 
F. I didn’t drink then 
 
 
 
Ordinal 
 
 
 
 
 
 
 
 
 
Ordinal 
 
 
 
 
Obtaining Oral Care Y3a When did you have your teeth cleaned by a 
dentist or dental hygienist? 
a. Before my most recent pregnancy 
i. No 
ii. Yes 
 
 
 
Ordinal 
Obtaining Medical 
Care 
L17 Before you got pregnant with your new baby, 
did you talk with a doctor, nurse, or other 
health care worker to prepare for a healthy 
pregnancy and baby? 
A. No 
B. Yes  
  
Ordinal 
POSTNATAL FACTORS 
Infant Sleep Position 48 How do you most often lay your baby down to 
sleep now? 
A. On his or her side 
B. On his or her back 
C. On his or her stomach 
Nominal 
Infant Feeding 
Practices 
43 
 
 
 
 
44 
Did you ever breastfeed or pump breast milk 
to feed your new baby after delivery? 
A. No (skip to #47) 
B. Yes 
 
Are you still breastfeeding or feeding pumped 
Ordinal 
 
 
Ordinal 
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45 
 
 
 
 
 
46 
milk to your new baby? 
A. No  
B. Yes (skip to #46) 
 
How many weeks or months did you 
breastfeed or pump milk to feed your baby? 
A. [  ]  Weeks 
B. [  ]  Months 
C. Less than 1 week 
 
How old was your baby the first time you fed 
him or her anything besides breast milk?  
(Include formula, baby food, juice, cow’s milk, 
water, sugar water, or anything else you fed your 
baby). 
A. [  ]  Weeks 
B. [  ]  Months 
C. My baby was less than 1 week old 
D. I have not fed my baby anything besides 
breast milk 
 
 
 
 
 
Ratio 
 
 
 
 
 
Ratio 
Infant Medical Care 49 
 
 
 
50 
Was your new baby seen by a doctor, nurse, 
or other health care worker during the first 
week after he or she left the hospital? 
A. No 
B. Yes 
 
Has your new baby had a well-baby checkup?  
(A well-baby checkup is a regular health visit for 
your baby usually at 2, 4, or 6 months of age). 
A. No  
B. Yes 
Ordinal 
 
 
Ordinal 
Postnatal Tobacco 
Use 
27 How many cigarettes do you smoke on an 
average day now?  (A pack has 20 cigarettes.) 
A. 41 cigarettes or more 
B. 21 to 40 cigarettes 
C. 11 to 20 cigarettes 
D. 6 to 10 cigarettes 
E. 1 to 5 cigarettes 
F. Less than 1 cigarette 
G. None (0 cigarettes) 
Ordinal 
Infant Smoke 
Exposure 
47 About how many hours a day, on average, is 
your new baby in the same room with 
someone who is smoking? 
A. [  ]  Hours 
B. Less than 1 hour a day 
C. My baby is never in the same room with 
someone who is smoking 
Ratio 
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PRENATAL FACTORS 
Initiation of Prenatal 
Care 
15 How many weeks or months pregnant were 
you when you had your first visit for prenatal 
care?  (Do not count a visit that was only for a 
pregnancy test or only for WIC [the Special 
Supplemental Nutrition Program for Women, 
Infants, and Children].) 
     A.  [  ]  Weeks 
           [  ]  Months 
     B.  I didn’t go for prenatal care 
Ratio 
Prenatal Education 19 
 
 
 
 
 
 
 
 
19a 
 
 
19c 
 
 
19d 
 
19e 
 
 
19f 
 
 
19g 
 
19h 
 
 
19i 
 
19j 
 
 
19k 
During any of your prenatal care visits, did a 
doctor, nurse, or other health care worker talk 
with you about any of the things listed below?  
(Please count only discussions, not reading 
materials or videos.  For each item, circle Y [Yes] 
if someone talked with you about it or circle N [No] 
if no one talked with you about it.) 
 
How smoking during pregnancy could affect my 
baby. 
 
How drinking alcohol during pregnancy could 
affect my baby. 
 
Using a seat belt during my pregnancy. 
 
Birth control methods to use after my pregnancy.   
 
Medicines that are safe to take during my 
pregnancy. 
 
How using illegal drugs could affect my baby. 
 
Doing tests to screen for birth defects or diseases 
that run in my family. 
 
What to do if my labor starts early. 
 
Getting tested for HIV (the virus that causes 
AIDS). 
 
Physical abuse to women by their husbands or 
partners. 
 
Ordinal 
Maternal 
Complications 
22 
 
 
 
 
Did you have any of these problems during 
your most recent pregnancy?  (For each item, 
circle Y [Yes] if you had the problem or circle N 
[No] if you did not.) 
 
Ordinal 
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22b 
 
 
22c 
 
22d 
 
22e 
 
22f 
 
 
22g 
 
 
 
22h 
 
 
22i 
 
 
22j 
 
 
 
22k 
High blood sugar (diabetes) that started during 
this pregnancy. 
 
Vaginal bleeding. 
 
Kidney or bladder (urinary tract) infection. 
 
Severe nausea, vomiting, or dehydration. 
 
Cervix had to be sewn shut (incompetent cervix). 
 
High blood pressure, hypertension (including 
pregnancy-induced hypertension [PIH], 
preeclampsia, or toxemia). 
 
Problems with the placenta (such as abruptio 
placentae or placenta previa). 
 
Labor pains more than 3 weeks before my baby 
was due (preterm or early labor). 
 
Water broke more than 3 weeks before my baby 
was due (premature rupture of membranes 
[PROM]). 
 
I had to have a blood transfusion. 
 
Alcohol Use During 
Pregnancy 
28 
 
 
 
 
 
 
30a 
 
 
 
 
 
 
 
 
 
30b 
Have you had any alcoholic drinks in the past 
2 years?  (A drink is 1 glass of wine, wine cooler, 
can or bottle of beer, shot of liquor, or mixed 
drink.) 
A. No  (skip 30a and 30b) 
B. Yes 
 
During the last 3 months of your pregnancy, 
how many alcoholic drinks did you have in an 
average week? 
A. 14 drinks or more a week 
B. 7 to 13 drinks a week 
C. 4 to 6 drinks a week 
D. 1 to 3 drinks a week 
E. Less than 1 drink a week 
F. I didn’t drink then 
 
During the last 3 months of your pregnancy, 
how many times did you drink 5 alcoholic 
drinks or more in one sitting? 
A. 6 or more times 
B. 4 to 5 times 
C. 2 to 3 times 
D. 1 time 
E. I didn’t have 5 drinks or more in 1 sitting 
F. I didn’t drink then 
Ordinal 
 
 
 
 
 
 
Ordinal 
 
 
 
 
 
 
 
 
 
Ordinal 
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Tobacco Use During 
Pregnancy 
24 
 
 
 
 
26 
Have you smoked at least 100 cigarettes in the 
past 2 years?  (A pack has 20 cigarettes.) 
A. No  (skip 26) 
B. Yes 
 
In the last 3 months of your pregnancy, how 
many cigarettes did you smoke on an average 
day?  (A pack has 20 cigarettes.) 
A. 41 cigarettes or more 
B. 21 to 40 cigarettes 
C. 11 to 20 cigarettes 
D. 6 to 10 cigarettes 
E. 1 to 5 cigarettes 
F. Less than 1 cigarette 
G. None (0 cigarettes) 
Ordinal 
 
 
 
 
Ordinal 
ADVERSE PREGNANCY OUTCOMES 
 
 
Maternal Morbidity 
 
Length of Maternal 
Hospital Stay 
 
 
 
35 
 
 
 
 
37 
Length of Hospital Stay derived from the 
following questions: 
 
When did you go into the hospital to have your 
baby? 
A. [  ]  Month  Day  Year 
B. I didn’t have my baby in a hospital 
 
When were you discharged from the hospital 
after your baby was born?  (It may help to use 
the calendar) 
A. [  ]  Month Day Year 
B. I didn’t have my baby in a hospital 
Ratio 
 
 
Infant Morbidity  
Preterm Delivery 
 
 
34 
 
36 
Preterm Delivery derived from the following 
questions: 
 
When was your baby due? 
     [  ]  Month Day Year 
 
When was your baby born? 
     [  ]  Month Day Year 
Ratio 
Low Birth Weight 
 
Low Birth Weight:  derived from birth 
certificate data 
Ratio 
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Small for Gestational 
Age 
 
Small for Gestational Age:  derived via an 
algorithm based upon birth weight and 
gestational age 
Interval 
Use of NICU 39 
 
After your baby was born, was he or she put in 
an intensive care unit? 
A. No 
B. Yes 
C. I don’t know 
Ordinal 
 
Length of Infant 
Hospital Stay 
40 After your baby was born, how long did he or 
she stay in the hospital? 
A. Less than 24 hours (less than 1 day) 
B. 24 to 48 hours (1 to 2 days) 
C. 3 days 
D. 4 days 
E. 5 days 
F. 6 days or more 
G. My baby was not born in a hospital 
H. My baby is still in the hospital 
Ordinal 
 
 
Infant Mortality 
 
Infant Mortality 41 Is your baby alive now? 
A. No 
B. Yes 
Ordinal 
 
 
 Scales of measurement.  This study includes variables of all levels of 
measurement:  nominal, ordinal, interval, and ratio-level variables.  The nominal 
variables, race/ethnicity, pregnancy intention, and infant sleep position (item 10) will be 
dummy coded for analysis purposes.  Maternal age, initiation of prenatal care, infant 
feeding practices, and infant smoke exposure are ratio-level variables, as are the items 
associated with preterm delivery, low birth weight, and length of maternal hospital stay.  
Gestational age will be collapsed to an ordinal level item, and preterm delivery will be 
categorized as a gestational age of 37 weeks or less.  Birth weight will be collapsed into 
an ordinal level item, and low birth weight will be categorized as a birth weight of 2,500 
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grams (5 pounds, 8 ounces) or less; very low birth weight as 1,500 grams (3 pounds, 5 
ounces) or less; and extreme low birth weight as less than 1,000 grams (2 pounds, 3 
ounces).  Maternal and infant hospital stay items will be collapsed into ordinal level 
items.  The average length of infant hospitalization in both regular and cesarean 
deliveries resulting in birth trauma is 3 days (Nair, 2007).  Excessive infant length of 
hospital stay will be categorized as a length of stay of 4 days or more.  Regarding 
maternal length of hospital stay, most federal and state legislation requires insurance 
plans to cover postpartum hospital stays of ≥48 hours for vaginal deliveries and ≥72 or 
96 hours for cesarean sections (Datar & Sood, 2006; Liu, Dow, & Norton, 2004).  
Cesarean section is considered a complication of the delivery process, and therefore, a 
type of maternal morbidity (Danel, Berg, Johnson, & Atrash, 2003).  Thus, the length of 
hospital stay due to cesarean section will not represent the upper limit in this case 
(Danel, Berg, Johnson, & Atrash, 2003).  Excessive maternal length of hospital stay will 
be categorized as a length of stay of 4 days or more.  Body Mass Index (BMI), a proxy 
for the interval-level weight management variable, will be calculated based upon 
participants’ reported weight and height.  Then, to accommodate the nonlinear parabolic 
curve attributed to BMI, a standard score will be developed.  A standard score indicates 
how many standard deviations a particular result is above or below the mean.  All 
remaining variables are ordinal-level or categorical variables.   
Data Analysis 
Both Projects 1 and 2 will be separately analyzed, pending acceptable fit of the 
reduced model based on the fixed parameters of the entire framework, using the 
following analysis plan.  For cross-validation purposes, the datasets associated with 
Project 1 and Project 2 will each be randomly divided into two subsamples prior to 
analysis.  Subsample A will be used as a calibration sample to build and test the 
proposed framework, and Subsample B will be used as the validation sample to only test 
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the proposed framework (Cudeck & Browne, 1983).  Replication of the study 
accomplished via cross-validation estimates the generalized performance of a predictive 
model, and both samples in this study are large enough to utilize this type of cross-
validation procedure (Cudeck & Browne, 1983). 
 Data analyses will be performed for each project of this study, including univariate 
procedures, bivariate procedures, confirmatory factor analysis, and structural equation 
modeling.  Univariate data analysis will be performed to determine the frequency and 
descriptive statistics of all exogenous variables.  Bivariate correlations will be performed 
to determine associations between all variables, which may influence the selection of 
variables for further analyses. 
 Answers to the proposed research questions for this study will be ascertained 
through the use of structural equation modeling.  Structural equation modeling (SEM), or 
path analysis, is a multivariate statistical method often used to test theoretical models 
and the underlying relationships that lie therein (Hatcher, 1994).  SEM provides an 
outlook on whether the model fits the data, as a whole, and then it examines significance 
tests for any causal relationships specified (Hatcher, 1994).  If there is a poor fit between 
the model and the data, the model may be modified to improve the fit (Hatcher, 1994).  
The reference to causal relationships is not entirely accurate for all SEM analyses, as 
the conditions of causality must be met in the study regardless of the use of SEM.  
These conditions include an association between the variables thought to exhibit cause-
and-effect (constant conjunction), a temporal ordering between the variables (the cause 
precedes the effect, antecedence), and ruling out alternative explanations (necessary 
conjunction) (Slife & Williams, 1995).  This study is a cross-sectional design, and thus, 
causality cannot be determined due to a lack of temporal ordering.  
SEM is achieving wider recognition in the social sciences.  SEM and regression methods 
exhibit similar characteristics, as both are part of the general linear model family (Buhi, 
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Goodson, & Neilands, 2007).  Both methods assess linear combinations of variables, 
maximize explained variance and minimize model error variance through the use of 
weights, use latent variables (underlying variables not directly observed), and produce 
effect sizes which account for variance (Buhi, Goodson, & Neilands, 2007).  According to 
Buhi and colleagues, when compared to other multivariate methods of analysis, SEM 
has several advantages:  1) the relationships between multiple independent and 
dependent variables may be evaluated in part or as a whole; 2) the ability to test 
hypotheses across several variables at once controls for inflations in experimentwise, or 
Type 1, error; 3) SEM allows for the testing of theory-driven models with empirical data; 
4) SEM examines relationships among latent variables with multiple observed variables 
reducing measurement error; and 5) SEM software provides advanced solutions for the 
treatment of missing data, such as optimal full information maximum likelihood (FIML) 
(Wothke, 2000; Arbuckle, 1996).  In addition, SEM is useful method to comprehensively 
test and develop theoretical models (Anderson & Gerbing, 1988). 
A comprehensive two-step approach to modeling allows the researcher to make 
meaningful inferences about constructs and their relationships while avoiding false 
inferences (Anderson & Gerbing, 1988).  The following two-step modeling approach is 
recommended for structural equation modeling (Kline, 1998; Hatcher, 1994).   
First, in Subsample A only, a measurement model will be developed and validated 
through the use of confirmatory factor analysis to determine item retention (Anderson & 
Gerbing, 1988).  A measurement model describes the relationships between latent 
constructs and their associated indicator variables (Hatcher, 1994; Anderson & Gerbing, 
1988).  Indicator variables must demonstrate a high level of convergent validity, or in 
other words, they must all be clearly measuring the same underlying construct (Hatcher, 
1994).  Model fit measures the extent to which the predicted covariances in the model 
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compare to observed covariances in the data, which is equivalent to diminishing the type 
II error (Garson, 2009).   
  There is no general agreement on preferred measures of fit, and therefore, 
different fit indices are reported for different research studies (Maruyama, 1998).  The 
use of several fit indices is recommended for triangulation (Klem, 2000).  Measures of fit 
may be assessed through the use of many fit indices, including among others the chi-
square statistic, the non-normed fit index (NNFI), the comparative fit index (CFI), the root 
mean square error of approximation (RMSEA), and the standardized root mean square 
residual (SRMR) (Klem, 2000).  With assumptions of a large sample size and 
multivariate normal distribution met, the chi-square test is a generally recognized fit 
index to test the null hypothesis that the model fits the observed data (Henson, 1999; Hu 
& Bentler, 1995).  Good overall fit of a model is generally determined by a relatively 
small chi-square value with a corresponding p-value close to one (Hatcher, 1994).  
However, large samples typically indicate a significant chi-square statistic even when 
there is good model fit (James, et al., 1982).  Thus, a relatively small chi-square value 
depends upon the degrees of freedom associated with the analysis (Hatcher, 1994).  
Researchers often accept the rule of thumb that the chi-square/degrees of freedom ratio 
should be less than two, but this is somewhat arbitrary and should be used with caution 
(Hatcher, 1994).  Due to the categorical nature of the indicator variables in this study, 
maximum likelihood estimation or weighted least squares estimation is recommended 
(M-plus, 2009).  To supplement the findings of the chi-square statistic, the non-normed 
fit index (NNFI), the comparative fit index (CFI), the root mean square error of 
approximation (RMSEA), and the standardized root mean square residual (SRMR) will 
also be analyzed.  The NNFI (Bentler & Bonett, 1980) and the CFI (Bentler, 1989) are 
recommended as overall goodness of fit indices, and a value over 0.9 indicates 
acceptable model fit (Hatcher, 1994).  The RMSEA is less affected by sample size than 
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the chi-square statistic, and therefore, has more descriptive value across various sample 
sizes (Meyers, Garnst, & Guarino, 2006).  According to Byrne, RMSEA cut-off values 
less than 0.08 are deemed acceptable and values greater than 0.10 are generally 
deemed unacceptable (Byrne, 1998).  With SRMR, a smaller value indicates better 
model fit, and a value of less than 0.08 is considered good fit (Hu & Bentler, 1998).  R2 
values will also be evaluated to determine the extent to which the independent variables 
account for the variability in adverse pregnancy outcomes (Hatcher, 1994).  R2 values 
range from zero to one, with higher values indicating a larger percent of variance 
accounted for (Hatcher, 1994).  Also, in a model with good fit, the absolute values of the 
normalized residual matrix should not exceed 2.0, the absolute value of the t statistics 
for each path coefficient should exceed 1.96, and the absolute value of standardized 
path coefficients should exceed 0.05 (Hatcher, 1994).  An acceptable model fit does not 
have to display all of these characteristics, but meeting more fit characteristics yields a 
greater degree of confidence in the model (Hatcher, 1994). 
 In the measurement model assessment, triangulation of measures of fit provides 
an evidentiary basis to determine the need for model modification (Hatcher, 1994).  
Modification indices may suggest ways to improve the fit of the model, and 
nonsignificant factor loadings may be examined for possible removal from the model 
(Hatcher, 1994).  The measurement model is therefore modified until it displays an 
acceptable fit to the data.  Any modified models will also be subjected to an analysis of 
overall model fit. 
 Second, the structural model is tested, in this case using path analysis with latent 
variables (Hatcher, 1994; Anderson & Gerbing, 1988).  The structural model will be 
tested in both Subsamples A and B.  The structural model determines if the model, as a 
whole, demonstrates an acceptable fit to the data (Hatcher, 1994; Anderson & Gerbing, 
1988).  Thus, the structural model demonstrates the predicted associations between the 
   
105 
 
constructs of theoretical interest (Hatcher, 1994).   
 After the measurement model demonstrates acceptable fit, a framework variation 
will be examined in both Projects 1 and 2 to assess the first proposed research question 
(see Table 6, Figure 5 for Project 1 and Table 7, Figure 6 for Project 2).  The path 
coefficients will be analyzed to determine the strength of associations between 
exogenous variables and adverse pregnancy outcomes.  The R2 values will be analyzed 
to determine the extent to which these groups of exogenous variables account for the 
variability in adverse pregnancy outcomes.  The proposed preconception health 
framework (Project 1) and the reduced preconception health framework (Project 2) will 
be subjected to the aforementioned measures of fit to assess how well they fit the 
sample data.   
 Statistical software.  Upon receipt of the data from the individual states, 
Statistical Analysis Software (SAS) will be used to combine the individual state datasets, 
dummy code variables, to calculate Z-scores, to calculate standard scores, and to 
calculate the formula variables, such as BMI and SGA.  M-plus statistical software will 
then be used to conduct the structural equation modeling procedures.  This software is 
capable of handling numerous dichotomous categorical variables, and it is also capable 
of handling the types of complex analysis or sampling weights used with PRAMS data 
(M-plus, 2009). 
Plans for Dissemination 
 This study will be submitted for publication in the American Journal of Public 
Health and the American Journal of Obstetricians and Gynecologists.  These results will 
also be submitted for the MCH Section of the APHA convention and for the National 
Summit on Preconception Health and Health Care. 
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Table 6.  Research question-specific analyses – Project 1. 
Research Questions Source of Data Type of Statistical 
Analysis 
1.  What is the relationship between 
preconception health behaviors and 
adverse pregnancy outcomes among 
women of reproductive age? 
 
Confirmatory 
Factor Analysis 
----------------------- 
SEM 
A. To what extent do preconception 
health behaviors explain the variance 
associated with adverse pregnancy 
outcomes? 
B. Which preconception health 
behaviors are most strongly associated 
with adverse pregnancy outcomes? 
Preconception behaviors 
     PRAMS Core Items:   
     3, 5, 6, 12, 24, 25, 28-29b 
     Standard State Items:  Y3a, L17 
Adverse pregnancy outcomes 
     PRAMS Core Items:  34-37, 39-  
                                        41 
     Birth certificate data:  LBW, SGA 
Figure 5 
2.  What is the relationship among 
preconception health behaviors, 
prenatal factors, postnatal factors, 
personal influences, environmental 
factors, and adverse pregnancy 
outcomes among women of 
reproductive age? 
 
Confirmatory 
Factor Analyses 
----------------------- 
SEM 
A. To what extent does the entire 
conceptual framework account for the 
variance associated with adverse 
pregnancy outcomes? 
B. Which factors are most strongly 
associated with adverse pregnancy 
outcomes? 
Preconception behaviors 
     PRAMS Core Items:   
     3, 5, 6, 12, 24, 25, 28-29b 
     Standard State Items:  Y3a, L17 
Prenatal factors 
     PRAMS Core Items:   
    15, 19a,c-k, 22b-k, 24, 26, 28,   
    30a-b 
Postnatal factors 
     PRAMS Core Items:  27, 43-50 
Environmental factors 
     PRAMS Core Items:   
     1, 2, 31, 32, 54 
Figure 3 
(full framework) 
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     Birth certificate data:  Education  
Personal Influences 
     PRAMS Core Items:  4, 8-11 
     Birth certificate data:   
                                    
Race/Ethnicity 
Adverse Pregnancy Outcomes 
     PRAMS Core Items:  34-37, 39-     
                                        41 
     Birth certificate data:  LBW, SGA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Conceptual framework for research questions 1A and 1B – Project 1. 
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Table 7.   Research question-specific analyses – Project 2. 
Research Questions Source of Data Type of Statistical 
Analysis 
1.  What is the relationship between 
preconception health behaviors and 
adverse pregnancy outcomes among 
women of reproductive age? 
 
Confirmatory Factor 
Analysis 
----------------------- 
SEM 
C. To what extent do preconception 
health behaviors explain the variance 
associated with adverse pregnancy 
outcomes? 
D. Which preconception health 
behaviors are most strongly associated 
with adverse pregnancy outcomes? 
Preconception behaviors 
     PRAMS Core Items:   
     3, 5, 6, 12, 24, 25, 28-29b 
Adverse pregnancy outcomes 
     PRAMS Core Items:  34-37, 39- 
                                        41 
     Birth certificate data:  LBW, 
SGA 
Figure 6 
2.  What is the relationship among 
preconception health behaviors, 
prenatal factors, postnatal factors, 
personal influences, environmental 
factors, and adverse pregnancy 
outcomes among women of 
reproductive age? 
 
Confirmatory Factor 
Analyses 
----------------------- 
SEM 
C. To what extent does the entire 
conceptual framework account for the 
variance associated with adverse 
pregnancy outcomes? 
D. Which factors are most strongly 
associated with adverse pregnancy 
outcomes? 
Preconception behaviors 
     PRAMS Core Items:   
     3, 5, 6, 12, 24, 25, 28-29b 
Prenatal factors 
     PRAMS Core Items:   
    15, 19a,c-k, 22b-k, 24, 26, 28,  
    30a-b 
Postnatal factors 
     PRAMS Core Items:  27, 43-50 
Environmental factors 
     PRAMS Core Items:   
     1, 2, 31, 32, 54 
     Birth certificate data:  Education  
Figure 4 
(full framework) 
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Personal Influences 
     PRAMS Core Items:  4, 8-11 
     Birth certificate data:   
                                    
Race/Ethnicity 
Adverse Pregnancy Outcomes 
     PRAMS Core Items:  34-37, 39- 
                                        41 
     Birth certificate data:  LBW, 
SGA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.   Conceptual framework for research questions 1A and 1B – Project 2.  
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Chapter 4:  Results 
 
Brief Overview 
The purpose of this study was to examine the impact of preconception health on 
adverse pregnancy outcomes through the theoretical lens of reciprocal determinism.  A 
non-experimental study in nature, this study involved an analysis of Pregnancy Risk 
Assessment Monitoring System (PRAMS) data, a cross-sectional survey designed and 
implemented by each participating state under the guidelines of the Centers for Disease 
Control and Prevention.  The aim was to develop a preconception health conceptual 
framework to account for the interactive relationships among behavior, environment, and 
the person.  The intention of the design was to answer the following research questions: 
1.  What is the relationship between preconception health behaviors and 
adverse pregnancy outcomes among women of reproductive age? 
a. To what extent do preconception health behaviors explain the 
variance associated with adverse pregnancy outcomes? 
b. Which factors are most strongly associated with adverse pregnancy 
outcomes? 
2. What is the relationship among preconception health behaviors, prenatal 
factors, postnatal factors, personal influences, environmental factors, and 
adverse pregnancy outcomes among women of reproductive age? 
a. To what extent does the entire framework explain the variance 
associated with adverse pregnancy outcomes? 
b. Which factors are most strongly associated with adverse pregnancy 
outcomes? 
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This chapter summarizes some changes made to the original plan of analysis 
(Chapter 3 – METHODS) because of characteristics associated with the datasets.  It 
also summarizes the results of this study including descriptive statistics, factor 
correlations, confirmatory factor analysis, and structural equation modeling conducted to 
examine the preconception health framework.  It is important to note that an issue with 
the postnatal variables in the framework.  Of the 431 women whose baby died in Project 
1 and of the 3,998 women whose baby died in Project 2, no one answered five of the six 
postnatal variables:  infant smoke exposure, infant medical care within the first week 
after birth, well-baby check-ups, breastfeeding duration, and infant sleep position.  
Postnatal maternal smoking was an exception to this lack of information with 133 and 
1,142 responses, respectively.  With a lack of information available for this population 
regarding these variables, data were not imputed due to the possibility of introducing 
bias.  Therefore postnatal variables were excluded from the following analyses.   
Study population.  As requested, the PRAMS dataset for Project 1 obtained 
from the Centers for Disease Control and Prevention (CDC) contained data from five 
states:  Maine, New Jersey, Ohio, Utah, and Vermont.  Vermont was removed from the 
analysis due to its automatic exclusion of the maternal race and Hispanic ethnicity 
variables as possible identifiers of their PRAMS population.  Of the four remaining states 
associated with Project 1, the first PRAMS dataset included 27,933 participants.  The 
PRAMS dataset for Project 2 contained data from all PRAMS participating states from 
2005-2008, with the exception of Vermont (32 states and one city – refer to Table 8).  Of 
the states associated with Project 2, the second PRAMS dataset included 200,008 
participants. 
Missing data.  Data were imputed for variables associated with skip patterns in 
the PRAMS questionnaire.  In one case, an item concerning alcohol consumption in the 
last two years was followed by questions regarding the frequency of alcohol 
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consumption and the occurrence of binge drinking in the preconception and prenatal 
periods.  If a woman did not consume alcohol in the last two years, the appropriate 
response would be: “I didn’t drink then.”  She would then skip the next two alcohol-
related questions.  Based upon this skip pattern, missing data in the two alcohol-related  
 
Table 8.  List of all PRAMS participating states 2005-2008 included in Project 2. 
Alaska Michigan * Rhode Island 
Arkansas * Minnesota South Carolina * 
Colorado Missouri Tennessee * 
Delaware * Mississippi * Utah 
Florida North Carolina * Washington 
Georgia * Nebraska Wisconsin 
Hawaii New Jersey West Virginia 
Illinois New Mexico Wyoming 
Louisiana * New York  
Massachusetts Ohio New York City 
Maryland * Oklahoma  
Maine Oregon  
Note:  * = Among the ten states with the highest infant mortality rates, 2003-2005 
 
items were re-coded as: “I didn’t drink then.”  Similarly, an item concerning smoking in 
the last two years was followed by the average number of cigarettes per day in the 
preconception, prenatal, and postnatal periods, respectively.  If a woman did not smoke 
in the last two years, the appropriate response would be: “None (zero cigarettes).”  She 
would then skip the next tobacco-related questions.  Based upon this skip pattern, 
missing data in the tobacco-related items were re-coded as: “None (zero cigarettes).”  
An examination of the randomness of missing data was conducted, and the 
contraceptive use variable and the oral health care variable were found to be the 
variables with the largest amount of missing data (53% and 39%, respectively).  The 
contraceptive use variable was, therefore, excluded from the analysis, and the oral 
health care variable was included in the analysis due to its pertinence to the framework, 
its uniqueness to Project 1, and its lower percentage of missing data.   
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Remaining missing data were removed by list-wise deletion.  In Project 1, this action 
resulted in a decrease from the original 27,933 participants to 12,239 participants.  In 
Project 2, this action resulted in a decrease from the original 200,008 participants to 
128,551 participants.  The demographic characteristics of the participants deleted from 
each sample are presented throughout the chapter as applicable. 
Variable modifications.  Upon receipt of the first PRAMS dataset, a few 
changes were made to the framework and to the calculation of composite variables.  An 
examination of the redundancy and pertinence of the four postnatal breastfeeding 
variables resulted in a reduction to one variable, duration of breastfeeding.  In addition, 
the adverse pregnancy outcomes and the maternal BMI variables were calculated 
differently than the z-score compilations originally planned.  The adverse pregnancy 
outcomes variable derives from the following variables (cutoffs based upon empirical 
literature):  use of the NICU, length of infant hospital stay (4 days or more), length of 
maternal hospital stay (4 days or more), low birth weight (2,500 grams or less), preterm 
delivery (259 days [37 weeks] or less), small for gestational age, and infant mortality.  
These variables were re-coded so the pertinent adverse pregnancy outcome would be 
equal to one with all other values equal to zero.  For example, a participant with a 1,578-
gram neonate would be assigned a “1” for the GRAM variable, whereas a participant 
with a 2,620-gram neonate would be assigned a “0” for the same variable.  The adverse 
pregnancy outcomes were then summed for each participant, resulting in a maximum 
adverse pregnancy outcomes value of “7” (experienced all adverse pregnancy 
outcomes) or a minimum value of “0” (experienced no adverse pregnancy outcomes).  
The adverse pregnancy outcomes variable was subsequently treated as a continuous 
variable.  To split the maternal BMI variable into underweight and overweight variables, 
two new vectors were created indicating the presence of underweight BMI (less than 
18.5 BMI, represented as the value of “1”) or the presence of overweight BMI (25.0 BMI 
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or higher, represented as the value of “1”).  Then, the new vectors were multiplied by the 
original maternal BMI variable, and the resulting new variables contained the 
underweight or overweight BMIs respectively.  Another variable modification involved the 
dummy coding of four nominal variables:  1) maternal race [reference group = white]; 2) 
pregnancy intention – timing [reference group = wanted to be pregnant then]; 3) 
pregnancy history [previous live birth was neither low birth weight nor preterm]; and 4) 
sleep position [side only].  In addition, the variables related to tobacco use (prior to 
pregnancy, during pregnancy, and after delivery), alcohol use (prior to pregnancy and 
during pregnancy; frequency and binge drinking), and abuse (before and during 
pregnancy) were reverse coded for ease in interpretation.  The variables associated with 
prenatal education and maternal complications were grouped as well.  The ten “Talk” 
variables were re-coded to equal “1” if the topic was discussed with a health care 
provider.  The talk variables were then summed for each participant represented as 
prenatal education.  Thus, the prenatal education variable ranged from a maximum 
value of 10 (discussed all listed topics with a health care provider) to a minimum value of 
0 (did not discuss any listed topics with a health care provider).  The ten maternal 
complication variables also were re-coded to equal “1” if the complication was 
experienced.  The complication variables were then summed for each participant 
represented as maternal complications.  Thus, the maternal complications variable 
ranged from a maximum value of 10 (experienced all listed complications) to a minimum 
value of 0 (did not experience any of the listed complications).   
Confirmatory Factor Analysis 
Descriptive statistics.  The sample was split into two random groups, one group 
containing 6,120 participants (Subsample A) and the other group containing 6,119 
participants (Subsample B).  Subsample A, a calibration sample, was designed to build 
and test the proposed framework; Subsample B, a validation sample, was designed 
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merely to test the framework.  The demographic characteristics of each random sample 
are shown in Table 9. 
 
Table 9.  Demographic characteristics of two random samples in Project 1. 
PROJECT 1 SAMPLE A (N=6,120) 
SAMPLE B 
(N=6,119) 
 Freq. Weighted Frequency Percent Freq. 
Weighted 
Frequency Percent 
AGE 
      
17 years of age or 
younger  
132 3,658 (1.5%) 111 3,823 (1.6%) 
18 to 19 years 330 14,564 (5.8%) 308 13,912 (5.7%) 
20 to 24 years 1,658 68,695 (27.4%) 1,654 61,275 (25.1%) 
25 to 29 years 1,981 82,611 (32.9%) 1,957 80,967 (33.1%) 
30 to 34 years 1,329 53,578 (21.4%) 1,384 56,042 (22.9%) 
35 to 39 years 582 23,080 (9.2%) 595 23,677 (9.7%) 
40 years of age or 
older 
108 4,639 (1.8%) 110 4,734 (1.9%) 
       
RACE/ETHNICITY 
      
HISPANIC       
Yes 310 10,503 (4.2%) 330 10,328 (4.2%) 
No 5,810 240,321 (95.8%) 5,789 234,103 (95.8%) 
       
RACE/ETHNICITY       
Other Asian 68 2,925 (1.2%) 74 2,969 (1.2%) 
White 5,563 222,328 (88.6%) 5,540 216,857 (88.7%) 
Black 383 17,757 (7.1%) 396 18,174 (7.4%) 
American Indian 39 1,400 (0.6%) 39 889 (0.4%) 
Chinese 6 501 (0.2%) 11 1,080 (0.4%) 
Japanese 3 114 (0.0%) 11 486 (0.2%) 
Filipino 3 32 (0.0%) 4 116 (0.0%) 
Hawaiian 2 95 (0.0%) 8 280 (0.1%) 
Other Nonwhite 37 4,019 (1.6%) 21 2,221 (0.9%) 
Alaskan Native 0 0 (0.0%) 0 0 (0.0%) 
Mixed Race 16 1,653 (0.7%) 15 1,358 (0.6%) 
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INSURANCE STATUS 
(excludes Medicaid)  
 
  
 
 
Insured  4,229 178,561 (71.2%) 4,216 168,099 (68.8%) 
Not insured  1,891 72,263 (28.8%) 1,903 76,331 (31.2%) 
       
MEDICAID STATUS 
      
Enrolled in Medicaid  863 31,347 (12.5%) 849 30,029 (12.3%) 
Not enrolled in 
Medicaid 
5,257 219,478 (87.5%) 5,270 214,402 (87.7%) 
       
INCOME LEVEL 
      
Less than $10,000 881 36,268 (14.5%) 876 33,946 (13.9%) 
$10,000 to $14,999 529 22,018 (8.8%) 499 19,374 (7.9%) 
$15,000 to $19,999 386 13,679 (5.5%) 364 14,269 (5.8%) 
$20,000 to $24,999 467 18,735 (7.5%) 456 18,117 (7.4%) 
$25,000 to $34,999 784 31,734 (12.7%) 783 31,453 (12.9%) 
$35,000 to $49,999 898 34,711 (13.8%) 927 35,668 (14.6%) 
$50,000 or more 2,175 93,679 (37.3%) 2,214 91,602 (37.5%) 
       
EDUCATION LEVEL 
      
0-8 years 71 2,803 (1.1%) 63 3,150 (1.3%) 
9-11 years 616 22,129 (8.8%) 587 18,344 (7.5%) 
12 years 1,919 73,198 (29.2%) 1,905 74,408 (30.4%) 
13-15 years 1,617 70,847 (28.2%) 1,620 71,840 (29.4%) 
16 years or more 1,897 81,847 (32.6%) 1,944 76,688 (31.4%) 
  
a
 Missing data not shown; percentages may not equal 100% due to rounding. 
 
 
 
 To determine differences between the two groups, the Rao-Scott modified chi square 
test was conducted regarding categorical variables, and unweighted two sample t-tests 
(Satterthwaite method reported) were conducted regarding continuous variables.  
Subsamples A and B did not differ with respect to the following demographic 
characteristics:  maternal age [t (12,235) = -1.01, p = 0.16], maternal education [X2 = 
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3.42, df = 4, p = 0.49], being insured [X2 = 2.73, df = 1, p = 0.10], receiving Medicaid 
benefits [X2 = 0.04, df = 1, p = 0.85], and Hispanic ethnicity [X2 = 0.01, df = 1, p = 0.94].  
The two groups did not differ on most maternal race categories:  other Asian [X2 = 0.02, 
df = 1, p = 0.88], black [X2 = 0.21, df = 1, p = 0.64], American Indian [X2 = 1.46, df = 1, p 
= 0.23], Chinese [X2 = 1.68, df = 1, p = 0.20], Filipino  [X2 = 2.40, df = 1, p = 0.12], 
Hawaiian  [X2 = 2.09, df = 1, p = 0.15], other nonwhite  [X2 = 2.38, df = 1, p = 0.12], and 
mixed race  [X2 = 0.12, df = 1, p = 0.73].  The random groups differed regarding the 
Japanese maternal race category [X2 = 4.84, df = 1, p = 0.03], but the sample size was 
extremely small with three and eleven participants in Subsamples A and B, respectively.  
The correlation matrix for all variables included in the confirmatory factor analysis 
(Subsample A) is provided in Table 10. 
 
Table 10.  Correlation matrix for the first random sample in Project 1.   
PROJECT 1 
Sample A 
N = 6,120 
CFA Correlation Matrix (w/ Variances on the Diagonal) 
 
Pregnancy 
Intention - 
Timing 
Pregnancy 
Intention - 
Feeling 
Maternal 
Race 
Hispanic 
Ethnicity 
Alcohol 
frequency 
before 
pregnancy 
Binge 
drinking 
before 
pregnancy 
Alcohol 
frequency 
after 
pregnancy 
Pregnancy 
Intention – 
Trying 
       
Pregnancy 
Intention – 
Timing 
-0.122       
Maternal Race -0.265 0.052      
Hispanic 
Ethnicity 0.092 0.044 -0.480     
Alcohol 
frequency 
before 
pregnancy 
0.163 -0.020 -0.012 -0.120    
Binge drinking 
before 
pregnancy 
0.200 -0.007 -0.008 -0.047 0.880   
Alcohol 
frequency  
after 
pregnancy 
0.085 0.085 -0.120 0.004 0.547 0.408  
Binge drinking 
after 
pregnancy 
0.035 0.025 -0.083 -0.003 0.508 0.459 0.930 
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Testing the measurement model.  Confirmatory factor analysis was conducted 
with Mplus using the mean and variance-adjusted weighted least squares estimator.  
This estimator calculates probit regressions for categorical factor indicators and linear 
regressions for continuous factor indicators (Muthen & Muthen, 2009).  Therefore, this 
estimator accounts for the non-normality associated with categorical data and the lack of 
optimization.  The CDC-provided complex analysis weights also were applied in Mplus 
using the finite population correction factor (a sampling fraction was calculated in SAS 
as SAMCNT/TOTCNT), the stratification variable (SUD_NEST), and the weight variable 
(WTANAL).  According to the confirmatory factor analysis (CFA), the latent variance 
covariance matrix posed a problem with the pregnancy intention variable associated with 
trying to become pregnant, so it was removed from the CFA.  Subsequently, there was a 
problem with the maternal race and Hispanic ethnicity variables, so they were removed 
from the CFA.  Then, there was a problem with the preconception alcohol variable, so it 
was removed from the CFA.  At this point, the framework was reevaluated, and the 
latent variables were removed to be replaced by their measured components.  With no 
latent variables in the model, confirmatory factor analysis was deemed unnecessary and 
subsamples A and B were recombined into one dataset.   
In addition to the elimination of latent variables, several other variables were 
altered as well.  The components of prenatal education were assigned a “1” for a “yes” 
response (affirmative to talking to a health care provider about the issue) and a “0” for a 
“no” response, and the affirmative responses were summed.  Thus, prenatal education 
became a continuous measured variable ranging from 0 (didn’t talk to a medical 
provider) to 10 (talked with a provider about many issues related to pregnancy).  In a 
similar way, maternal complications were re-coded, summed, and compiled into one 
measured variable ranging from 0 (experienced no complications) to 10 (experienced all 
complications listed).  Therefore, the revised just-identified framework included 32 
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measured independent variables and one measured dependent variable in Project 1, as 
shown in Figure 7.  Project 2 comprised the same framework with the exclusion of the 
preconception oral care and preconception medical care variables associated only with 
Project 1.   
Assumptions and Issues of Concern 
 Taking into account the non-normal and non-linear categorical nature of many of 
the variables, as well as the complex analysis weights inherent in the PRAMS datasets, 
the maximum likelihood estimator with robust standard errors (MLR) was used in the 
revised analysis.  This estimator, computed using a sandwich estimator, is robust to non-
normality and non-independence of observations when dealing with complex analysis 
weights (Muthen, 2009).  In addition, the MLR estimator protects against 
heteroscedasticity (White, 1980).  Another issue of possible concern was 
multicollinearity.  Multicollinearity is difficult to assess in Mplus and SAS when working 
with complex analysis weights.  However, the correlations derived from all variations of 
the framework, as well as the large sample size, indicated that multicollinearity was not a 
pertinent factor in this analysis.  To triangulate this finding, a test of multicollinearity was  
performed on the unweighted sample of Project 1.  As a rule of thumb when testing for 
multicollinearity, a variance inflation factor (VIF) greater than 10 indicates the need for 
further investigation (Marquardt, 1970; Mason, et al., 1970; Menard, 1995).  The VIFs for 
all variables in the model in Project 1 were well below 10, with the highest value 
associated with the postnatal maternal smoking variable at 4.68.  Therefore, 
multicollinearity was not deemed a pertinent factor in this analysis.     
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Figure 7.  Revised preconception framework.  
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Descriptive Statistics 
  Due to list-wise deletion, the sample in Project 1 contained 12,239 participants as 
compared to the original 27,933 participants.  The sample in Project 2 contained 
128,551 participants as compared to the original 200,008 participants.  The demographic 
characteristics of each sample are listed in Table 11.  Frequency distributions for all 
variables for each sample are included in Appendix A.  In comparison, the demographic 
characteristics of participants deleted by list-wise deletion are displayed in Table 12. 
 
Table 11.  Demographic characteristics of Projects 1 and 2. 
 
Project 1 
(N=12,239) 
Project 2 
(N=128,551) 
Variables Freq. Weighted Frequency Percent Freq. 
Weighted 
Frequency Percent 
AGE 
      
17 years of age or 
younger  
243 7,480 (1.5%) 3,153 114,074 (2.0%) 
18 to 19 years 638 28,476 (5.7%) 8,392 330,978 (5.7%) 
20 to 24 years 3,012 129,969 (26.2%) 31,759 1,358,219 (23.6%) 
25 to 29 years 3,938 163,577 (33.0%) 36,380 1,701,642 (29.5%) 
30 to 34 years 2,713 109,619 (22.1%) 29,058 1,414,774 (24.5%) 
35 to 39 years 1,177 46,757 (9.4%) 16,240 696,919 (12.1%) 
40 years of age or 
older 
218 9,375 (1.9%) 3,569 148,390 (2.6%) 
       
RACE/ETHNICITY 
      
HISPANIC       
Yes 640 20,831 (4.2%) 13,909 657,016 (11.4%) 
No 11,599 474,424 (95.8%) 114,642 5,107,979 (88.6%) 
       
RACE/ETHNICITY       
Other Asian 142 5,895 (1.2%) 5,038 149,348 (2.6%) 
White 11,103 439,185 (88.7%) 86,917 4,380,459 (76.0%) 
Black 779 35,931 (7.3%) 21,615 884,073 (15.3%) 
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American Indian 78 2,288 (0.5%) 3,611 55,038 (1.0%) 
Chinese 17 1,581 (0.3%) 1,682 41,826 (0.7%) 
Japanese 14 601 (0.1%) 988 14,176 (0.2%) 
Filipino 7 148 (0.0%) 1,960 38,683 (0.7%) 
Hawaiian 10 376 (0.1%) 1,296 17,703 (0.3%) 
Other Nonwhite 58 6,240 (1.3%) 2,612 129,341 (2.2%) 
Alaskan Native 0 0 (0.0%) 1,400 7,218 (0.1%) 
Mixed Race 31 3,011 (0.6%) 1,432 47,130 (0.8%) 
       
INSURANCE STATUS 
(excludes Medicaid)       
Insured  8,445 346,660 (70.0%) 80,727 3,777,541 (65.5%) 
Not insured  3,794 148,595 (30.0%) 47,824 1,987,455 (34.5%) 
       
MEDICAID STATUS 
      
Enrolled in Medicaid  1,712 61,375 (12.4%) 18,629 754,826 (13.1%) 
Not enrolled in 
Medicaid 
10,527 433,880 (87.6%) 109,922 5,010,170 (86.9%) 
       
INCOME LEVEL 
      
Less than $10,000 1,757 70,215 (14.2%) 25,437 988,505 (17.1%) 
$10,000 to $14,999 1,028 41,392 (8.4%) 11,944 491,887 (8.5%) 
$15,000 to $19,999 750 27,948 (5.6%) 8,439 364,991 (6.3%) 
$20,000 to $24,999 923 36,853 (7.4%) 9,533 415,866 (7.2%) 
$25,000 to $34,999 1,567 63,187 (12.8%) 13,455 595,318 (10.3%) 
$35,000 to $49,999 1,825 70,379 (14.2%) 14,417 634,854 (11.0%) 
$50,000 or more 4,389 185,282 (37.4%) 45,326 2,273,575 (39.4%) 
       
EDUCATION LEVEL 
      
0-8 years 134 5,953 (1.2%) 2,749 135,998 (2.4%) 
9-11 years 1,203 40,474 (8.2%) 14,661 604,889 (10.5%) 
12 years 3,824 147,605 (29.8%) 38,412 1,625,109 (28.2%) 
13-15 years 3,237 142,688 (28.8%) 32,727 1,460,212 (25.3%) 
16 years or more 3,841 158,535 (32.0%) 40,002 1,938,786 (33.6%) 
  
a
 Missing data not shown; percentages may not equal 100% due to rounding. 
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Table 12.  Demographic characteristics of participants deleted in a list-wise manner from 
Projects 1 and 2 due to missing data. 
 
Infant Mortality 
Samplea 
Project 1 
(N=15,694) 
Project 2 
(N=71,457) 
 
Freq. 
Weighted 
Frequency 
Percent Freq. 
Weighted 
Frequency 
Percent 
AGE 
      
17 years of age or 
younger 
543 22,240 (3.2%) 4,134 163,619 (5.4%) 
18 to 19 years of age 943 37,093 (5.3%) 6,475 250,538 (8.3%) 
20 to 24 years of age 3,627 144,586 (20.8%) 17,623 740,295 (24.6%) 
25 to 29 years of age 4,268 185,650 (26.8%) 17,703 788,374 (26.2%) 
30 to 34 years of age 3,792 181,390 (26.2%) 14,462 633,194 (21.1%) 
35 to 39 years of age 2,034 99,565 (14.4%) 8,693 345,751 (11.5%) 
40 years of age or older 487 22,868 (3.3%) 2,355 84,115 (2.8%) 
       
RACE/ETHNICITY 
      
HISPANIC       
Yes 3,553 145,406 (21.2%) 16,503 788,092 (26.8%) 
No 12,006 541,770 (78.8%) 52,588 2,149,789 (73.2%) 
       
RACE/ETHNICITY       
Other Asian 1,072 31,709 (4.6%) 3,333 107,233 (3.6%) 
White 10,978 506,070 (73.6%) 42,242 2,018,631 (68.0%) 
Black 2,522 106,603 (15.5%) 14,019 561,296 (18.9%) 
American Indian 106 2,925 (0.4%) 2,128 27,020 (0.9%) 
Chinese 252 7,641 (1.1%) 807 20,581 (0.7%) 
Japanese 38 1,462 (0.2%) 475 7,758 (0.3%) 
Filipino 223 6,107 (0.9%) 1,257 29,200 (1.0%) 
Hawaiian 12 247 (0.0%) 771 10,880 (0.4%) 
Other Nonwhite 322 21,956 (3.2%) 3,060 155,168 (5.2%) 
Alaskan Native 0 0 (0.0%) 1,206 5,934 (0.2%) 
Mixed Race 19 2,686 (0.4%) 660 23,701 (0.8%) 
       
INSURANCE STATUS 
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(excludes Medicaid) 
Insured  9,057 437,952 (63.4%) 35,007 1,456,996 (48.9%) 
Not insured  6,556 252,311 (36.6%) 35,798 1,523,850 (51.1%) 
       
MEDICAID STATUS 
      
Enrolled in Medicaid  2,615 96,665 (14.0%) 14,030 541,198 (18.2%) 
Not enrolled in Medicaid 12,989 593,206 (86.0%) 56,625 2,434,556 (81.8%) 
       
INCOME LEVEL 
      
Less than $10,000 3.014 114,767 (18.9%) 16,141 630,288 (28.2%) 
$10,000 to $14,999 1,336 51,688 (8.5%) 6,138 253,766 (11.3%) 
$15,000 to $19,999 917 37,238 (6.1%) 4,010 157,100 (7.0%) 
$20,000 to $24,999 973 38,682 (6.4%) 4,142 162,024 (7.2%) 
$25,000 to $34,999 1,355 56,718 (9.3%) 5,307 206,471 (9.2%) 
$35,000 to $49,999 1,337 56,964 (9.4%) 5,149 202,645 (9.0%) 
$50,000 or more 4,710 250,610 (41.3%) 14,207 624,616 (27.9%) 
       
EDUCATION LEVEL 
      
0-8 years 997 42,075 (6.2%) 5,725 284,774 (9.9%) 
9-11 years 2,605 88,351 (13.0%) 13,704 569,697 (19.8%) 
12 years 4,489 192,600 (28.4%) 21,848 878,657 (30.5%) 
13-15 years 2,946 136,524 (20.1%) 13,468 541,644 (18.8%) 
16 years or more 4,177 218,150 (32.2%) 13,852 605,350 (21.0%) 
  
a
 Percentages may not equal 100% due to rounding. 
 
To determine differences between the two groups, the Rao-Scott modified chi square 
test was conducted regarding categorical variables, and unweighted two sample t-tests 
(Satterthwaite method reported) were conducted regarding continuous variables.  In 
Project 1, participants included in the study differed from participants excluded from the 
study with respect to the following demographic characteristics:  maternal age [t (27,417) 
= 8.43, p<.0001], maternal education [X2 = 250.45, df = 4, p<.0001], being insured [X2 = 
41.60, df = 1, p<.0001], and Hispanic ethnicity [X2 = 985.50, df = 1, p<.0001].  The two 
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groups differed according to the following maternal race categories:  other Asian [X2 = 
131.64, df = 1, p<.0001], black [X2 = 267.20, df = 1, p<.0001], Chinese [X2 = 25.36, df = 
1, p<.0001], Filipino  [X2 = 137.63, df = 1, p<.0001],  and other nonwhite  [X2 = 30.09, df 
= 1, p<.0001].  The groups did not differ with respect to American Indian maternal race 
[X2 = 1.52, df = 1, p = 0.22], Japanese maternal race [X2 = 0.50, df = 1, p = 0.48], 
Hawaiian maternal race [X2 = 1.82, df = 1, p = 0.18], mixed maternal race [X2 = 3.08, df = 
1, p = 0.08], and receiving Medicaid benefits [X2 = 1.53, df = 1, p = 0.22].  Also in Project 
1, participants included in the study differed from participants excluded from the study 
with respect to the following selected variables:  adverse pregnancy outcomes [t 
(24,005) = -12.55, p <0.0001], dental visit before pregnancy [X2 = 6.47, df = 1, p = 0.01], 
talking with a health care provider before pregnancy [X2 = 39.49, df = 1, p<.0001], folic 
acid use [X2 = 61.80, df = 3, p<.0001], tobacco use before pregnancy  [X2 = 64.28, df = 
6, p<.0001], alcohol frequency before pregnancy  [X2 = 13.47, df = 5, p = 0.02], and 
binge drinking before pregnancy [X2 = 33.60, df = 5, p<.0001].   
In Project 2, participants included in the study differed from participants excluded 
from the study with respect to the following demographic characteristics:  maternal age [t 
(134,600) = -25.63, p <0.0001], maternal education [X2 = 4,023.00, df = 4, p<.0001], 
being insured [X2 = 1,882.00, df = 1, p<.0001], receiving Medicaid benefits [X2 = 333.86, 
df = 1, p<.0001], and Hispanic ethnicity [X2 = 2,751.01, df = 1, p<.0001].  The two groups 
differed according to the following maternal race categories:  other Asian [X2 = 65.28, df 
= 1, p<.0001], black [X2 = 132.85, df = 1, p<.0001], Filipino  [X2 = 33.44, df = 1, p<.0001], 
Hawaiian maternal race [X2 = 9.04, df = 1, p = 0.003], other nonwhite  [X2 = 443.59, df = 
1, p<.0001], and Alaskan native [X2 = 139.84, df = 1, p<.0001].  The groups did not differ 
with respect to American Indian maternal race [X2 = 1.12, df = 1, p = 0.29], Chinese 
maternal race [X2 = 0.50, df = 1, p = 0.48], Japanese maternal race [X2 = 0.29, df = 1, p 
= 0.59, and mixed maternal race [X2 = 0.12, df = 1, p = 0.73].  Also in Project 2, 
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participants included in the study differed from participants excluded from the study with 
respect to the following selected variables:  adverse pregnancy outcomes [t (79,172) = 
5.26, p <0.0001], folic acid use [X2 = 277.20, df = 3, p<.0001], tobacco use before 
pregnancy  [X2 = 188.49, df = 6, p<.0001], alcohol frequency before pregnancy  [X2 = 
2,033.02, df = 5, p<.0001], and binge drinking before pregnancy [X2 = 2,188.39, df = 5, 
p<.0001].   
In both projects, those participants excluded from the study were more extreme 
in maternal age (younger and older), more racially diverse (more identified as black and 
other racial categories; more identified as Hispanic ethnicity), uninsured, receiving 
Medicaid, with less income, and with less education.  These differences will be 
discussed at greater length in the next chapter.  The correlation matrices associated with 
the variables in Projects 1 and 2 are represented in Tables 13 and 14, respectively. 
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Table 13.  Correlation matrix - Project 1. 
PROJECT 1  Correlation Matrix 
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ADVERSE PREGNANCY 
OUTCOMES 1.000        
      
INSURED -0.039 1.000             
MEDICAID 0.046 -0.404 1.000            
INCOME -0.072 0.590 -0.413 1.000           
EDUCATION -0.047 0.428 -0.268 0.531 1.000          
STRESS 0.090 -0.354 0.231 -0.466 -0.317 1.000         
ABUSE BEFORE PREGNANCY 0.051 -0.150 0.106 -0.196 -0.166 0.348 1.000        
PREGNANCY – TRYING -0.030 0.310 -0.182 0.370 0.296 -0.331 -0.118 1.000       
INTENTION – SOONER 0.008 0.146 -0.092 0.180 0.136 -0.126 -0.030 0.316 1.000      
INTENTION – LATER 0.009 -0.218 0.111 -0.274 -0.215 0.239 0.065 -0.603 -0.309 1.000     
INTENTION – NEVER 0.022 -0.126 0.096 -0.148 -0.110 0.165 0.095 -0.334 -0.157 -0.209 1.000    
MATERNAL AGE -0.005 0.336 -0.187 0.513 0.455 -0.297 -0.133 0.225 0.198 -0.297 0.016 1.000   
HISPANIC 0.009 -0.071 -0.019 -0.102 -0.106 0.036 0.033 -0.024 -0.006 0.038 -0.014 -0.028 1.000  
RACE – OTHER ASIAN -0.002 0.015 0.009 -0.002 0.048 -0.024 -0.010 -0.003 -0.003 0.009 -0.013 0.020 -0.017 1.000 
RACE – BLACK 0.103 -0.100 0.159 -0.245 -0.112 0.150 0.075 -0.177 -0.077 0.098 0.165 -0.079 -0.039 -0.031 
RACE – AMERICAN INDIAN 0.021 -0.029 0.021 -0.038 -0.053 0.029 -0.002 -0.015 -0.021 -0.002 0.016 -0.002 -0.008 -0.007 
RACE – CHINESE -0.008 0.034 -0.020 0.009 0.062 -0.035 -0.012 0.030 0.013 -0.035 -0.011 0.050 -0.012 -0.006 
RACE – JAPANESE -0.005 0.020 -0.013 0.022 0.022 -0.015 -0.008 0.021 0.042 -0.016 -0.011 0.042 -0.007 -0.004 
RACE – FILIPINO -0.001 0.004 -0.001 -0.009 0.006 -0.005 -0.004 0.001 0.011 0.006 -0.006 -0.004 -0.004 -0.002 
RACE – HAWAIIAN -0.015 -0.010 0.005 -0.003 0.005 0.009 0.009 0.000 -0.004 0.018 -0.009 -0.002 0.010 -0.003 
RACE – OTHER NONWHITE 0.006 0.011 0.002 -0.029 -0.037 0.040 0.016 -0.025 0.029 0.008 0.030 -0.001 0.390 -0.012 
RACE – MIXED RACE 0.025 -0.011 -0.013 -0.033 -0.003 0.046 0.012 -0.030 -0.018 0.025 0.011 -0.033 0.041 -0.009 
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PROJECT 1   (continued) Correlation Matrix 
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PREGNANCY HISTORY – NO 
HISTORY 0.097 0.003 -0.136 -0.109 0.007 0.036 0.018 0.016 0.042 0.050 -0.105 -0.330 -0.028 0.005 
PREGNANCY HISTORY – LOW 
BIRTH WEIGHT 0.022 -0.012 0.031 -0.039 -0.047 0.026 -0.002 -0.027 -0.010 0.026 -0.007 0.022 0.000 0.009 
PREGNANCY HISTORY – 
PRETERM 0.046 -0.054 0.076 -0.026 -0.045 0.074 0.058 -0.014 0.006 -0.002 0.041 0.025 0.004 -0.009 
PREGNANCY HISTORY – LOW 
BIRTH WEIGHT & PRETERM 0.121 -0.038 0.049 -0.054 -0.061 0.046 0.027 -0.025 0.012 -0.015 0.058 -0.006 0.006 0.021 
BMI - UNDERWEIGHT 0.017 -0.077 0.039 -0.091 -0.054 0.050 0.008 -0.049 -0.018 0.004 0.024 -0.082 0.002 -0.002 
BMI – OVERWEIGHT 0.046 -0.019 0.050 -0.046 -0.082 0.081 0.006 -0.062 0.046 0.022 0.064 0.070 0.008 -0.012 
FOLIC ACID USE 0.000 0.249 -0.124 0.313 0.318 -0.252 -0.111 0.354 0.151 -0.217 -0.150 0.266 -0.029 -0.008 
TOBACCO USE BEFORE 
PREGNANCY 0.050 -0.309 0.194 -0.321 -0.334 0.310 0.116 -0.241 -0.082 0.133 0.157 -0.217 -0.059 -0.030 
ALCOHOL FREQUENCY 
BEFORE PREGNANCY 0.003 -0.071 0.024 -0.043 -0.014 0.185 0.086 -0.139 -0.066 0.102 0.060 0.002 -0.038 -0.029 
BINGE DRINKING BEFORE 
PREGNANCY 0.009 -0.103 0.037 -0.082 -0.076 0.222 0.097 -0.162 -0.069 0.124 0.052 -0.061 -0.021 -0.033 
DENTAL VISIT BEFORE 
PREGNANCY -0.012 0.172 -0.067 0.202 0.188 -0.138 -0.103 0.112 0.041 -0.056 -0.061 0.126 -0.054 -0.003 
TALK W/ HEALTH PROVIDER 
BEFORE PREGNANCY 0.064 0.229 -0.071 0.272 0.244 -0.201 -0.085 0.399 0.221 -0.240 -0.167 0.203 -0.024 0.013 
TOBACCO USE DURING 
PREGNANCY 0.050 -0.259 0.187 -0.289 -0.294 0.266 0.128 -0.176 -0.060 0.083 0.150 -0.143 -0.047 -0.034 
ALCOHOL FREQUENCY 
DURING PREGNANCY -0.014 -0.007 0.046 -0.001 -0.007 0.059 0.050 -0.046 -0.005 0.023 0.009 0.078 0.000 0.020 
BINGE DRINKING DURING 
PREGNANCY -0.013 0.024 0.021 0.024 -0.001 0.038 0.047 -0.015 -0.014 0.010 0.000 0.094 -0.002 0.016 
MATERNAL COMPLICATIONS 0.296 -0.102 0.113 -0.161 -0.156 0.267 0.116 -0.128 -0.002 0.082 0.075 -0.089 -0.008 -0.035 
PRENATAL EDUCATION 0.049 -0.125 0.114 -0.182 -0.157 0.102 0.032 -0.117 -0.067 0.087 0.058 -0.153 0.011 -0.017 
PRENATAL CARE INITIATION 0.000 -0.160 0.027 -0.134 -0.121 0.089 0.063 -0.135 -0.083 0.098 0.094 -0.085 0.017 -0.003 
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PROJECT 1  (continued) Correlation Matrix 
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RACE – BLACK 1.000              
RACE – AMERICAN INDIAN -0.019 1.000             
RACE - CHINESE -0.016 -0.004 1.000            
RACE - JAPANESE -0.010 -0.002 -0.002 1.000           
RACE – FILIPINO -0.005 -0.001 -0.001 -0.001 1.000          
RACE – HAWAIIAN -0.008 -0.002 -0.002 -0.001 0.000 1.000         
RACE – OTHER NONWHITE -0.032 -0.008 -0.006 -0.004 -0.002 -0.003 1.000        
RACE – MIXED RACE -0.022 -0.005 -0.004 -0.003 -0.001 -0.002 -0.009 1.000        
PREGNANCY HISTORY – NO 
HISTORY -0.019 -0.022 -0.010 0.013 0.018 -0.007 -0.025 0.044 1.000  
    
PREGNANCY HISTORY – LOW 
BIRTH WEIGHT 0.061 0.007 0.051 -0.005 -0.002 -0.004 0.014 -0.011 -0.112 1.000 
    
PREGNANCY HISTORY – 
PRETERM 0.015 0.004 -0.003 -0.007 -0.003 -0.006 0.003 -0.013 -0.161 -0.028 1.000    
PREGNANCY HISTORY – LOW 
BIRTH WEIGHT & PRETERM 0.075 0.043 -0.010 0.000 -0.003 -0.005 0.018 -0.008 -0.138 -0.024 -0.035 1.000   
BMI – UNDERWEIGHT -0.001 -0.007 -0.005 0.017 0.024 -0.006 -0.004 -0.012 0.063 -0.004 0.021 -0.018 1.000  
BMI – OVERWEIGHT 0.083 -0.012 -0.033 -0.022 -0.011 -0.005 0.003 0.016 -0.063 0.001 0.041 0.016 -0.185 1.000 
FOLIC ACID USE -0.093 -0.009 0.044 0.023 -0.002 -0.016 0.004 -0.029 0.013 -0.014 -0.002 -0.045 -0.014 -0.073 
TOBACCO BEFORE PREGNANCY -0.014 0.005 -0.029 -0.016 -0.009 -0.009 -0.029 -0.008 0.050 0.004 0.004 0.036 0.056 0.037 
ALCOHOL FREQUENCY BEFORE 
PREGNANCY -0.002 -0.003 -0.019 -0.008 -0.011 -0.012 -0.009 0.000 0.141 -0.010 -0.017 -0.010 -0.002 0.003 
BINGE DRINKING BEFORE 
PREGNANCY -0.013 -0.001 -0.029 -0.009 -0.011 -0.009 -0.007 0.013 0.127 -0.013 -0.023 -0.013 0.001 0.022 
DENTAL VISIT BEFORE 
PREGNANCY -0.053 -0.020 0.022 0.009 -0.010 -0.020 -0.054 0.006 0.011 -0.016 -0.035 -0.033 -0.017 -0.032 
TALK W/ HEALTH PROVIDER 
BEFORE PREGNANCY -0.053 -0.005 0.037 0.008 -0.006 -0.010 0.002 0.016 0.077 -0.002 0.027 0.011 -0.010 -0.028 
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PROJECT 1  (continued) Correlation Matrix 
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TOBACCO DURING PREGNANCY -0.009 0.014 -0.021 -0.011 -0.006 -0.005 -0.022 -0.007 -0.027 0.014 0.026 0.039 0.044 0.042 
ALCOHOL FREQUENCY DURING 
PREGNANCY 0.020 -0.004 -0.012 -0.007 -0.004 0.011 0.014 0.016 -0.027 0.013 0.049 -0.013 -0.023 -0.041 
BINGE DRINKING BEFORE 
PREGNANCY 0.034 -0.004 -0.012 -0.007 -0.004 0.013 0.006 -0.002 -0.036 0.006 0.016 -0.014 -0.023 -0.028 
MATERNAL COMPLICATIONS 0.075 0.024 -0.025 -0.010 -0.001 0.002 0.010 0.006 -0.025 0.013 0.140 0.095 0.005 0.146 
PRENATAL EDUCATION 0.147 -0.004 -0.010 -0.011 0.000 -0.007 0.008 -0.006 0.133 0.030 0.015 0.019 0.011 0.028 
PRENATAL CARE INITIATION 0.056 0.003 -0.013 0.002 -0.004 0.005 -0.006 0.011 -0.045 -0.007 0.013 -0.017 0.026 -0.014 
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PROJECT 1  (continued) Correlation Matrix 
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FOLIC ACID USE 1.000            
TOBACCO BEFORE PREGNANCY -0.236 1.000           
ALCOHOL FREQUENCY BEFORE 
PREGNANCY -0.072 0.271 1.000  
        
BINGE DRINKING BEFORE 
PREGNANCY -0.116 0.302 0.802 1.000 
        
DENTAL VISIT BEFORE 
PREGNANCY 0.124 -0.093 -0.020 -0.023 1.000    
    
TALK W/ HEALTH PROVIDER 
BEFORE PREGNANCY 0.426 -0.165 -0.027 -0.075 0.078 1.000   
    
TOBACCO DURING PREGNANCY -0.171 0.735 0.157 0.193 -0.074 -0.115 1.000      
ALCOHOL FREQUENCY DURING 
PREGNANCY 0.017 0.021 0.283 0.186 -0.048 0.012 0.030 1.000 
    
BINGE DRINKING DURING 
PREGNANCY 0.005 0.031 0.229 0.191 -0.016 0.001 0.032 0.776 1.000   
 
MATERNAL COMPLICATIONS -0.090 0.124 0.018 0.029 -0.069 -0.013 0.132 -0.009 -0.006 1.000   
PRENATAL EDUCATION -0.013 0.133 0.096 0.095 -0.032 0.050 0.087 0.031 0.018 0.048 1.000  
PRENATAL CARE INITIATION -0.079 0.036 -0.044 -0.029 -0.031 -0.123 0.057 0.018 0.001 -0.061 -0.038 1.000 
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Table 14.  Correlation matrix – Project 2. 
PROJECT 2 Correlation Matrix 
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ADVERSE PREGNANCY 
OUTCOMES 1.000        
      
INSURED -0.018 1.000             
MEDICAID 0.035 -0.338 1.000            
INCOME -0.047 0.627 -0.399 1.000           
EDUCATION -0.027 0.458 -0.283 0.575 1.000          
STRESS 0.049 -0.305 0.185 -0.399 -0.261 1.000         
ABUSE BEFORE PREGNANCY 0.027 -0.152 0.101 -0.196 -0.140 0.344 1.000        
PREGNANCY – TRYING -0.015 0.291 -0.165 0.371 0.274 -0.284 -0.109 1.000       
INTENTION – SOONER 0.034 0.133 -0.085 0.162 0.116 -0.105 -0.037 0.318 1.000      
INTENTION – LATER -0.001 -0.207 0.099 -0.280 -0.192 0.204 0.076 -0.579 -0.307 1.000     
INTENTION – NEVER 0.025 -0.120 0.100 -0.143 -0.117 0.156 0.074 -0.310 -0.151 -0.215 1.000    
MATERNAL AGE 0.018 0.331 -0.217 0.487 0.448 -0.263 -0.124 0.258 0.193 -0.325 0.022 1.000   
HISPANIC 0.005 -0.168 0.029 -0.197 -0.233 0.018 0.028 -0.039 -0.028 0.053 -0.019 -0.063 1.000  
RACE – OTHER ASIAN 0.005 0.030 -0.023 0.036 0.070 -0.064 -0.020 0.037 0.035 -0.020 -0.017 0.046 -0.040 1.000 
RACE – BLACK 0.105 -0.159 0.209 -0.266 -0.127 0.138 0.062 -0.206 -0.076 0.118 0.153 -0.127 -0.105 -0.069 
RACE – AMERICAN INDIAN 0.000 -0.054 0.025 -0.052 -0.049 0.047 0.022 -0.025 -0.011 0.013 0.014 -0.037 -0.017 -0.016 
RACE – CHINESE -0.001 0.029 -0.017 0.030 0.053 -0.046 -0.014 0.031 0.026 -0.021 -0.010 0.060 -0.029 -0.014 
RACE – JAPANESE -0.002 0.022 -0.010 0.024 0.027 -0.022 -0.006 0.016 0.020 -0.011 -0.006 0.034 -0.010 -0.008 
RACE – FILIPINO 0.007 0.021 -0.014 0.016 0.024 -0.022 -0.005 -0.002 0.006 0.001 -0.002 0.026 0.002 -0.013 
RACE – HAWAIIAN -0.005 0.006 0.028 -0.019 -0.017 0.010 0.007 -0.017 -0.007 0.010 0.008 -0.018 0.016 -0.009 
RACE – OTHER NONWHITE -0.005 -0.073 0.015 -0.085 -0.105 0.007 0.009 -0.016 -0.006 0.021 -0.013 -0.024 0.331 -0.025 
RACE – MIXED RACE -0.001 -0.025 0.009 -0.017 -0.023 0.008 0.009 -0.006 -0.004 0.003 0.005 -0.013 -0.008 -0.006 
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PROJECT 2   (continued) Correlation Matrix 
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PREGNANCY HISTORY – NO 
HISTORY 0.090 0.038 -0.118 -0.030 0.055 0.003 0.000 0.032 0.064 0.073 -0.142 -0.280 -0.024 0.021 
PREGNANCY HISTORY – LOW 
BIRTH WEIGHT 0.015 -0.056 0.050 -0.065 -0.070 0.024 0.016 -0.037 -0.014 0.007 0.042 0.027 0.055 0.011 
PREGNANCY HISTORY – 
PRETERM 0.042 -0.017 0.040 -0.015 -0.035 0.035 0.025 -0.010 -0.009 -0.006 0.031 0.032 0.014 -0.001 
PREGNANCY HISTORY – LOW 
BIRTH WEIGHT & PRETERM 0.102 -0.035 0.064 -0.044 -0.046 0.027 0.015 -0.020 0.000 -0.001 0.028 0.020 0.009 0.000 
BMI - UNDERWEIGHT -0.001 -0.063 0.026 -0.074 -0.051 0.036 0.026 -0.045 -0.026 0.042 0.002 -0.085 -0.013 0.034 
BMI – OVERWEIGHT 0.063 -0.044 0.062 -0.069 -0.092 0.079 0.004 -0.053 0.031 0.002 0.059 0.044 0.010 -0.061 
FOLIC ACID USE 0.017 0.278 -0.112 0.328 0.298 -0.231 -0.104 0.349 0.170 -0.241 -0.133 0.272 -0.088 0.017 
TOBACCO BEFORE 
PREGNANCY 0.014 -0.219 0.119 -0.238 -0.260 0.285 0.141 -0.178 -0.062 0.113 0.095 -0.179 -0.097 -0.058 
ALCOHOL FREQUENCY 
BEFORE PREGNANCY -0.028 0.069 -0.079 0.121 0.133 0.097 0.062 -0.029 -0.026 0.032 0.020 0.061 -0.113 -0.076 
BINGE DRINKING BEFORE 
PREGNANCY -0.026 0.033 -0.058 0.070 0.070 0.135 0.079 -0.060 -0.040 0.063 0.020 -0.012 -0.096 -0.074 
TOBACCO USE DURING 
PREGNANCY 0.007 -0.206 0.139 -0.226 -0.241 0.249 0.133 -0.139 -0.049 0.069 0.108 -0.114 -0.083 -0.044 
ALCOHOL FREQUENCY 
DURING PREGNANCY -0.018 0.038 -0.019 0.062 0.066 0.007 0.014 0.019 -0.001 -0.013 0.006 0.092 -0.009 -0.017 
BINGE DRINKING DURING 
PREGNANCY -0.013 0.033 -0.018 0.057 0.057 0.003 0.007 0.020 -0.001 -0.014 0.005 0.079 -0.006 -0.017 
MATERNAL COMPLICATIONS 0.276 -0.100 0.085 -0.141 -0.137 0.237 0.097 -0.083 0.015 0.045 0.067 -0.091 0.000 -0.036 
PRENATAL EDUCATION 0.026 -0.120 0.103 -0.176 -0.174 0.034 0.008 -0.079 -0.039 0.064 0.017 -0.154 0.042 -0.017 
PRENATAL CARE INITIATION -0.009 -0.226 0.073 -0.236 -0.202 0.131 0.074 -0.203 -0.107 0.132 0.132 -0.172 0.061 -0.010 
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PROJECT 2  (continued) Correlation Matrix 
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RACE – BLACK 1.000              
RACE – AMERICAN INDIAN -0.042 1.000             
RACE - CHINESE -0.036 -0.008 1.000            
RACE - JAPANESE -0.021 -0.005 -0.004 1.000           
RACE – FILIPINO -0.035 -0.008 -0.007 -0.004 1.000          
RACE – HAWAIIAN -0.024 -0.005 -0.005 -0.003 -0.005 1.000         
RACE – OTHER NONWHITE -0.064 -0.015 -0.013 -0.008 -0.012 -0.008 1.000        
RACE – MIXED RACE -0.015 -0.003 -0.003 -0.002 -0.003 -0.002 -0.005 1.000       
PREGNANCY HISTORY – NO 
HISTORY -0.039 -0.009 -0.008 -0.005 -0.007 -0.005 -0.014 -0.003 1.000  
    
PREGNANCY HISTORY – LOW 
BIRTH WEIGHT -0.019 -0.011 0.019 0.006 0.007 -0.005 -0.022 -0.007 0.013 1.000     
PREGNANCY HISTORY – 
PRETERM 0.062 0.002 0.002 0.001 0.011 0.000 0.034 -0.003 0.010 -0.030 1.000    
PREGNANCY HISTORY – LOW 
BIRTH WEIGHT & PRETERM 0.011 0.008 -0.006 -0.004 0.003 0.000 0.009 0.001 0.000 -0.028 -0.033 1.000   
BMI – UNDERWEIGHT 0.045 0.004 -0.003 -0.002 0.000 0.001 0.010 -0.001 -0.005 0.001 0.009 0.009 1.000  
BMI – OVERWEIGHT -0.014 -0.003 0.025 0.010 0.005 -0.001 -0.003 -0.006 0.001 0.010 0.031 0.017 -0.185 1.000 
FOLIC ACID USE 0.119 0.019 -0.058 -0.020 -0.026 0.004 -0.006 0.010 0.009 -0.022 -0.012 -0.014 -0.028 -0.078 
TOBACCO BEFORE PREGNANCY -0.112 -0.028 0.021 0.009 0.011 -0.013 -0.035 -0.011 -0.019 0.003 0.003 0.023 0.050 0.024 
ALCOHOL FREQUENCY BEFORE 
PREGNANCY -0.080 0.032 -0.040 -0.014 -0.021 0.003 -0.051 0.013 0.006 -0.034 -0.033 -0.036 -0.016 -0.063 
BINGE DRINKING BEFORE 
PREGNANCY -0.124 0.015 -0.048 -0.001 -0.028 0.003 -0.065 0.006 0.010 -0.035 -0.030 -0.032 -0.016 -0.029 
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PROJECT 2  (continued) Correlation Matrix 
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TOBACCO DURING PREGNANCY -0.046 0.021 -0.029 -0.011 -0.017 -0.004 -0.039 0.012 -0.002 0.026 0.017 0.041 0.046 0.023 
ALCOHOL FREQUENCY DURING 
PREGNANCY -0.030 -0.008 -0.008 0.004 -0.005 -0.004 -0.002 -0.004 0.017 0.004 -0.005 -0.005 -0.014 -0.047 
BINGE DRINKING BEFORE 
PREGNANCY -0.023 -0.008 -0.010 0.001 0.001 -0.002 -0.004 -0.003 0.018 -0.001 -0.006 -0.004 -0.011 -0.035 
MATERNAL COMPLICATIONS 0.075 0.021 -0.029 -0.011 -0.010 0.003 0.003 0.001 0.005 0.019 0.100 0.097 0.003 0.123 
PRENATAL EDUCATION 0.117 0.014 -0.029 -0.023 0.003 0.004 0.027 0.004 0.007 0.021 0.006 0.014 0.006 0.045 
PRENATAL CARE INITIATION 0.091 0.014 -0.013 -0.013 -0.005 0.000 0.025 0.008 0.015 0.026 -0.001 -0.002 0.028 0.000 
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PROJECT 2  (continued) Correlation Matrix 
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FOLIC ACID USE 1.000          
TOBACCO BEFORE PREGNANCY -0.207 1.000         
ALCOHOL FREQUENCY BEFORE 
PREGNANCY -0.022 0.225 1.000  
      
BINGE DRINKING BEFORE 
PREGNANCY -0.066 0.269 0.780 1.000 
      
TOBACCO DURING PREGNANCY -0.157 0.709 0.096 0.136 1.000      
ALCOHOL FREQUENCY DURING 
PREGNANCY 0.020 0.011 0.294 0.217 0.031 1.000     
BINGE DRINKING DURING 
PREGNANCY 0.018 0.012 0.246 0.198 0.028 0.779 1.000    
MATERNAL COMPLICATIONS -0.078 0.096 -0.026 -0.012 0.087 -0.033 -0.024 1.000   
PRENATAL EDUCATION -0.025 0.055 -0.032 -0.024 0.040 -0.035 -0.030 0.026 1.000  
PRENATAL CARE INITIATION -0.141 0.058 -0.037 -0.022 0.071 -0.002 -0.008 -0.014 -0.006 1.000 
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Structural Equation Modeling   
Structural equation modeling was conducted to test the conceptual 
preconception framework and to answer the proposed research questions in this study.  
The revised preconception framework is a just-identified, or saturated, model, and 
therefore, exhibits perfect model fit.  Thus, the revised analysis plan proceeded with a 
path analysis of the framework to answer the proposed research questions. 
Research Question #1 
What is the relationship between preconception health behaviors and adverse 
pregnancy outcomes among women of reproductive age? 
a. To what extent do preconception health behaviors explain the variance 
associated with adverse pregnancy outcomes? 
b. Which factors are most strongly associated with adverse pregnancy 
outcomes? 
To answer these questions, a path analysis was conducted on the reduced framework 
with data from Project 1.  Parameter estimates, measures of error, and measures of 
statistical significance are presented in Table 15, and the standardized estimates are 
shown in Figure 8.  The R-squared value for this iteration was 0.011.  Therefore, 
preconception health behaviors explained about 1.1% of the variance associated with 
adverse pregnancy outcomes.  Three variables were significantly associated with 
adverse pregnancy outcomes at the α=.05 level.  Among four PRAMS states, the 
statistically significant variables associated with increased adverse pregnancy outcomes 
in the reduced preconception framework were as follows:   
• Higher BMI for women in the overweight BMI category 
• Tobacco use prior to pregnancy 
• Talking with a health care provider prior to pregnancy   
 = Seemingly counterintuitive predictors will be discussed in Chapter 5. 
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Table 15.  Summary of the unstandardized and standardized estimates for the reduced 
preconception framework in Project 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.  Path analysis with standardized estimates for the reduced preconception 
framework in Project 1. 
VARIABLES 
Adverse Pregnancy Outcomes 
regressed on: 
UNSTD. 
ESTIMATE 
STD. 
ERROR 
T-
VALUE 
TWO-TAILED 
P-VALUE 
STD. 
ESTIMATE 
Maternal BMI – Underweight 0.007 0.004 1.864 0.062 0.023 
Maternal BMI – Overweight 0.004 0.001 3.846 0.000 0.049 
Folic Acid Use -0.014 0.011 -1.276 0.202 -0.017 
Tobacco Use – Before 
Pregnancy 0.042 0.011 3.897 0.000 0.059 
Alcohol Use – Frequency 
BeforePregnancy -0.021 0.021 -1.043 0.297 -0.021 
Alcohol Use – Binge Drinking 
Before Pregnancy 0.010 0.020 0.510 0.610 0.011 
Dental Visit Before Pregnancy -0.029 0.040 -0.735 0.462 -0.009 
Talk with Health Care 
Provider Before Pregnancy 0.209 0.035 6.003 0.000 0.083 
 
Adverse Pregnancy Outcomes    R2 = 0.011 
 
.083* 
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Underweight 
BMI 
Folic Acid Use 
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To provide further insight into these questions, a path analysis was conducted on 
the reduced framework with data from Project 2.  Parameter estimates, measures of 
error, and measures of statistical significance are presented in Table 16, and the 
standardized estimates are depicted in Figure 9.  The R-squared value for this iteration 
was 0.006.  Therefore, preconception health behaviors explained about 0.6% of the 
variance associated with adverse pregnancy outcomes.  All variables in the reduced 
framework were significantly associated with adverse pregnancy outcomes at the α=.05 
level.  Among all PRAMS-participating states, the statistically significant variables 
associated with increased adverse pregnancy outcomes in the reduced preconception 
framework were as follows:   
• Higher BMI for women in the underweight BMI category   
• Higher BMI for women in the overweight BMI category 
• Increased folic acid use   
• Tobacco use prior to pregnancy 
• Less frequent of alcohol use prior to pregnancy   
• Decreased prevalence of binge drinking prior to pregnancy   
 = Seemingly counterintuitive predictors will be discussed in Chapter 5. 
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Table 16.  Summary of the unstandardized and standardized estimates for the reduced 
preconception framework in Project 2. 
 
VARIABLES 
Adverse Pregnancy 
Outcomes regressed 
on: 
UNSTD. 
ESTIMATE 
STD. 
ERROR 
T-VALUE TWO-TAILED 
P-VALUE 
STD. 
ESTIMATE 
Maternal BMI – 
Underweight 0.003 0.001 2.954 0.003 0.010 
Maternal BMI – 
Overweight 0.005 0.000 17.355 0.000 0.065 
Folic Acid Use 0.023 0.003 7.022 0.000 0.026 
Tobacco Use – Before 
Pregnancy 0.020 0.003 6.618 0.000 0.026 
Alcohol Use - 
Frequency Before 
Pregnancy  
-0.015 0.006 -2.502 0.012 -0.014 
Alcohol Use – Binge 
Drinking Before 
Pregnancy 
-0.018 0.006 -3.226 0.001 -0.018 
 
Adverse Pregnancy Outcomes    R2 = 0.006 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.  Path analysis with standardized estimates for the reduced preconception 
framework in Project 2. 
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Research Question #2 
What is the relationship among preconception health behaviors, prenatal factors, 
postnatal factors, personal influences, environmental factors, and adverse pregnancy 
outcomes among women of reproductive age? 
a. To what extent does the entire framework explain the variance associated 
with adverse pregnancy outcomes? 
b. Which factors are most strongly associated with adverse pregnancy 
outcomes? 
To answer these questions, a path analysis was conducted on the preconception 
framework with data from Project 1.  Parameter estimates, measures of error, and 
measures of statistical significance are presented in Table 17, and the standardized 
estimates are shown in Figure 10.   
 
Table 17.  Summary of the unstandardized and standardized estimates for the 
preconception framework in Project 1. 
 
VARIABLES 
Adverse Pregnancy 
Outcomes regressed on: 
UNSTD. 
ESTIMATE 
STD. 
ERROR 
T-VALUE TWO-TAILED 
P-VALUE 
STD. 
ESTIMATE 
Insurance status -0.017 0.036 -0.487 0.626 -0.007 
Medicaid  0.068 0.053 1.283 0.199 0.020 
Income  -0.005 0.009 -0.586 0.558 -0.011 
Maternal Education -0.016 0.017 -0.983 0.326 -0.015 
Stress 0.002 0.009 0.247 0.805 0.004 
Physical Abuse 0.073 0.080 0.912 0.362 0.013 
Pregnancy Intention – 
Trying -0.027 0.043 -0.628 0.530 -0.012 
Pregnancy Intention – 
Timing – Sooner -0.056 0.035 -1.591 0.112 -0.019 
Pregnancy Intention – 
Timing – Later -0.047 0.047 -0.995 0.320 -0.019 
Pregnancy Intention – -0.072 0.064 -1.124 0.261 -0.019 
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Timing – Never  
Maternal Age 0.020 0.004 5.694 0.000 0.100 
Hispanic Ethnicity 0.107 0.053 2.008 0.045 0.019 
Maternal Race – Other 
Asian 0.065 0.109 0.599 0.549 0.006 
Maternal Race – Black 0.343 0.061 5.598 0.000 0.079 
Maternal Race – American 
Indian 0.220 0.187 1.178 0.239 0.013 
Maternal Race – Chinese -0.055 0.246 -0.225 0.822 -0.003 
Maternal Race – Japanese -0.184 0.144 -1.275 0.202 -0.006 
Maternal Race – Filipino -0.103 0.291 -0.355 0.723 -0.002 
Maternal Race – Hawaiian -0.495 0.145 -3.415 0.001 -0.012 
Maternal Race – Other 
Nonwhite 0.010 0.164 0.059 0.953 0.001 
Maternal Race – Mixed 
Race 0.311 0.183 1.703 0.089 0.021 
Pregnancy History – No 
History 0.371 0.031 11.932 0.000 0.160 
Pregnancy History – Low 
Birth Weight 0.257 0.131 1.967 0.049 0.031 
Pregnancy History – 
Preterm Delivery 0.166 0.083 2.007 0.045 0.028 
Pregnancy History – Low 
Birth Weight and Preterm 
Delivery 
0.737 0.127 5.795 0.000 0.109 
Maternal BMI – 
Underweight 0.003 0.003 0.883 0.377 0.010 
Maternal BMI – 
Overweight 0.000 0.001 -0.044 0.965 -0.001 
Folic Acid Use 0.008 0.012 0.712 0.477 0.010 
Tobacco Use – Before 
Pregnancy 0.017 0.014 1.206 0.228 0.023 
Alcohol Use – Frequency 
Before Pregnancy -0.039 0.020 -1.915 0.055 -0.038 
Alcohol Use – Binge 
Drinking Before Pregnancy 0.015 0.019 0.783 0.434 0.015 
Dental Visit Before 
Pregnancy 0.035 0.039 0.904 0.366 0.011 
Talk with Health Care 0.134 0.035 3.874 0.000 0.053 
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Provider Before 
Pregnancy 
Tobacco Use – During 
Pregnancy 0.006 0.022 0.283 0.777 0.006 
Alcohol Use – Frequency 
During Pregnancy -0.028 0.056 -0.505 0.614 -0.009 
Alcohol Use – Binge 
Drinking During Pregnancy -0.020 0.062 -0.316 0.752 -0.005 
Maternal Complications 0.252 0.013 20.055 0.000 0.281 
Prenatal Education 0.002 0.005 0.355 0.722 0.004 
Prenatal Care Initiation 0.007 0.003 2.203 0.028 0.029 
 
Adverse Pregnancy Outcomes    R2 = 0.131 
  
 
 
The R-squared value for this iteration was 0.131.  Therefore, preconception health 
behaviors explained about 13.1% of the variance associated with adverse pregnancy 
outcomes.  Eleven variables were significantly associated with adverse pregnancy 
outcomes at the α=.05 level.  Among four PRAMS states, the statistically significant 
variables associated with increased adverse pregnancy outcomes in the preconception 
framework were as follows:   
• Increasing maternal age 
• Hispanic ethnicity 
• Black participants when compared with white participants 
• Talking with a health care provider prior to pregnancy   
• Increased maternal complications 
• Later prenatal care initiation  
• Participants with no previous pregnancies, participants with a previous 
pregnancy resulting in low birth weight, participants with a previous pregnancy resulting  
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Figure 10.  Path analysis with standardized estimates for the preconception framework 
in Project 1. 
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Legend for Figure 10: 
ENVINS Insurance status PIHPT  Pregnancy history – preterm delivery 
ENVMED Medicaid benefits PIHLP Pregnancy history – low birth weight 
and preterm delivery 
ENVINC Income status PCUND Maternal BMI – underweight 
ENVEDU Education level PCOVR Maternal BMI - overweight 
ENVSTR External stress PCFOL Folic acid use 
ENVPAB Physical abuse before pregnancy PCTOB Tobacco use before pregnancy 
PIITRY Pregnancy intention – trying PCAFR Alcohol use – frequency before 
pregnancy 
PIISON Pregnancy intention – sooner PCABNG Alcohol use – binge drinking before 
pregnancy 
PIILTR Pregnancy intention – later PCDDS Dental visit before pregnancy 
PIINEV Pregnancy intention – never PCMD Talk w/ health care provider before 
pregnancy 
PIAGE Maternal age PRNTOB Tobacco use during pregnancy 
PIHSP Hispanic ethnicity PRNAFR Alcohol use – frequency during 
pregnancy 
PIROA Maternal race – other Asian PRNBNG Alcohol use – binge drinking during 
pregnancy 
PIRBL Maternal race – Black PRNMC Maternal complications 
PIRAI Maternal race – American Indian PRNEDU Prenatal education 
PIRCH Maternal race – Chinese PRN1WK Prenatal care initiation 
PIRJA Maternal race – Japanese   
PIRFI Maternal race – Filipino   
PIRHA Maternal race – Hawaiian   
PIRON Maternal race – other nonwhite   
PIRMR Maternal race – mixed race   
PIHNH Pregnancy history – no history   
PIHLB Pregnancy history – low birth weight   
 
in preterm delivery, and participants with a previous pregnancy resulting in low birth 
weight and preterm delivery when compared to participants with normal previous 
pregnancy (not associated with low birth weight or preterm delivery) 
 = Seemingly counterintuitive predictors will be discussed in Chapter 5. 
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Hawaiian participants were associated with decreased adverse pregnancy outcomes 
when compared to white participants.  For every one standard deviation increase in 
these eleven variables, there was a corresponding change in adverse pregnancy 
outcomes that, when measured in standard deviation units, was equal to the 
standardized estimates provided in Table 17.  For example, for every one standard 
deviation increase in maternal age, there was a 0.100 standard deviation increase in 
adverse pregnancy outcomes.   
The research questions may be further explored in Project 2.  The Centers for 
Disease Control and Prevention (CDC) renamed two variables in the new dataset:  1) 
the GRAM variable was renamed GRAM_NAPHSIS and 2) the maternal age variable 
(MAT_AGE) was renamed MAT_AGE_NAPHSIS.  A path analysis was conducted on 
the preconception framework with data from Project 2.  Parameter estimates, measures 
of error, and measures of statistical significance are presented in Table 18, and the 
standardized estimates are shown in Figure 11.  The R-squared value for this iteration 
was 0.114.  Therefore, preconception health behaviors explained about 11.4% of the 
variance associated with adverse pregnancy outcomes.  Twenty-two variables were 
significantly associated with adverse pregnancy outcomes at the α=.05 level.  Among all 
PRAMS-participating states, the statistically significant variables associated with 
increased adverse pregnancy outcomes in the preconception framework were as 
follows:   
• Being insured   
• Being on Medicaid 
• Lower income status 
• Lower education 
• Fewer external stresses   
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• Increasing maternal age 
• Hispanic ethnicity 
• Other Asian, black, Filipino, and Alaskan native participants when compared with 
white participants 
• Higher BMI for women in the overweight category 
• Increased folic acid use   
• Tobacco use prior to pregnancy 
• Less frequent alcohol use prior to pregnancy   
• Increasing maternal complications   
• Participants with no previous pregnancies, participants with a previous 
pregnancy resulting in low birth weight, participants with a previous pregnancy 
resulting in preterm delivery, and participants with a previous pregnancy resulting 
in low birth weight and preterm delivery when compared with participants with 
normal previous pregnancy (not associated with low birth weight or preterm 
delivery) 
• Participants wanting to become pregnant sooner and participants not wanting to 
become pregnant when compared with participants wanting to become pregnant 
at the time they became pregnant. 
 = Seemingly counterintuitive predictors will be discussed in Chapter 5 
For every one standard deviation increase in these 22 variables, there was a 
corresponding change in adverse pregnancy outcomes that, when measured in standard 
deviation units, was equal to the standardized estimates provided in Table 18.  For 
example, for every one standard deviation increase in education level, there was a 0.014 
standard deviation decrease in adverse pregnancy outcomes. 
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Table 18.  Summary of the unstandardized and standardized estimates for the 
preconception framework in Project 2. 
 
VARIABLES 
Adverse Pregnancy Outcomes 
regressed on: 
UNSTD. 
ESTIMATE 
STD. 
ERROR 
T-VALUE TWO-TAILED 
P-VALUE 
STD. 
ESTIMATE 
Insurance Status 0.024 0.012 2.043 0.041 0.010 
Medicaid Benefits 0.064 0.014 4.514 0.000 0.019 
Income  -0.008 0.003 -2.701 0.007 -0.015 
Maternal Education -0.015 0.005 -2.867 0.004 -0.014 
External Stress -0.009 0.003 -3.510 0.000 -0.016 
Physical Abuse Before 
Pregnancy 0.037 0.021 1.797 0.072 0.007 
Pregnancy – Trying 0.003 0.012 0.228 0.820 0.001 
Pregnancy Intention – Sooner 0.027 0.012 2.305 0.021 0.009 
Pregnancy Intention – Later 0.008 0.013 0.607 0.544 0.003 
Pregnancy Intention – Never 0.041 0.018 2.259 0.024 0.010 
Maternal Age 0.093 0.005 20.466 0.000 0.100 
Hispanic Ethnicity 0.073 0.015 4.839 0.000 0.020 
Maternal Race – Other Asian 0.108 0.023 4.721 0.000 0.015 
Maternal Race – Black 0.287 0.014 21.017 0.000 0.088 
Maternal Race – American 
Indian 0.027 0.030 0.912 0.362 0.002 
Maternal Race – Chinese 0.041 0.040 1.012 0.311 0.003 
Maternal Race – Japanese -0.001 0.047 -0.030 0.976 0.000 
Maternal Race – Filipino 0.128 0.043 2.978 0.003 0.009 
Maternal Race – Hawaiian -0.051 0.033 -1.565 0.118 -0.002 
Maternal Race – Other 
Nonwhite -0.034 0.029 -1.184 0.237 -0.004 
Maternal Race – Alaskan 
Native 0.086 0.024 3.635 0.000 0.003 
Maternal Race – Mixed Race 0.028 0.051 0.541 0.589 0.002 
Pregnancy History – No History 0.367 0.010 38.502 0.000 0.155 
Pregnancy History – Low Birth 
Weight 0.175 0.029 6.009 0.000 0.023 
Pregnancy History – Preterm 
Delivery 0.246 0.025 9.689 0.000 0.039 
Pregnancy History – Low Birth 
Weight & Preterm Delivery 0.642 0.031 20.649 0.000 0.093 
Maternal BMI – Underweight 0.001 0.001 0.902 0.367 0.003 
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Maternal BMI – Overweight 0.002 0.000 7.137 0.000 0.027 
Folic Acid Use 0.024 0.003 7.057 0.000 0.028 
Tobacco Use Before 
Pregnancy 0.018 0.004 4.129 0.000 0.023 
Alcohol Use – Frequency 
Before Pregnancy -0.017 0.006 -2.774 0.006 -0.016 
Alcohol Use – Binge Drinking 
Before Pregnancy -0.007 0.006 -1.191 0.234 -0.007 
Tobacco Use During 
Pregnancy -0.011 0.006 -1.833 0.067 -0.009 
Alcohol Use – Frequency 
During Pregnancy -0.009 0.015 -0.551 0.581 -0.003 
Alcohol Use – Binge Drinking 
During Pregnancy -0.005 0.016 -0.302 0.762 -0.002 
Maternal Complications 0.249 0.004 60.254 0.000 0.263 
Prenatal Education 0.001 0.002 0.763 0.445 0.003 
Prenatal Care Initiation 0.001 0.001 1.544 0.123 0.006 
 
Adverse Pregnancy Outcomes    R2 = 0.114 
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Figure 11.  Path analysis with standardized estimates for the preconception framework 
in Project 2. 
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Legend for Figure 11
ENVINS Insurance status PIHPT  Pregnancy history – preterm delivery 
ENVMED Medicaid benefits PIHLP Pregnancy history – low birth weight 
and preterm delivery 
ENVINC Income status PCUND Maternal BMI – underweight 
ENVEDU Education level PCOVR Maternal BMI - overweight 
ENVSTR External stress PCFOL Folic acid use 
ENVPAB Physical abuse before pregnancy PCTOB Tobacco use before pregnancy 
PIITRY Pregnancy intention – trying PCAFR Alcohol use – frequency before 
pregnancy 
PIISON Pregnancy intention – sooner PCABNG Alcohol use – binge drinking before 
pregnancy 
PIILTR Pregnancy intention – later PRNTOB Tobacco use during pregnancy 
PIINEV Pregnancy intention – never PRNAFR Alcohol use – frequency during 
pregnancy 
PIAGE Maternal age PRNBNG Alcohol use – binge drinking during 
pregnancy 
PIHSP Hispanic ethnicity PRNMC Maternal complications 
PIROA Maternal race – other Asian PRNEDU Prenatal education 
PIRBL Maternal race – Black PRN1WK Prenatal care initiation 
PIRAI Maternal race – American Indian   
PIRCH Maternal race – Chinese   
PIRJA Maternal race – Japanese   
PIRFI Maternal race – Filipino   
PIRHA Maternal race – Hawaiian   
PIRON Maternal race – other nonwhite   
PIRNA Maternal race – Alaskan native   
PIRMR Maternal race – mixed race   
PIHNH Pregnancy history – no history   
PIHLB Pregnancy history – low birth weight   
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Due to the relatively low R-squared values in the previous path analyses, the 
PRAMS dataset was re-examined for additional variables related to adverse pregnancy 
outcomes that might add insight to the preconception framework.  Seven variables 
related to delivery were added to the framework:  1) vacuum delivery; 2) use of forceps; 
3) vaginal birth; 4) vaginal birth after cesarean section; 5) first cesarean section; 6) 
repeat cesarean section; and 7) plurality.  In addition, one environmental factor was 
added, physical abuse during pregnancy, as well as four prenatal factors:  1) Kessner 
index (prenatal care classification developed by the Institutes of Medicine in 1973 that 
adjusts the timing and quantity of prenatal care for the length of gestation to determine 
levels of adequate, inadequate, and intermediate prenatal care); 2) number of prenatal 
care visits; 3) hospitalization during pregnancy; and 4) maternal weight gain during 
pregnancy.  Also, a variable regarding birth defects was added to the adverse pregnancy 
outcomes variable.  Univariate characteristics and bivariate correlations for these 
variables are included in Appendices B and C respectively.  A path analysis was 
conducted on the preconception framework with extra variables from the second 
dataset.  Parameter estimates, measures of error, and measures of statistical 
significance are presented in Table 19, and the standardized estimates are depicted in 
Figure 12.  The R-squared value for this iteration was 0.305.  Therefore, the 
preconception health framework explained about 30.5% of the variance associated with 
adverse pregnancy outcomes.  Twenty-seven variables were significantly associated 
with adverse pregnancy outcomes at the α=.05 level.  Among all PRAMS-participating 
states, the statistically significant variables associated with increased adverse pregnancy 
outcomes in the preconception framework were as follows:   
• Receiving Medicaid benefits 
• Less income  
• Fewer external stresses   
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• Increasing maternal age 
• Hispanic ethnicity 
• Other Asian, black, Chinese, Filipino, and Alaskan native participants when 
compared with white participants   
• Higher BMI for women in the underweight category   
• Lower BMI for women in the overweight category   
• Increased folic acid use   
• Tobacco use prior to pregnancy 
• Less maternal weight gain during pregnancy   
• Increasing hospitalization during pregnancy 
• Increasing maternal complications 
• Toward adequate on the Kessner Index   
• Fewer prenatal care visits 
• Multiple gestation 
• First cesarean section 
• Repeated cesarean section   
• Participants with no previous pregnancies, participants with a previous 
pregnancy resulting in low birth weight, participants with a previous pregnancy 
resulting in preterm delivery, and participants with a previous pregnancy resulting 
in low birth weight and preterm delivery when compared with participants with 
normal previous pregnancy (not associated with low birth weight or preterm 
delivery) 
• Participants not wanting to become pregnant were associated with increased 
adverse pregnancy outcomes when compared to participants wanting to become 
pregnant at the time they became pregnant.   
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 = Seemingly counterintuitive predictors will be discussed in Chapter 5. 
For every one standard deviation increase in these 27 variables, there was a 
corresponding change in adverse pregnancy outcomes that, when measured in standard 
deviation units, was equal to the standardized estimates provided in Table 19.  For 
example, for every one standard deviation increase in plurality, there was a 1.457 
standard deviation increase in adverse pregnancy outcomes.   
 
Table 19.  Summary of the unstandardized and standardized estimates for the 
post hoc analysis of the preconception framework. 
 
VARIABLES 
Adverse Pregnancy Outcomes 
regressed on: 
UNSTD. 
ESTIMATE 
STD. 
ERROR 
T-VALUE TWO-TAILED 
P-VALUE 
STD. 
ESTIMATE 
Insurance Status 0.012 0.012 1.055 0.291 0.005 
Medicaid Benefits 0.050 0.014 3.449 0.001 0.014 
Income  -0.007 0.003 -2.421 0.015 -0.013 
Maternal Education -0.006 0.005 -1.169 0.242 -0.006 
External Stress -0.006 0.003 -2.172 0.030 -0.010 
Physical Abuse – Before 
Pregnancy 0.006 0.024 0.267 0.790 0.001 
Physical Abuse – During 
Pregnancy 0.057 0.030 1.911 0.056 0.009 
Pregnancy – Trying 0.004 0.012 0.287 0.774 0.001 
Pregnancy Intention – Sooner -0.004 0.012 -0.365 0.715 -0.001 
Pregnancy Intention – Later 0.014 0.013 1.052 0.293 0.005 
Pregnancy Intention – Never 0.048 0.018 2.662 0.008 0.012 
Maternal Age 0.043 0.005 9.355 0.000 0.046 
Hispanic Ethnicity 0.056 0.015 3.688 0.000 0.015 
Maternal Race – Other Asian 0.094 0.023 4.100 0.000 0.013 
Maternal Race – Black 0.205 0.014 14.965 0.000 0.062 
Maternal Race – American 
Indian -0.015 0.033 -0.467 0.641 -0.001 
Maternal Race – Chinese 0.075 0.038 1.980 0.048 0.005 
Maternal Race – Japanese 0.071 0.048 1.487 0.137 0.003 
Maternal Race – Filipino 0.106 0.041 2.614 0.009 0.007 
Maternal Race – Hawaiian 0.003 0.031 0.090 0.928 0.000 
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Maternal Race – Other 
Nonwhite -0.033 0.029 -1.133 0.257 -0.004 
Maternal Race – Alaskan 
Native 0.145 0.025 5.858 0.000 0.004 
Maternal Race – Mixed Race -0.031 0.055 -0.560 0.575 -0.002 
Pregnancy History – No 
History 0.240 0.010 24.192 0.000 0.101 
Pregnancy History – Low Birth 
Weight 0.137 0.028 4.844 0.000 0.018 
Pregnancy History – Preterm 
Delivery 0.180 0.025 7.143 0.000 0.028 
Pregnancy History – Low Birth 
Weight & Preterm Delivery 0.437 0.031 14.264 0.000 0.063 
Maternal BMI – Underweight 0.003 0.001 3.007 0.003 0.010 
Maternal BMI – Overweight -0.001 0.000 -4.165 0.000 -0.016 
Folic Acid Use 0.011 0.003 3.356 0.001 0.013 
Tobacco Use Before 
Pregnancy 0.011 0.004 2.438 0.015 0.014 
Alcohol Use – Frequency 
Before Pregnancy -0.008 0.006 -1.279 0.201 -0.007 
Alcohol Use – Binge Drinking 
Before Pregnancy -0.009 0.005 -1.732 0.083 -0.009 
Tobacco Use During 
Pregnancy -0.011 0.006 -1.699 0.089 -0.009 
Alcohol Use – Frequency 
During Pregnancy 0.002 0.015 0.137 0.891 0.001 
Alcohol Use – Binge Drinking 
During Pregnancy -0.005 0.016 -0.309 0.757 -0.002 
Maternal Weight Gain During 
Pregnancy -0.003 0.000 -9.808 0.000 -0.037 
Hospitalization During 
Pregnancy 0.768 0.018 43.070 0.000 0.215 
Maternal Complications 0.134 0.004 32.274 0.000 0.142 
Kessner Index 0.108 0.011 9.679 0.000 0.050 
Prenatal Education 0.000 0.002 0.313 0.754 0.001 
Number of Prenatal Care 
Visits -0.197 0.008 -26.206 0.000 -0.125 
Prenatal Care Initiation 0.002 0.001 1.733 0.083 0.007 
Plurality 1.457 0.039 37.132 0.000 0.173 
First Cesarean Section  0.879 0.056 15.630 0.000 0.292 
Forceps Delivery 0.014 0.035 0.398 0.691 0.001 
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Repeated Cesarean Section  0.618 0.057 10.913 0.000 0.168 
Vacuum Delivery -0.007 0.021 -0.351 0.725 -0.001 
Vaginal Delivery 0.016 0.055 0.287 0.774 0.006 
Vaginal Delivery After 
Cesarean Section 0.066 0.061 1.087 0.277 0.006 
 
Adverse Pregnancy Outcomes    R2 = 0.305 
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Figure 12.  Path analysis with standardized estimates for the post hoc analysis of the 
preconception framework. 
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Legend for Figure 12: 
ENVINS Insurance status PIHPT  Pregnancy history – preterm delivery 
ENVMED Medicaid benefits PIHLP Pregnancy history – low birth weight 
and preterm delivery 
ENVINC Income status PCUND Maternal BMI – underweight 
ENVEDU Education level PCOVR Maternal BMI - overweight 
ENVSTR External stress PCFOL Folic acid use 
ENVPAB Physical abuse before pregnancy PCTOB Tobacco use before pregnancy 
ENVPAD Physical abuse during pregnancy   
PIITRY Pregnancy intention – trying PCAFR Alcohol use – frequency before 
pregnancy 
PIISON Pregnancy intention – sooner PCABNG Alcohol use – binge drinking before 
pregnancy 
PIILTR Pregnancy intention – later PRNTOB Tobacco use during pregnancy 
PIINEV Pregnancy intention – never PRNAFR Alcohol use – frequency during 
pregnancy 
PIAGE Maternal age PRNBNG Alcohol use – binge drinking during 
pregnancy 
  PRNWT Maternal weight gain while pregnant 
PIHSP Hispanic ethnicity PRNMC Maternal complications 
  PRNHSP Hospitalized during pregnancy 
PIROA Maternal race – other Asian PRNEDU Prenatal education 
PIRBL Maternal race – Black PRN1WK Prenatal care initiation 
PIRAI Maternal race – American Indian PRN#VT Number of prenatal care visits 
PIRCH Maternal race – Chinese PRNKI Kessner Index 
PIRJA Maternal race – Japanese NRPLU Plurality 
PIRFI Maternal race – Filipino NRCSC Repeated cesarean section 
PIRHA Maternal race – Hawaiian N1CSC First cesarean section 
PIRON Maternal race – other nonwhite NVBAC Vaginal birth after cesarean section 
PIRNA Maternal race – Alaskan native NVAGB Vaginal delivery 
PIRMR Maternal race – mixed race NFORC Forceps delivery 
PIHNH Pregnancy history – no history NVACM Vacuum delivery 
PIHLB Pregnancy history – low birth weight   
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A summary view comparing the statistically significant variables associated with these 
five framework iterations is presented in Table 20.  
 
Table 20.  Summary of statistically significant variables associated with the 
preconception framework iterations. 
 
 
 
Project 1 
Reduced 
Framework 
Project 2 
Reduced 
Framework 
Project 1  
Full 
Framework 
Project 2 
Full 
Framework 
Dataset 2 
Full 
Framework 
Post hoc 
Analysis 
Sample Size 12,239 128,551 12,239 128,551 112,675 
% Variance Accounted 
For 1.1% 0.6% 13.1% 11.4% 30.5% 
VARIABLES 
 
ENVIRONMENTAL FACTORS 
Insurance Status X X  +  
Medicaid Benefits X X  + + 
Income X X  - - 
Maternal Education X X  -  
External Stress X X  - - 
Physical Abuse – Prior to 
Pregnancy X X    
Physical Abuse – During 
Pregnancy X X X X  
PERSONAL INFLUENCES 
Pregnancy – Trying X X    
Pregnancy Intention– 
Timing - Sooner X X  +  
Pregnancy Intention – 
Timing - Later X X    
Pregnancy Intention – 
Timing - Never X X  + + 
Maternal Age X X + + + 
Hispanic Ethnicity X X + + + 
Maternal Race – Other 
Asian X X  + + 
Maternal Race – Black X X + + + 
Maternal Race – 
American Indian X X    
Maternal Race – Chinese X X   + 
Maternal Race – 
Japanese X X    
Maternal Race – Filipino X X  + + 
Maternal Race – Hawaiian X X -   
Maternal Race – Other 
Nonwhite X X    
Maternal Race – Alaskan 
Native X X  + + 
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Maternal Race – Mixed 
Race X X    
Pregnancy History – No 
History X X + + + 
Pregnancy History – Low 
Birth Weight X X + + + 
Pregnancy History – 
Preterm Delivery X X + + + 
Pregnancy History – Low 
Birth Weight & Preterm 
Delivery 
X X + + + 
PRECONCEPTION HEALTH BEHAVIORS 
Maternal BMI – 
Underweight  +   + 
Maternal BMI – 
Overweight + +  + - 
Folic Acid Use 
 +  + + 
Tobacco Use Before 
Pregnancy + +  + + 
Alcohol Use – Frequency 
Before Pregnancy  -  -  
Alcohol Use – Binge 
Drinking Before 
Pregnancy 
 -    
Dental Visit Before 
Pregnancy  X  X X 
Talk with Health Care 
Provider Before 
Pregnancy 
+ X + X X 
PRENATAL FACTORS 
Tobacco Use During 
Pregnancy X X    
Alcohol Use – Frequency 
During Pregnancy X X    
Alcohol Use – Binge 
Drinking During 
Pregnancy 
X X    
Maternal Complications X X + + + 
Hospitalization During 
Pregnancy X X X X + 
Prenatal Education X X    
Prenatal Care Initiation X X +   
Kessner Index X X X X + 
# of Prenatal Care Visits X X X X - 
Maternal Weight Gain 
During Pregnancy X X X X - 
NATAL FACTORS 
Plurality X X X X + 
First Cesarean Section X X X X + 
Forceps Delivery X X X X  
Repeated Cesarean 
Section X X X X + 
Vacuum Delivery X X X X  
Vaginal Delivery X X X X  
Vaginal Delivery After X X X X  
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Cesarean Section 
Shaded cell = Demonstrated statistical significance; X = Variable not applicable for framework 
iteration; +/- = Sign associated with significance (+ = increase/ - = decrease in adverse 
pregnancy outcomes when variable experiences an increase). 
 
 
  
Sub-Analysis 
In the analysis plan, sub-analyses were to be conducted to account for recall 
bias, differences between early and late responders, and the impact of response waves.  
Due to PRAMS privacy limitations, the impact of recall bias was not assessed.  As a 
proxy for difference detection among early and late responders, as well as detection of 
differences in response waves, a sub-analysis was conducted regarding mode of 
participation.  The mode of participation variable categorizes participants by mail or 
telephone response.  According to study protocol, PRAMS surveys are primarily 
distributed via mail.  Only those participants failing to respond to a third mailing are 
contacted by telephone to complete the survey via telephone.  Therefore, participants 
categorized as telephone mode of participation are also indicative of late response and 
are among the last wave of responders in relation to survey initiation date.  Due to the 
uneven sample sizes between mail and telephone participants, the frequency 
percentages are shown in Table 21 for Projects 1 and 2.   
To determine differences between the two groups, the Rao-Scott modified chi 
square test was conducted regarding categorical variables, and unweighted two sample 
t-tests (Satterthwaite method reported) were conducted regarding continuous variables.  
In Project 1, participants responding by mail differed from participants responding by 
telephone with respect to the following demographic characteristics:  maternal age [t 
(7,957) = 16.68, p <0.0001], maternal education [X2 = 139.11, df = 4, p<.0001], being 
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insured [X2 = 74.94, df = 1, p<.0001], receiving Medicaid benefits [X2 = 33.36, df = 1, 
p<.0001], Hispanic ethnicity [X2 = 29.13, df = 1, p<.0001], black maternal race [X2 = 
 
Table 21.  Mode of participation frequency for Projects 1 and 2. 
Infant Mortalitya 
 
Project 1 
(Frequency Percentages) 
Project 2 
(Frequency Percentages) 
Variables 
Mail 
(N=10,858) 
Telephone 
(N=1,381) 
Mail 
(N=106,199) 
Telephone 
(N=22,352) 
AGE 
    
17 years of age or younger  1.2 3.6 1.7 3.4 
18 to 19 years 5.1 10.6 5.2 8.3 
20 to 24 years 25.2 33.8 22.1 31.1 
25 to 29 years 33.4 30.4 30.0 27.3 
30 to 34 years 23.3 14.0 25.7 18.9 
35 to 39 years 10.0 5.6 12.7 8.9 
40 years of age or older 1.8 2.0 2.7 2.0 
     
RACE/ETHNICITY 
    
HISPANIC     
Yes 3.7 8.1 10.1 17.9 
No 96.3 91.9 89.9 82.1 
     
RACE/ETHNICITY     
Other Asian 1.2 0.8 2.6 2.5 
White 90.8 73.2 79.2 60.0 
Black 5.4 20.6 12.4 30.1 
American Indian 0.4 0.9 0.9 1.1 
Chinese 0.3 0.2 0.8 0.3 
Japanese 0.1 0.0 0.3 0.1 
Filipino 0.0 0.0 0.7 0.6 
Hawaiian 0.1 0.0 0.3 0.4 
Other Nonwhite 1.0 3.2 1.9 3.8 
Alaskan Native 0.0 0.0 0.1 0.2 
Mixed Race 0.5 1.2 0.8 1.1 
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INSURANCE STATUS 
(excludes Medicaid)   
 
 
Insured  72.3 52.8 68.7 49.7 
Not insured  27.7 47.2 31.3 50.3 
     
MEDICAID STATUS 
    
Enrolled in Medicaid  11.2 21.0 10.8 24.5 
Not enrolled in Medicaid 88.8 79.0 89.2 75.5 
     
INCOME LEVEL 
    
Less than $10,000 12.6 25.4 15.4 25.9 
$10,000 to $14,999 7.9 11.8 7.9 11.8 
$15,000 to $19,999 5.1 9.5 5.8 9.2 
$20,000 to $24,999 7.2 9.1 6.9 8.8 
$25,000 to $34,999 12.5 14.6 10.1 11.4 
$35,000 to $49,999 14.7 10.5 11.3 9.7 
$50,000 or more 39.9 19.1 42.6 23.3 
     
EDUCATION LEVEL 
    
0-8 years 1.1 1.8 2.0 4.1 
9-11 years 7.0 16.9 9.0 17.8 
12 years 28.2 41.4 26.5 36.6 
13-15 years 29.3 25.2 25.6 24.0 
16 years or more 34.4 14.7 36.8 17.5 
   
  a
 Missing data not shown; percentages may not equal 100% due to rounding. 
 
 
151.01, df = 1, p<.0001] and other nonwhite maternal race [X2 = 9.14, df = 1, p = .003].  
The groups did not differ with respect to other Asian maternal race [X2 = 1.85, df = 1, p = 
0.17], American Indian maternal race [X2 = 2.71, df = 1, p = 0.10], Chinese maternal race 
[X2 = 0.97, df = 1, p = 0.33], Filipino maternal race [X2 = 0.03, df = 1, p = 0.87], mixed 
maternal race [X2 = 2.05, df = 1, p = 0.15].  Also in Project 1, participants responding by 
mail differed from participants responding by telephone with respect to the following 
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selected variables:  adverse pregnancy outcomes [t (7,705) = -10.96, p=0.04], talking 
with a health care provider before pregnancy [X2 = 12.40, df = 1, p = .0004], folic acid 
use [X2 = 16.12, df = 3, p = .001], and tobacco use before pregnancy  [X2 = 29.18, df = 6, 
p<.0001].  The groups did not differ with respect to dental visit before pregnancy [X2 = 
1.55, df = 1, p = 0.21], alcohol frequency before pregnancy [X2 = 5.27, df = 5, p = 0.38], 
and binge drinking before pregnancy [X2 = 9.58, df = 5, p = 0.09].   
In Project 2, participants included in the study differed from participants excluded 
from the study with respect to the following demographic characteristics:  maternal age [t 
(61,614) = 57.48, p <.0001], maternal education [X2 = 1,597.85, df = 4, p<.0001], being 
insured [X2 = 1,070.74, df = 1, p<.0001], receiving Medicaid benefits [X2 = 1,096.13, df = 
1, p<.0001], and Hispanic ethnicity [X2 = 407.56, df = 1, p<.0001].  The two groups 
differed according to the following maternal race categories:  black [X2 = 1,663.48, df = 
1, p<.0001], American Indian maternal race [X2 = 7.16, df = 1, p = 0.01], Chinese 
maternal race [X2 = 60.22, df = 1, p<.0001], Japanese maternal race [X2 = 39.65, df = 1, 
p<.0001], Hawaiian maternal race [X2 = 29.72, df = 1, p<0001], other nonwhite  [X2 = 
114.52, df = 1, p<.0001], Alaskan native [X2 = 243.05, df = 1, p<.0001], and mixed 
maternal race [X2 = 6.47, df = 1, p = 0.01].  The groups did not differ with respect to 
other Asian maternal race [X2 = 0.18, df = 1, p = 0.67] or Filipino maternal race [X2 = 
0.45, df = 1, p = 0.50].  Also in Project 2, participants responding by mail differed from 
participants responding by telephone with respect to the following selected variables:  
adverse pregnancy outcomes [t (53,640) = -15.52, p <.0001], folic acid use [X2 = 314.77, 
df = 3, p<.0001], tobacco use before pregnancy  [X2 = 148.58, df = 6, p<.0001], alcohol 
frequency before pregnancy  [X2 = 824.83, df = 5, p<.0001], and binge drinking before 
pregnancy [X2 = 1,070.66, df = 5, p<.0001].  In both projects, participants responding by 
telephone were younger, more racially diverse (more identified as black and other racial 
categories; more identified as Hispanic ethnicity), uninsured, receiving Medicaid, with 
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lower income levels, and with less education.  These differences will be discussed at 
greater length in the next chapter. 
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Chapter 5:  Discussion 
This chapter explores the impact of preconception health on adverse pregnancy 
outcomes through the theoretical lens of reciprocal determinism.  It includes the 
following sections: research summary, discussion of results, strengths and limitations of 
the study, implications for future research, implications for public health practice, 
suggestions for dissemination of the findings, and a summary of the conclusions. 
Research Summary 
 Research indicates that prenatal care alone is insufficient to effect necessary 
change in infant mortality, thus explicating the need for other prevention strategies, such 
as preconception care (DHHS, 2000; Korenbrot, Steinberg, Bender, & Newberry, 2002).  
The idea of preconception health derives from ancient times and it is not a new idea.  
Yet, preconception health is only now being considered as supplemental prevention to 
prenatal care in the United States (Atrash, 2008).  Preconception health, however, does 
not occur in a vacuum.  The literature fails to demonstrate the effectiveness of 
preconception health as a whole on reducing adverse pregnancy outcomes, especially in 
the context of environmental and personal influences.  The preconception framework 
may help explain the impact of preconception health on adverse pregnancy outcomes in 
a broader context.  The purpose of this study was to examine the impact of 
preconception health on adverse pregnancy outcomes, with and without the influence of 
extenuating factors, such as environmental factors, personal influences, prenatal factors, 
and postnatal factors.  Project 1 of this study included four PRAMS-participating states 
that administered two optional survey items related to oral health care and medical 
health care prior to pregnancy in their PRAMS surveys (original N = 27,933).  Project 2 
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of this study included 32 PRAMS-participating states and one city (original N = 200,008).  
For each project, the preconception framework was examined with preconception health 
factors alone (reduced framework), in its entirety (the preconception framework), and 
with additional post hoc factors.  Structural equation modeling was used to examine the 
multiple iterations of the preconception framework. 
Discussion of Results 
 The research questions posed in this study were resolved through the path 
analyses of the reduced and full preconception frameworks in Projects 1 and 2.  The 
analysis of the reduced frameworks for both projects revealed extremely low R-squared 
values (1.1% or less).  Therefore, it was concluded that preconception health behaviors 
alone account for a negligible portion of the variance in adverse pregnancy outcomes.  
According to the principle of reciprocal determinism, preconception health behaviors 
interact with environmental factors and personal influences.  Thus, the subsequent 
analyses examined the full framework in Projects 1 and 2, as well as an additional post 
hoc analysis with supplementary PRAMS variables.  In these analyses, certain variables 
emerged as stronger predictors of adverse pregnancy outcomes than others. 
 Environmental factors.  According to the literature, adverse pregnancy 
outcomes are often linked with lower socioeconomic status (Dobie, et al., 1998; Howell, 
et al., 1991; Krieger, Connell, & LoGerfo, 1992; Liu, et al., 2010; Matijasevich, et al., 
2010; Schwethelm, Margolis, Miller, & Smith, 1989; Snyder, 2004).  In this study, 
receiving Medicaid benefits, having less income, and having lower maternal education 
were associated with increased adverse pregnancy outcomes.  However, the results of 
this study also demonstrate that being insured was associated with increased adverse 
pregnancy outcomes, and being exposed to more external stresses (e.g., moving, 
divorce, loss of employment, death of another) was associated with decreased adverse 
pregnancy outcomes.  These results seem counterintuitive; possible explanations for 
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these unexpected results are presented below.   
 The average cost for a vaginal delivery with a maternal and infant hospital stay of 
two days is $5,992 (Healthcare Blue Book, 2011).  The average cost for a cesarean 
section delivery with a maternal hospital stay of four days is $8,558 (Healthcare Blue 
Book).  Each additional day charge is $1,800 for the mother and $335 for the baby, and 
these costs do not include the possible use of the neonatal intensive care unit 
(Healthcare Blue Book).  Hospital costs associated with delivery may be prohibitive for 
uninsured women.  Most federal and state legislation requires insurance plans to cover 
postpartum hospital stays of ≥48 hours for vaginal deliveries and ≥72 or 96 hours for 
cesarean sections (Datar & Sood, 2006; Liu, Dow, & Norton, 2004).  It is possible that 
insured participants take advantage of longer maternal hospital stays than uninsured 
participants, and a maternal hospital stay of four days or more was categorized as an 
adverse pregnancy outcome in this study.  Thus, longer maternal hospital stays among 
insured women may account for the association with increased adverse pregnancy 
outcomes in this study.  Also, insurance status may be associated with cases of in vitro 
fertilization which in turn are associated with increased adverse pregnancy outcomes.  In 
vitro fertilization has been associated with increased risk of maternal complications such 
as preeclampsia, gestational hypertension, placental abruption, placenta previa, risk of 
cesarean section, as well as adverse pregnancy outcomes such as preterm delivery, low 
birth weight, and neonatal intensive care admission (Jackson, Gibson, Wu, & Croughan, 
2004; Shevell, et al., 2005).  Thus, insurance status may lead to increased adverse 
pregnancy outcomes via the use of in vitro fertilization.  In addition, there is an 
association between being privately insured and increased rates of cesarean section 
(Murray, 2000).  Delivery by cesarean section may be performed in cases of placental 
abnormalities, maternal infections, plurality, fetal distress, certain birth defects, and 
maternal distress (March of Dimes, 2008).  These conditions often result in the adverse 
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pregnancy outcomes associated with this study:  preterm delivery, low birth weight, small 
for gestational age, use of the neonatal intensive care unit, longer infant hospital stay, 
longer maternal hospital stay, and infant mortality (March of Dimes, 2008).  Thus, as 
indicated in this study, being insured may be associated with increased adverse 
pregnancy outcomes due to lengthier hospitalization, use of in vitro fertilization, and 
increased cesarean section deliveries, a statistical artifact so to speak. 
 Stress during pregnancy has been associated with increased risk of preterm 
delivery and small for gestational age (Hobel, Goldstein, & Barrett, 2008).  However, 
these associations are inconsistent due to limitations in stress scales, associations with 
smoking, and associations only evident among subgroups (Dole, et al., 2008; Harville, et 
al., 2010;  Neggers, et al., 2006; St-Laurent, et al., 2008).  Stress may be segmented 
into pregnancy-related stress, anxiety state, perceived stress, and life event stress 
(Lynn, et al., 2010).  Pregnancy-related stress may include physical or physiological 
changes during pregnancy, concerns about labor and delivery, concerns about the 
health of the fetus, or concerns about parenting (Lynn, et al., 2010; Stanton, et al., 
2002).  This type of stress is considered to be a better predictor of adverse pregnancy 
outcomes compared to other measures, like anxiety state, perceived stress, and life 
event stress (Dole, et al., 2003; Huizink, et al., 2004; Lobel, et al., 2008; Lynn, et al., 
2010; O’Connor, et al., 2002).  In the PRAMS data used in this study, the total number of 
stresses was based upon life event stress, such as loss of employment, change of 
residence, divorce, death of another, family illness, and homelessness.  In this study, 
increased life event stress was associated with decreased adverse pregnancy 
outcomes.  Accordingly, if pregnancy-related stress had been included in this study as 
opposed to life event stress, it is possible that there would have been the expected 
association between more stress and increased adverse pregnancy outcomes supported 
by the literature. Another possible explanation for the unexpected finding in this study is 
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a woman’s reactivity to stress during pregnancy.  Previous studies have demonstrated 
that women become less reactive physiologically and psychologically to external stress 
exposure as a pregnancy progresses (deWeerth & Buitelaar, 2005; Glynn, et al., 2004).  
After inducing the same stress among pregnant women at two points in time, study 
participants had significantly lower heart rate, blood pressure, and psychological distress 
at the second assessment (31 weeks gestation) compared to the first assessment at 17 
weeks gestation (deWeerth & Buitelaar, 2005).  Thus, later gestational timing of stress 
exposure results in less physiologic reactivity (deWeerth & Buitelaar).  This attenuation 
of reactivity may account for the association between increased stress during pregnancy 
and decreased adverse pregnancy outcomes, but the timing of the stress exposures in 
this study is unknown. 
 Personal influences.  Older maternal age is often associated with increased 
adverse pregnancy outcomes (Bell, et al., 2001; Buescher & Mittal, 2006; Lisonkova, et 
al., 2010; Martin, et al., 2002; Prysak, et al., 1995; Seoud, et al., 2002; Vercellini, et al., 
1993; Ziadeh, 2002), and this association was present in all possible iterations in this 
study.  Hispanic ethnicity also impacts adverse pregnancy outcomes.  The Latina 
paradox suggests that Latina women, especially Mexican-born women, experience more 
favorable birth outcomes than non-Hispanic women with similar socioeconomic profiles 
(Hummer, et al., 2007; McGlade, Saha, & Dahlstrom, 2004).  Puerto Rican Black women 
have been shown to experience more favorable birth outcomes than non-Hispanic 
blacks (Reichman & Kenney, 1998).   However, Puerto Rican white women have been 
shown to experience higher rates of low birth weight babies and infant mortality when 
compared to non-Hispanic white women (Mathews & MacDorman, 2007; Reichman & 
Kenney, 1998).  In opposition to the paradox, Hispanic ethnicity was associated with 
increased adverse pregnancy outcomes in all possible iterations of the study.  However, 
the impact of race or country of origin was not ascertained in this study. 
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 Maternal race also impacts adverse pregnancy outcomes.  Black maternal race, 
when compared to white maternal race, was associated with increased adverse 
pregnancy outcomes in all possible iterations of this study.  This coincides with the 
black-white infant mortality gap demonstrated in the literature.  Weathering, or early 
health deterioration due to social inequality, may account for this racially biased outcome 
(Geronimus, 1996).  However, after controlling for socioeconomic status, African 
American infants continue to experience increased infant mortality rates, increased rates 
of very preterm delivery and preterm delivery, and increased rates of very low birth 
weight and low birth weight compared to white Americans (Buescher & Mittal, 2006; 
Dominguez, et al., 2005; Dunlop, et al., 2008; Iyasu, et al., 1992; Lu & Halfon, 2003; 
Paneth, 1995; Singh & Yu, 1995; Ward, et al., 2010).  In addition, Other Asian, Chinese, 
and Filipino maternal races were associated with increased adverse pregnancy 
outcomes, and Hawaiian maternal race was associated with decreased adverse 
pregnancy outcomes when compared to white maternal race in this study.  According to 
the literature, Asians and Pacific Islanders (including Hawaiians) have lower rates of 
infant mortality and preterm birth compared to non-Hispanic whites and non-Hispanic 
blacks (Institute of Medicine, 2007; Kieffer, Mor, & Alexander, 1996; Mathews & 
MacDorman, 2007).  This study partially corroborates these findings. 
 Pregnancy intention also impacts adverse pregnancy outcomes.  Pregnancy 
intention is difficult to measure, because maternal response may fluctuate depending on 
physical, emotional, social, and environmental changes and events occurring before, 
during, and after the pregnancy (Sable, et al., 1997).  Unintended pregnancies are 
generally classified as mistimed or unwanted (Shah,et al., 2011).  Mistimed pregnancies, 
or those pregnancies desired at another time, are shown to be associated with low birth 
weight status (Shah, et al., 2011).  Unwanted pregnancies, or those pregnancies not 
desired at any time, are shown to be associated with low birth weight status and preterm 
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delivery (Shah, et al., 2011).  The results of this study coincide with these findings.  
When compared to intended pregnancy, mistimed pregnancies (among participants 
wanting to become pregnant sooner) and unwanted pregnancies were associated with 
increased adverse pregnant outcomes.   
 A history of adverse pregnancy outcomes may influence subsequent pregnancy 
outcomes.  Recurrences of adverse pregnancy outcomes in subsequent deliveries may 
be linked with maternal diabetes (Kovilam, et al., 2002; Sibai, et al., 2000), bacterial 
vaginosis (Jacobsson, et al., 2002), periodontitis (Madianos, et al., 2001; Offenbacher, et 
al., 2001); preconception body mass index (Cnattingius, et al., 1998; Sebire, et al., 
2001); anemia during pregnancy (Xiong, et al., 2000; Scanlon, et al., 2000); chronic 
stress and depression (Orr, James, & Blackmore-Prince, 2002; Wadha, et al., 2001), 
and short interpregnancy intervals (Conde-Agudelo, Rosas-Bermudez, & Kafury-Goeta, 
2006; Klerman, Cliver, & Goldenberg, 1998).  Health, social, and behavioral factors 
persisting after a first pregnancy may affect subsequent pregnancies, especially given 
short interpregnancy periods (Dunlop, et al., 2008).  The results of this study coincide 
with these findings.  In all possible iterations of this study, when compared to a prior 
history of normal pregnancy (no low birth weight or preterm delivery), having no history 
and a having a prior history of low birth weight status and/or preterm delivery were 
associated with increased adverse pregnancy outcomes.   
 Preconception health behaviors.  Prepregnancy weight may impact adverse 
pregnancy outcomes.  Obesity prior to pregnancy has been linked to perinatal mortality 
(Cnattingius, et al., 1998; Kristensen, et al., 2005) and maternal complications (Choi, 
Park, & Shin, 2011; Doherty, 2006; Leeners, 2006; Ehrenberg, Mercer, & Catalano, 
2004; Rode, Nilas, Wojdemann, & Tabor, 2005, Rudra, et al., 2007; Sebire, et al., 
2001b).  The results of this study corroborate these findings.   Overweight status prior to 
pregnancy was associated with increased adverse pregnancy outcomes in the majority 
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of the iterations in this study.   
 Underweight prepregancy status has also been linked to preterm delivery, 
intrauterine growth restriction, and low birth weight status (Ehrenberg, Dierker, Milluzzi, 
& Mercer, 2003).  In contrast, Cnattingius and colleagues concluded that underweight 
BMI status prior to pregnancy was associated with decreased risk of preeclampsia, 
small-for-gestational age infants, and infant mortality (1998).  The results of this study 
support those of Cnattingius and colleagues.  For women in the underweight BMI 
category prior to pregnancy, higher BMI was associated with increased adverse 
pregnancy outcomes.  In this study, the reliance on self-reported responses and the 
small underweight sample (5%, as opposed to almost 50% in the overweight category) 
limit generalizability to another population. 
 The findings for folic acid use in this study were counterintuitive.  An increase in 
the use of folic acid supplementation was associated with increased adverse pregnancy 
outcomes.  There are several possible explanations for this anomaly.  First, 
measurement error may account for the counterintuitive results.  The PRAMS survey 
item addressed the number of times per week a multivitamin was taken.  This item 
assumes that all multivitamins contain the recommended 400 micrograms of folic acid.  
Without supplementation regulation by the Federal Drug Administration, this assumption 
cannot be met.  Second, maternal age may impact the use of folic acid supplementation.  
Women between 18 and 24 years of age exhibited the least amount of knowledge 
regarding the importance of supplementation, and they had the lowest reported daily use 
of supplementation when compared with older women of reproductive age (Centers for 
Disease Control and Prevention, 2007g; Evans & Weisman, 2010).  In this study, 
whereas 22.9% of women 24 years and younger, 25.5% of women 25-34 years of age, 
and 5.4% of women over 34 years of age did not take a multivitamin prior to pregnancy, 
5.2%, 19.5%, and 6.6% took a multivitamin every day, respectively.  These results 
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support the finding that younger women report the lowest daily use of supplementation 
when compared with older women of reproductive age.  Older maternal age, as 
discussed previously, is associated with increased adverse pregnancy outcomes.  Thus, 
the association between increased folic acid use and increased adverse pregnancy 
outcomes may be impacted by maternal health or pregnancy conditions associated with 
advancing maternal age.  Third, the women taking folic acid supplements may have 
other risk factors, only one of which is vitamin deficiency.  Therefore, their risk would be 
higher due to the presence of other co-risk factors.  Fourth, observational studies 
demonstrate the effectiveness of folic acid in reducing low birth weight, preterm birth, 
pre-eclampsia, abruption placentae (Chiaffarino, et al., 2010).  However, among 12 
controlled clinical trials with folate supplementation versus placebo, supplementation 
demonstrated no statistically significant effects (Chiaffarino, et al., 2010).   
 Preconception use of tobacco may impact adverse pregnancy outcomes.  The 
literature links preconception tobacco use with conception delay and infertility 
(Rosenthal, Melvin, & Barker, 2006).  Maternal complications and fetal health risks are 
typically associated with tobacco use during pregnancy (CDC, 2007; DHHS, 2001).  This 
study demonstrated that cigarette use prior to pregnancy was associated with increased 
adverse pregnancy outcomes in four out of five iterations.   
 The results regarding alcohol use prior to pregnancy were counterintuitive in this 
study.  Research demonstrates an increased risk of birth defects, alcohol-related 
disorders, and fetal brain damage associated with fetal alcohol exposure (CDC, 2006d; 
Claren, 1986; Jones & Smith, 1973; Moore, Khoury, & Liu, 1997; Mattson & Riley, 1996; 
Mengel, Searight, & Cook, 2006; Riley, McGee, & Sowell, 2004; Sokol, Delaney-Black, & 
Nordstrom, 2003; Stratton, Howe, & Battaglia, 1996; Streissguth, 1994; Windham, et al., 
1997).  However, in the reduced and full framework analyses of Project 2, increased 
frequency of drinking alcohol and increased prevalence of binge drinking were 
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associated with decreased adverse pregnancy outcomes.  These findings seem 
counterintuitive, but there are a few possible explanations for such unexpected results.  
One possibility is measurement error.  It is possible that there was a coding error in the 
PRAMS dataset provided by the Centers for Disease Control and Prevention.  Or, it is 
possible that recall bias impacted the study results.  The PRAMS survey ascertained the 
number of drinks consumed per week (frequency of alcohol use) and the number of 
occasions on which more than five drinks were consumed (binge drinking) within the 
three months prior to conception.  As the survey was administered several months after 
delivery, there is over a one-year window of recall for the women responding to these 
preconception items.  In that time frame, a woman’s response may vary.  Second, the 
majority of pregnant women tend to reduce their preconception risk behaviors following 
pregnancy recognition (Anderson, et al., 2006; Tough, Tofflemire, Clarke, & Newburn-
Cook, 2006).  After pregnancy recognition, participants with higher preconception 
alcohol consumption may have felt guilty about the possible infliction of harm on their 
fetus.  At that point, these women may have adopted healthier behaviors and increased 
medical care during the pregnancy to compensate for any possible damage.  However, 
this theory is less feasible when applied to the binge drinking sample.  According to 
Naimi and colleagues (2003b), women who participated in preconception binge drinking 
were more likely to consume alcohol, binge drink, and smoke during pregnancy.  After 
considering these possible explanations, the association between preconception alcohol 
use (frequency of use and binge drinking) and decreased adverse pregnancy outcomes 
is most likely due to measurement error. 
 The impact of preconception counseling on adverse pregnancy outcomes is also 
counterintuitive in this study.  Preconception counseling has been shown to increase 
women’s knowledge, to increase folic acid use prior to pregnancy, and to reduce alcohol 
use in early pregnancy (Elsinga, et al., 2008).  Studies also demonstrate the association 
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between preconception counseling and reducing adverse pregnancy outcomes 
(Dudenhausen, Friese, & Kirschner, 2007; Elsinga, et al., 2008).  This study contradicts 
these findings.  In future iterations of the preconception framework, it is possible that 
folic acid use and contraceptive use may mediate the association between 
preconception counseling and adverse pregnancy outcomes.  Measurement error may 
be responsible for the counterintuitive association between preconception counseling 
and increased adverse pregnancy outcomes in this study.  Unfortunately, the impact of 
the preconception counseling item could not be confirmed in Project 2 due its exclusion 
from the core PRAMS survey. 
 Prenatal factors.  Maternal complications, such as gestational diabetes, 
incompetent cervix, hypertension, and premature rupture of the membranes, are 
commonly associated with adverse pregnancy outcomes in the literature (Bάnhidy, 
Acds, Puhά, & Czeizel, 2007; Blickstein, et al., 1989; Casey, et al., 1997; Czeizel & 
Bάnhidy, 2010; Dang, Homko, & Reece, 2000; Ganzevoort, et al., 2007; Jauniaux, Van 
Oppenraaij, & Burton, 2010; Kjos & Buchanan, 1999; Mitanchez, 2010; Nelson, et al., 
2009; Pettitt, et al., 1980; Schneider, et al., 2010; Setji, Brown, & Feinglos, 2005; 
Treadwell, et al., 1991;  Walsh, et al., 2010; Yang, et al., 2004; Yeast & Garite, 1988; 
Zetterstrάm, et al., 2005).  This study confirmed these findings.  Maternal complications 
and hospitalization during pregnancy were associated with increased adverse pregnancy 
outcomes.  Maternal complications are also associated with smoking, maternal age, 
inadequate gestational weight gain, and underweight prepregnancy body mass index 
(Choi, Park, & Shin, 2011; Hayashi, et al., 2011; Ziadeh, 2002).  In future iterations of 
the preconception framework, maternal complications may be integrated as a mediator 
between such factors and adverse pregnancy outcomes. 
 Through the treatment of maternal medical conditions, reducing potential risk 
factors, and addressing behavioral factors, prenatal care attempts to reduce adverse 
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pregnancy outcomes (U.S. Department of Health and Human Services, 2000).  Early 
and continuous prenatal care is recommended by the American Academy of Pediatrics 
[AAP] and the American College of Obstetricians and Gynecologists [ACOG] (AAP & 
ACOG, 1992).  This study supports these recommendations.  Later prenatal care 
initiation and fewer prenatal care visits were associated with increased adverse 
pregnancy outcomes.  However, in this study, the Kessner Index indicated an 
association between adequate prenatal care and increased adverse pregnancy 
outcomes.  This variable was added in the post hoc analysis, and this finding is 
counterintuitive.  The Kessner Index adjusts the timing and quantity of prenatal care for 
the length of gestation to obtain the adequacy of prenatal care (Kessner, Singer, Kalk, & 
Schlesinger, 1973).  Measurement error may account for this discrepancy.  When 
applying four indices of prenatal care utilization (GINDEX, Kessner Index, Adequacy of 
Prenatal Care Utilization [APNCU], and the revised GINDEX [R-GINDEX]) to models for 
preterm delivery and infant mortality, results varied (VanderWeele, Lantos, Siddique, & 
Lauderdale, 2009).  One index (the GINDEX) even provided counterintuitive results 
similar to those found in this study (VanderWeele, Lantos, Siddique, & Lauderdale). 
However, most researchers no longer use the Kessner Index or the GINDEX due to the 
restricted nine-visit coding limitation which inaccurately classifies prenatal care utilization 
of term and post-term pregnancies (Alexander & Kotelchuck, 2001; Alexander & 
Kotelchuck, 1996; Heaman, et al., 2008).   
 Gestational weight gain was included in the post hoc analysis.  The Institutes of 
Medicine (IOM) provides general guidelines for gestational weight gain based upon 
prepregnancy body mass index [BMI] (2009).  Recommendations indicate that women 
with lower BMI scores should gain more weight during pregnancy (e.g., underweight 
women should gain 28-40 pounds) and women with higher BMI scores should gain less 
weight during pregnancy (e.g., obese women should gain 11-20 pounds) (IOM).  
  
179 
 
According to a study conducted by Crane and colleagues, only 30.6% of women gained 
the recommended amount of weight during pregnancy; 52.3% of women gained more 
than recommended, and 17.1% gained less than recommended (2009).  Among women 
of normal weight, overweight, or obese status, adverse pregnancy outcomes were 
decreased among women with recommended weight gain than in those with excessive 
weight gain (Crane, 2009).  In opposition, the finding of the present study indicated an 
association between increased gestational weight gain and decreased adverse 
pregnancy outcomes.  The PRAMS data regarding gestational weight gain is derived 
from birth certificate data.  However, birth certificate data relies on self-report of 
gestational weight gain (Wright, et al., 2010).  Wright and colleagues examined self-
report birth certificate data regarding gestational weight gain compared with electronic 
medical records to ascertain accuracy (2010).  Among women within the normal BMI 
range, those with excessive gestational weight gain were more likely to under-report 
their gain compared to women with adequate gestational weight gain (RR 6.0; 95% CI: 
3.0-12.1) (Wright, et al., 2010).  These findings may partially explain the unexpected 
results in the present study.  Systematic bias may limit the use of birth certificate data 
regarding gestational weight gain (Wright, et al.). 
 Natal factors.  The natal factors included in this discussion were part of the post 
hoc analysis.  Three variables demonstrated significant associations:  plurality, first 
cesarean-section, and repeated cesarean-section.  Between 1971 and 1997, twin births 
increased 53%, 32%, 31%, and 83% among White, African-American, Native American, 
and Mexican-American women, respectively (Keith, Oleszczuk, & Keith, 2000).  In the 
same time period, triplet, quadruplet, and quintuplet births increased four-fold, eleven-
fold, and five-fold, respectively (Keith, Oleszczuk, & Keith).  In vitro fertilization, which is 
associated with increased risk of adverse pregnancy outcomes, often results in plurality 
(Jackson, Gibson, Wu, & Croughan, 2004; Shevell, et al., 2005).  Multiple gestation is 
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associated with increased risk of preterm delivery (1.7% for singletons vs. 41.2% for 
triplets), low birth weight (1.1% for singletons vs. 31.9% for triplets), and infant mortality 
(11.2 for singletons vs. 190.4 for triplets) (Keith, Oleszczuk, & Keith; Mathews & 
MacDorman, 2007; National Center for Health Statistics, 2008; Onyiriuka, 2010).  Thus, 
this study supports the findings that plurality is associated with an increase in adverse 
pregnancy outcomes.   
 Delivery by cesarean section was also associated with increased adverse 
pregnancy outcomes in this study.  In part, this may be due to the cutoff point chosen for 
length of maternal hospital stay.  Cesarean section delivery is associated with a longer 
hospital stay due to its surgical nature, and the four-day cutoff period chosen in this 
study may have been exceeded by mothers who underwent a cesarean section.  
Cesarean sections are also performed in cases associated with maternal complications 
or high-risk pregnancy, increasing the chance of an association between c-section and 
adverse pregnancy outcomes (March of Dimes, 2008c).  In addition, older maternal age 
is associated with cesarean section in the literature.  Deliveries by cesarean section 
occurred in 71.2%, 78.5%, and 85.9% of twin gestation cases among women 20-34 
years of age, 35-39 years of age, and 40 years and older, respectively (Kathiresan, et 
al., 2010).  Higher rates of cesarean section and older maternal age are associated with 
induced labor, especially elective induction (Ecker, et al., 2001).  It is possible that 
cesarean section acts as a mediating factor between maternal age and adverse 
pregnancy outcomes.  Cesarean sections are also associated with body mass index 
(BMI) in the literature.  Cesarean section rates increased from 18.2% among women 
with normal BMI scores to 40.6% among women with obese BMI scores (RR 2.2; 95% 
CI: 1.7-2.8) (Mantakas & Farrell, 2010).  It is possible that cesarean section acts as a 
mediating factor between prepregnancy maternal weight status and adverse pregnancy 
outcomes. 
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 The estimates obtained for these variables were small in magnitude, and 
therefore regardless of the direction of the estimate, these results must be interpreted 
with caution.  The highest R-squared value obtained corresponds to the post hoc 
analysis with an R-squared value of 0.305.  This figure indicates that, at most, the 
preconception framework with supplemental variables explains only 30.5% of the 
variance associated with adverse pregnancy outcomes as specified in this study.   
Strengths and Limitations 
 Strengths.  This study contributes to the literature in several ways.  First, this 
study uniquely assessed the impact of preconception health behaviors on adverse 
pregnancy outcomes in relation to environmental factors, personal influences, and 
prenatal factors.  This study demonstrated that preconception health behaviors alone 
had a negligible impact on adverse pregnancy outcomes.  When combined with other 
factors, the preconception framework explained less than one-third of the variance in 
adverse pregnancy outcomes, and further research is necessary to address the 
unexplained variance.   
 Second, this was the first study to examine PRAMS data in relation to 
preconception health behaviors using structural equation modeling.  This type of 
analysis was made possible through the use of Mplus statistical software which allowed 
for an analysis of the complex analysis weights and the numerous categorical variables 
associated with the PRAMS dataset.  Use of structural equation modeling allowed for an 
examination of the framework as a whole while controlling for Type I, or experimentwise, 
error (Wothke, 2000; Arbuckle, 1996).   
 Third, this study resulted in some unexpected associations.  These associations 
may be products of measurement error, but they may have some theoretical grounding.  
Further analyses are necessary to confirm or deny such unexpected findings.   
 Finally, this was the starting point toward the development of the preconception 
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framework.  Several modifications require investigation, but the framework in its entirety 
may prove useful in the future study of preconception health. 
 Limitations.  The scope of any study is restricted by its limitations.  In this study, 
there are several limitations to consider.  First, this study relied on self-reported cross-
sectional data.  Self-reported data may be subject to potential sources of error including 
response bias which is a concern in any pregnancy-related study.  Participants may be 
influenced to respond in the way they think the researcher or society wants them to 
respond.  For example, a mother that consumes alcohol during her pregnancy may 
deem the behavior socially undesirable.  She might then respond untruthfully to a survey 
about her alcohol use during pregnancy.  Several preconception health behaviors may 
fall into this social desirability bias trap, such as the use of folic acid to prevent birth 
defects and the harmful effects of cigarettes and alcohol prior to pregnancy.  This type of 
bias may influence the results of this study.  In addition, cross-sectional data is collected 
at one point in time, thus rendering the inference of cause and effect impossible. 
 Second, the PRAMS data used in this study relied heavily on recall bias.  Recall 
bias poses a problem when dealing with retrospective preconception health behaviors 
studies and the PRAMS dataset is no exception.  Whether participants responded to the 
PRAMS survey within one week or several months following delivery, there is 
automatically at least a nine-month pregnancy window in addition to the three-month 
preconception period.  Therefore, preconception survey questions are posed at least 
one year after the behaviors in question.  For example, an item concerning the number 
of alcoholic beverages consumed per week in the three months prior to becoming 
pregnant is subject to recall bias.  Thus, this type of bias may influence the results of this 
study.  Variables allowing the linkage of the date of survey completion to the date of birth 
were not available to the public due to privacy limitations associated with the PRAMS 
dataset.  Therefore, recall bias was not assessed in this study. 
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 Third, this study may be affected by nonresponse bias.  The PRAMS complex 
sampling weights initially accounted for nonresponse bias according to those 
participants failing to complete the survey.  However, a list-wise deletion of the missing 
data in Projects 1 and 2 resulted in a large portion of participant exclusion.  According to 
descriptive statistical analyses, the demographic profile of missing participants 
significantly differed from the demographic profile of study participants.  In both projects, 
those participants excluded from the study were more extreme in maternal age (younger 
and older), more racially diverse (more identified as black, Asian, and other racial 
categories), more identified as Hispanic, uninsured, receiving Medicaid, with lower 
income levels, and with less education.  Due to less education and possibly due to racial 
or ethnic barriers, the PRAMS dataset may have posed issues of readability that 
contributed to the amount of missing data from this population.  The PRAMS dataset 
may benefit from a reduction in the level of readability.  Following list-wise deletion, this 
study demonstrated response bias due to the differences in early responders and late 
responders.  According to the results of the sub-analysis comparing mail and telephone 
responders, there were demographic differences between the two groups.  Late 
responders, or those participants responding by telephone, were younger, more racially 
diverse (more identified as black and other nonwhite racial categories), more identified 
as Hispanic, uninsured, receiving Medicaid, with lower income levels, and with less 
education.  Again, readability of the survey may have posed problems for the telephone 
participants due to lower levels of literacy. 
 Fourth, the preconception framework may require modification to more 
accurately reflect the interactive nature among the variables included.  The 
conceptualization of the preconception framework began based upon the literature 
related to preconception health.  Over time, it encompassed environmental and personal 
factors, and later prenatal and postnatal factors.  All of these factors are thought to 
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influence the prevalence of adverse pregnancy outcomes, but their interactions within 
the comprehensive framework are less known.  Therefore, this study assessed the 
influence of all factors on adverse pregnancy outcomes.  However, there may be other 
variable configurations that improve the fit of the framework.  For example, this study 
demonstrated the statistical significance of maternal complications on adverse 
pregnancy outcomes.  Some of these complications, like placenta previa, may be 
caused by random occurrence or by genetics.  However, other complications, like 
preeclampsia, may be more heavily influenced by preconception behaviors.  Therefore, 
certain maternal complications may in fact be mediating factors between preconception 
health behaviors and adverse pregnancy outcomes.  The interactions between the 
variables in the preconception framework would need to be reevaluated based upon 
theory and research results prior to framework reconfiguration.   
 Fifth, there may be unmeasured variables or unknown factors not presently 
included in the framework.  This study was limited to the variables included in the 
PRAMS dataset.  However, there are other preconception behaviors that may influence 
adverse pregnancy outcomes, such as mercury exposure from frequent fish 
consumption.  The PRAMS dataset limits preconception health behaviors to a possible 
six variables, but there may be other behaviors or different types of factors that influence 
the results of this study.  In addition, unknown variables may have been omitted from the 
PRAMS dataset and subsequently from this study.  According to nature versus nurture, 
some variables can be measured, such as those in the preconception framework, and 
some cannot, such as genetic predisposition.  Thus, there are possible unknown factors 
that may not be measured in relation to the preconception framework that influence 
adverse pregnancy outcomes. 
 Finally, the use of secondary data presents several limitations related to this 
study.  As with any study, there is the possibility of measurement error.  Measurement 
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error increases the chance of making a Type II error, or failing to detect an existing 
relationship.   Item construction and psychometric testing play a significant role in 
response rate and accurate completion of survey data.  For example, the construction of 
the contraception item excluded from this analysis may have accounted for its low 
response rate.  The length of the survey may have been prohibitive as well.  The 
PRAMS survey length varies from about 60-90 questions depending upon optional 
standard state and state-specific question inclusion (D’Angelo, D.V., November 13, 
2009).  Longer surveys may have influenced survey completion and missing data 
frequency for certain states.  Even with pilot testing, it is apparent that the PRAMS 
dataset does not account for the relationship between infant mortality and postnatal 
variables.  In addition, the use of multi-state data requires strenuous data cleaning and 
accurate coding verification, and any possible errors may influence the results of the 
study.  Also, validity for the PRAMS questionnaire has only been assessed via two 
studies limited to the smoking and assisted reproductive technology items (D’Angelo, 
D.V., November 13, 2009).  The present study is limited to the items and scaling 
inherent in the PRAMS questionnaire, with noted exclusion of such items as emotional 
violence, sexual violence, maternal narcotic/amphetamine/marijuana use, genetic 
testing, maternal sexually transmitted infections, and postnatal insurance status.  The 
study is also limited to the core items of the PRAMS data and to the standard state items 
used by only certain states.  This study is limited to an examination of PRAMS state data 
available for public use.  For example, the PRAMS data from Vermont is small enough to 
require restricted use based upon privacy issues.  Therefore, this study is limited to only 
those states that participated in PRAMS between 2005 and 2008 with complete data and 
no privacy exclusions.  The exclusion criteria also present certain limitations when 
working with the PRAMS dataset.  All out-of-state births to residents and all in-state 
births to nonresidents were excluded from the PRAMS dataset.  Therefore, mothers who 
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have immigrated legally without permanent residency or immigrated illegally to the 
United States were excluded from the study.  The immigrant population in the United 
States increased from about 4% in 1970 to about 12.5% in 2007 (Camarota, 2007; Singh 
& Yu, 1996), and nearly one in three immigrants is an illegal alien (Camarota, 2007).  
The immigrant population tends to be less educated, poorer, and lacking health 
insurance compared to the native population (Camarota, 2007).  Therefore, immigration 
status may impact adverse pregnancy outcomes, and its exclusion is a limitation of the 
PRAMS dataset.  Also, the PRAMS dataset includes only pregnancies resulting in a live-
born infant, thus excluding stillbirths or late fetal deaths.  Stillbirths are shown to be 
associated with adverse pregnancy outcomes (Astolfi, De Pasquale, & Zonta, 2005; 
Rasmussen, Irgens, Skjaerven, & Melve, 2009; Subramoney, d’Espaignet, & Gupta, 
2010).  Thus, the exclusion of stillbirths is a limitation of the PRAMS dataset. 
Implications for Future Research 
 This study is a building block in the study of preconception health behaviors in a 
broad context.  Further research is required to establish the reliability of the results of 
this study and to examine possible variations of the preconception framework.   
 First, the PRAMS questionnaire may benefit from modification.  The two 
preconception health behavior items related to obtaining oral health care and obtaining 
medical health care should be included in the core portion of the PRAMS questionnaire 
administered to all states.  Additional preconception health variables might warrant 
consideration, such as weekly fish consumption to ascertain the impact of mercury on a 
developing fetus.  An effort to obtain postnatal information from women who experienced 
infant mortality should be made.  Further efforts to obtain any missing information should 
also be attempted. 
 Second, the preconception framework requires modification.  The configuration 
of the existing variables may be modified to further identify possible mediating variables, 
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such as certain maternal complications.  Additional variables impacting adverse 
pregnancy outcomes may be added to increase the amount of explained variance 
associated with adverse pregnancy outcomes in the preconception framework.  A few of 
the studies that have demonstrated associations with adverse pregnancy outcomes 
include vitamin D (Bodnar & Simhan, 2010; Scholl & Chen, 2009); sleep (Naud, et al., 
2010); rurality (Bailey & Cole, 2009); maternal employment (Bell, Zimmerman, & Diehr, 
2008); racial density (Pickett, et al., 2005); and particulate air pollution (Yi, Kim, & Ha, 
2010).   
 Third, the preconception framework may be applied to other research datasets.  
It is possible that other datasets also incorporate items related to preconception health 
behaviors, as well as the items related to surrounding contextual factors.  Application of 
the preconception framework to another dataset may substantiate the results found with 
the PRAMS dataset or it may render different results entirely.  Datasets that include 
some preconception health variables include the Behavioral Risk Factor Surveillance 
System and the Central Pennsylvania Women’s Health Study. 
 Ideally, any preconception health behavior study would be prospective in nature, 
because retrospective recall is difficult for many participants and may introduce bias.  A 
prospective study would ensure the accuracy of preconception health behavior data, but 
it is often considered too time-consuming and cost-prohibitive for most research projects.  
To reduce the costs associated with a purely prospective study, it would be possible to 
initiate a study that collects preconception data from women in the first trimester of 
pregnancy and follows them to term. 
 Considering the limitations associated with this study, the limitations associated 
with the PRAMS dataset, and the resulting poor predictive value of preconception health 
behaviors, the validity of recommendations regarding preconception health behaviors 
and the cost of accumulating vast amounts of data must be scrutinized.  If the PRAMS 
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survey is flawed by the exclusion of high-risk populations for adverse pregnancy 
outcomes and an innate potential for recall bias, then the impact of preconception health 
behaviors may be greater than the results presented in this study.  If so, the PRAMS 
survey could be split into two sections:  1) the current PRAMS survey without 
preconception health behaviors and 2) a separate preconception health behaviors 
survey administered in the first trimester of pregnancy.  The PRAMS survey, in either 
case, would benefit from improved psychometric evaluation and reducing the readability 
level to decrease the amount of missing data.  However, if the PRAMS survey accurately 
ascertains preconception health behaviors, then the impact of preconception health 
behaviors is negligible per the results of this study.  If so, emphasizing preconception 
health behaviors in the public health arena will be ineffectual in remedying adverse 
pregnancy outcomes and other solutions must be examined. 
Implications for Public Health Practice 
 Because nearly half of all pregnancies are unintended, yielding about three 
million unintended pregnancies in the U.S. annually (DHHS, 2000), there is a need to 
shift care to an earlier period in a woman’s life cycle with greater potential to prevent 
birth defects and other adverse pregnancy outcomes, also known as preconception care 
(Bennett & Kotelchuck, 2005). The goal of preconception care is to provide health 
promotion, screening, and interventions for the more than 62 million women of 
childbearing age in the United States (Johnson, 2006; U.S. Census Bureau, 2005).  
  According to this study, the relationship between preconception health behaviors 
and adverse pregnancy outcomes is unclear.  Preconception health behaviors alone 
account for a negligible portion of the variance associated with adverse pregnancy 
outcomes.  In combination with other contextual factors, like environmental factors, 
personal influences, prenatal factors, and natal factors, the framework accounts for 
almost a third of the total variance in adverse pregnancy outcomes.  The majority of 
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significant factors in this study were not related to behavior change, and therefore, 
present as predisposing factors for adverse pregnancy outcomes:  pregnancy history, 
maternal age, maternal race, Hispanic ethnicity, maternal complications, hospitalization 
during pregnancy, plurality, and cesarean section.  However, several of these factors 
may be influenced by behavior, such as the impact of exercise and diet on maternal 
complications like preconception diabetes and hypertension.     
 Further studies are necessary to provide preconception health guidelines for 
health care providers and the general public.  The results of this study must be 
interpreted with caution, and the findings from this study have limited generalizability to 
the general population.  Until the findings of this study are corroborated or otherwise 
substantiated through additional analysis, however, it is still conscionable that health 
care providers, insurance companies, and health educators promote basic health 
guidelines to all women of reproductive age at any and all possible health encounters.  
Basic health guidelines include maintenance of a healthy BMI score (not underweight or 
overweight), consumption of appropriate levels of folate (preferably through whole foods 
high in folate), avoidance of tobacco products, and limitations of alcohol intake.  These 
health guidelines may be employed by all persons, regardless of age and gender.  
However, the adherence to these guidelines among women of reproductive age may 
improve adverse pregnancy outcomes in the event that a planned or unplanned 
pregnancy may occur. 
Dissemination of Findings 
  The findings of this study in relation to preconception health behaviors are 
indeterminate.  Nevertheless, dissemination of the findings is still important to encourage 
other researchers to determine what has been done and what can be done in the future.  
Therefore, the results from this study will be submitted for publication, targeting such 
journals as the American Journal of Public Health, the Maternal and Child Health 
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Journal, and the American Journal of Obstetricians and Gynecologists.  The results also 
will be submitted for the MCH Section of the APHA convention and for the National 
Summit on Preconception Health and Health Care.  Research results also will be shared 
with the Centers for Disease Control and Prevention, as well as the PRAMS-participating 
states in Project 1, in exchange for the use of the PRAMS dataset. 
Summary of the Conclusions 
 This study examined the impact of preconception health behaviors on adverse 
pregnancy outcomes through the theoretical lens of reciprocal determinism.  
Preconception health behaviors alone accounted for a negligible portion of the variance 
associated with adverse pregnancy outcomes.  As hypothesized, preconception health 
behaviors work in concert with environmental factors, personal influences, prenatal and 
natal factors.  Significant predictors supported in the literature included lower 
socioeconomic status, pregnancy intention, pregnancy history, older maternal age, black 
maternal race, Hispanic ethnicity, overweight maternal BMI, tobacco use prior to 
pregnancy, maternal complications, hospitalization during pregnancy, later prenatal care 
initiation, fewer prenatal care visits, plurality, and cesarean section.  Even so, there is a 
large portion of the variance in adverse pregnancy outcomes that is not accounted for, 
and further examination is required.   
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Appendix A:  Frequency Distributions for All Variables for Each Sample 
Variable 
(Variable Name) Survey Items and Response Options Project 1 Project 2 
  Freq. Wtd. Freq. % Freq. 
Wtd. 
Freq. % 
 
Insurance status 
(INSURE) 
 
Just before you got pregnant, did you have health insurance? 
A.  No 
B. Yes 
 
 
 
3,794 
8,445 
 
 
148,595 
346,660 
 
 
30.0 
70.0 
 
 
47,824 
80,727 
 
 
1,987,455 
3,777,541 
 
 
34.5 
65.5 
 
Medicaid status 
(MEDICAD3) 
 
Just before you got pregnant, were you on Medicaid? 
A.  No 
B. Yes 
 
 
 
10,527 
1,712 
 
 
433,880 
61,375 
 
 
87.6 
12.4 
 
 
109,922 
18,629 
 
 
5,010,170 
754,826 
 
 
86.9 
13.1 
 
Income level 
(INCOME5) 
 
During the 12 months before your new baby was born, what 
was your total household income before taxes? 
A.  Less than $10,000 
B. $10,000 to $14,999 
C. $15,000 to $19,999 
D. $20,000 to $24,999 
E. $25,000 to $34,999 
F. $35,000 to $49,999 
G. $50,000 or more 
 
 
 
 
1,757 
1,028 
750 
923 
1,567 
1,825 
4,389 
 
 
 
70,215 
41,392 
27,948 
36,853 
63,187 
70,379 
185,282 
 
 
 
14.2 
8.4 
5.6 
7.4 
12.8 
14.2 
37.4 
 
 
 
25,437 
11,944 
8,439 
9,533 
13,455 
14,417 
45,326 
 
 
 
988,505 
491,887 
364,991 
415,866 
595,318 
634,854 
2,273,575 
 
 
 
17.1 
8.5 
6.3 
7.2 
10.3 
11.0 
39.4 
 
Education level 
(MAT_ED) 
 
From birth certificate data 
A.  0-8 years 
B. 9-11 years 
C. 12 years 
D. 13-15 years 
E. 16 years or more 
 
 
 
134 
1,203 
3,824 
3,237 
3,841 
 
 
5,953 
40,474 
147,605 
142,688 
158,535 
 
 
1.2 
8.2 
29.8 
28.8 
32.0 
 
 
 
2,749 
14,661 
38,412 
32,727 
40,002 
 
 
135,998 
604,889 
1,625,109 
1,460,212 
1,938,786 
 
 
2.4 
10.5 
28.2 
25.3 
33.6 
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External stress 
(STRS_TT3) 
 
 
CDC Computed – total number of stresses 
A.  0 
B. 1 
C. 2 
D. 3 
E. 4 
F. 5 
G. 6 
H. 7 
I. 8 
J. 9 
K. 10 
L. 11 
M. 12 
N. 13 
 
 
 
 
3,262 
3,142 
2,157 
1,487 
878 
536 
317 
216 
145 
56 
22 
11 
7 
3 
 
 
 
131,551 
125,122 
84,861 
61,236 
38,932 
22,290 
12,963 
8,901 
5,971 
1,829 
690 
505 
184 
220 
 
 
 
26.6 
25.3 
17.1 
12.4 
7.9 
4.5 
2.6 
1.8 
1.2 
0.4 
0.1 
0.1 
0.0 
0.0 
 
 
 
35,235 
30,801 
22,382 
15,219 
9,640 
6,326 
3,953 
2,438 
1,357 
666 
329 
138 
50 
17 
 
 
 
1,658,437 
1,417,764 
999,639 
672,249 
394,939 
270,706 
161,777 
95,313 
51,838 
22,895 
11,914 
4,699 
1,927 
896 
 
 
 
28.8 
25.0 
17.3 
11.7 
6.9 
4.7 
2.8 
1.7 
0.9 
0.4 
0.2 
0.1 
0.0 
0.0 
 
 
Physical abuse 
(PABF5_NO) 
 
CDC Computed – no physical abuse during the 12 months 
before pregnancy 
A. No 
B. Yes 
 
 
 
 
551 
11,688 
 
 
 
21,972 
473,283 
 
 
 
4.4 
95.6 
 
 
 
7,555 
120,996 
 
 
 
293,300 
5,471,695 
 
 
 
5.1 
94.9 
 
Pregnancy intention 
(FEEL_PG) 
 
 
 
 
 
 
 
 
 
 
Thinking back to just before you got pregnant with your new 
baby, how did you feel about becoming pregnant? 
A. I wanted to be pregnant sooner 
B. I wanted to be pregnant later 
C. I wanted to be pregnant then 
D. I didn’t want to be pregnant then or any time in the 
future 
 
 
 
 
 
 
 
2,479 
3,365 
5,384 
1,011 
 
 
 
 
 
 
 
 
93,025 
144,444 
210,262 
47,523 
 
 
 
 
 
 
 
 
18.8 
29.2 
42.5 
9.6 
 
 
 
 
 
 
 
 
23,747 
39,507 
52,191 
13,106 
 
 
 
 
 
 
 
 
1,021,740 
1,753,428 
2,439,778 
550,048 
 
 
 
 
 
 
 
 
17.7 
30.4 
42.3 
9.5 
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(PREG_TRY) 
 
When you got pregnant with your new baby, were you trying to 
get pregnant? 
A. No 
B. Yes 
 
 
 
5,352 
6,887 
 
 
 
 
231,473 
263,782 
 
 
 
46.7 
53.3 
 
 
 
65,136 
63,415 
 
 
 
2,845,748 
2,919,247 
 
 
 
49.4 
50.6 
 
Maternal age 
Dataset 1: 
(MAT_AGE) 
Dataset 2: 
(MAT_AGE_NAPHS
IS) 
 
From birth certificate data 
A.  17 years of age or younger 
B.  18-19 years of age 
C.  20-24 years of age 
D.  25-29 years of age 
E.  30-34 years of age 
F.  35-39 years of age 
G.  40 years of age or older 
 
 
 
243 
638 
3,012 
3,938 
2,713 
1,177 
218 
 
 
7,480 
28,476 
129,969 
163,577 
109,619 
46,757 
9,375 
 
 
1.5 
5.7 
26.2 
33.0 
22.1 
9.4 
1.9 
 
 
3,153 
8,392 
31,759 
36,380 
29,058 
16,240 
3,569 
 
 
 
114,074 
330,978 
1,358,219 
1,701,642 
1,414,774 
696,919 
148,390 
 
 
2.0 
5.7 
23.6 
29.5 
24.5 
12.1 
2.6 
 
 
Race/Ethnicity 
 
(HISP_BC) 
 
 
 
(MAT_RACE) 
 
From birth certificate data 
 
Hispanic 
A. Yes 
B. No 
 
Race/Ethnicity 
A. Other Asian 
B. White 
C. Black 
D. American Indian 
E. Chinese 
F. Japanese 
G. Filipino 
H. Hawaiian 
I. Other Nonwhite 
J. Alaskan Native 
K. Mixed Race 
 
 
 
 
640 
11,599 
 
 
142 
11,103 
779 
78 
17 
14 
7 
10 
58 
0 
31 
 
 
 
 
20,831 
474,424 
 
 
5,895 
439,185 
35,931 
2,288 
1,581 
601 
148 
376 
6,240 
0 
3,011 
 
 
 
 
4.2 
95.8 
 
 
1.2 
88.7 
7.3 
0.5 
0.3 
0.1 
0.0 
0.1 
1.3 
0.0 
0.6 
 
 
 
 
 
13,909 
114,642 
 
 
5,038 
86,917 
21,615 
3,611 
1,682 
988 
1,960 
1,296 
2,612 
1,400 
1,432 
 
 
 
 
657,016 
5,107,979 
 
 
149,348 
4,380,459 
884,073 
55,038 
41,826 
14,176 
38,683 
17,703 
129,341 
7,218 
47,130 
 
 
 
 
11.4 
88.6 
 
 
2.6 
76.0 
15.3 
1.0 
0.7 
0.2 
0.7 
0.3 
2.2 
0.1 
0.8 
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Previous pregnancy 
outcomes 
(PREGHX) 
 
CDC computed – history of previous live births 
A. No previous live birth 
B. OK (not low birth weight or preterm) 
C. Low birth weight 
D. Preterm 
E. Low birth weight and preterm 
 
 
 
5,262 
5,714 
276 
448 
539 
 
 
193,172 
258,894 
9,544 
19,341 
14,305 
 
 
39.0 
52.3 
1.9 
3.9 
2.9   
 
 
57,907 
55,832 
3,771 
5,016 
6,025 
 
 
2,493,470 
2,757,066 
139,498 
203,128 
171,833 
 
 
43.3 
47.8 
2.4 
3.5 
3.0 
 
Weight Management 
(MOM_BMI) 
 
 
CDC calculated – Body Mass Index (based on height and 
weight prior to pregnancy) 
 
A. Underweight - BMI under 18.5 
B. Normal weight – BMI 18.5 to 24.9 
C. Overweight – BMI 25.0 to 29.9 
D. Obese (includes all classes) – BMI 30.0 or greater 
 
 
 
 
 
658 
6,131 
2,993 
2,457 
 
 
 
 
24,074 
246,364 
124,450 
100,367 
 
 
 
 
4.9 
49.7 
25.1 
20.3 
 
 
 
 
 
6,856 
61,174 
32,604 
27,917 
 
 
 
 
264,376 
2,795,807 
1,489,123 
1,215,689 
 
 
 
 
4.6 
48.5 
25.8 
21.1 
 
Folic acid use 
(VITAMIN) 
 
During the month before you got pregnant with your new baby, 
how many times a week did you take a multivitamin or a 
prenatal vitamin? 
A. I didn’t take a multivitamin or a prenatal vitamin at all. 
B. 1 to 3 times a week 
C. 4 to 6 times a week 
D. Every day of the week 
 
 
 
 
 
6,096 
1,178 
1,024 
3,941 
 
 
 
 
 
256,037 
45,961 
42,522 
150,735 
 
 
 
 
51.7 
9.3 
8.6 
30.4 
 
 
 
 
70,278 
11,210 
7,924 
39,139 
 
 
 
 
3,101,347 
499,130 
378,737 
1,785,782 
 
 
 
 
53.8 
8.7 
6.6 
31.0 
 
Preconception 
avoidance of 
tobacco 
(SMK5_3B) 
 
In the 3 months before you got pregnant, how many cigarettes 
did you smoke on an average day? 
A. 41 cigarettes or more 
B. 21 to 40 cigarettes  
C. 11 to 20 cigarettes 
D. 6 to 10 cigarettes 
E. 1 to 5 cigarettes 
F. Less than 1 cigarette 
G. None (0 cigarettes) 
 
 
 
112 
290 
1,062 
698 
503 
94 
9,480 
 
 
 
3,922 
12,637 
45,095 
30,030 
20,090 
3,320 
380,160 
 
 
 
0.8 
2.6 
9.1 
6.1 
4.1 
0.7 
76.8 
 
 
 
1,410 
2,758 
11,111 
9,273 
7,369 
1,159 
95,471 
 
 
 
51,653 
104,801 
461,822 
378,232 
307,792 
54,346 
4,406,349 
 
 
 
0.9 
1.8 
8.0 
6.6 
5.3 
0.9 
76.4 
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Preconception 
avoidance of alcohol 
(DRK5_3B) 
 
 
 
 
 
(DRK5_3BB) 
 
During the 3 months before you got pregnant, how many 
alcoholic drinks did you have in an average week? 
A. 14 drinks or more a week 
B. 7 to 13 drinks a week 
C. 4 to 6 drinks a week 
D. 1 to 3 drinks a week 
E. Less than 1 drink a week 
F. I didn’t drink then 
 
During the 3 months before you got pregnant, how many times 
did you drink 5 alcoholic drinks or more in one sitting? 
A. 6 or more times 
B. 4 to 5 times 
C. 2 to 3 times 
D. 1 time 
E. I didn’t have 5 drinks or more in 1 sitting 
F. I didn’t drink then 
 
 
 
 
136 
283 
612 
1,511 
3,112 
6,585 
 
 
 
246 
259 
883 
756 
3,524 
6,571 
 
 
 
 
5,212 
10,562 
26,352 
63,986 
133,939 
255,204 
 
 
 
9,705 
10,602 
38,859 
33,767 
148,456 
253,866 
 
 
 
1.0 
2.1 
5.3 
12.9 
27.0 
51.5 
 
 
 
2.0 
2.1 
7.8 
6.8 
30.0 
51.3 
 
 
 
 
1,553 
3,065 
7,428 
18,857 
36,192 
61,456 
 
 
 
2,800 
2,831 
10,061 
8,600 
42,805 
61,454 
 
 
 
 
61,438 
145,670 
361,098 
916,884 
1,706,791 
2,573,114 
 
 
 
125,259 
132,663 
476,993 
415,797 
2,040,279 
2,574,004 
 
 
 
1.1 
2.5 
6.3 
15.9 
29.6 
44.6 
 
 
 
2.2 
2.3 
8.3 
7.2 
35.4 
44.6 
 
 
Obtaining oral care 
(DDS_BEFR) 
 
When did you have your teeth cleaned by a dentist or a dental 
hygienist? 
a. Before my most recent pregnancy 
i. No 
ii. Yes 
 
 
 
 
 
1,649 
10,590 
 
 
 
 
67,504 
427,751 
 
 
 
 
13.6 
86.4 
 
 
 
 
N/A 
N/A 
 
 
 
 
N/A 
N/A 
 
 
 
 
N/A 
N/A 
 
 
Obtaining medical 
care 
(BPG_TALK) 
 
Before you got pregnant with your new baby, did you talk with 
a doctor, nurse, or other health care worker to prepare for a 
healthy pregnancy and baby? 
A. No 
B. Yes 
 
 
 
 
 
 
8,486 
3,753 
 
 
 
 
 
356,638 
138,617 
 
 
 
 
 
72.0 
28.0 
 
 
 
 
 
N/A 
N/A 
 
 
 
 
 
N/A 
N/A 
 
 
 
 
 
N/A 
N/A 
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Tobacco use during 
pregnancy 
(SMK5_3L) 
 
In the last 3 months of your pregnancy, how many cigarettes 
did you smoke on an average day? 
A. 41 cigarettes or more 
B. 21 to 40 cigarettes 
C. 11 to 20 cigarettes 
D. 6 to 10 cigarettes 
E. 1 to 5 cigarettes 
F. Less than 1 cigarette 
G. None (0 cigarettes) 
 
 
 
 
26 
36 
293 
486 
616 
171 
10,611 
 
 
 
769 
2,357 
13,680 
20,841 
22,865 
7,598 
427,145 
 
 
 
0.2 
0.5 
2.8 
4.2 
4.6 
1.5 
86.2 
 
 
 
319 
633 
3,096 
5,204 
7,801 
2,121 
109,377 
 
 
 
11,898 
23,069 
119,687 
194,127 
290,027 
87,488 
5,038,699 
 
 
 
0.2 
0.4 
2.1 
3.4 
5.0 
1.5 
87.4 
 
 
Alcohol use during 
pregnancy 
(DRK5_3L) 
 
 
 
 
 
 
(DRK5_3LB) 
 
 
During the last 3 months of your pregnancy, how many 
alcoholic drinks did you have in an average week? 
A. 14 drinks or more a week 
B. 7 to 13 drinks a week 
C. 4 to 6 drinks a week 
D. 1 to 3 drinks a week 
E. Less than 1 drink a week 
F. I didn’t drink then 
 
During the last 3 months of your pregnancy, how many times 
did you drink 5 alcoholic drinks or more in one sitting? 
A. 6 or more times 
B. 4 to 5 times 
C. 2 to 3 times 
D. 1 time 
E. I didn’t have 5 drinks or more in 1 sitting 
F. I didn’t drink then 
 
 
 
 
9 
12 
15 
109 
503 
11,591 
 
 
 
 
13 
5 
21 
23 
584 
11,593 
 
 
 
 
 
368 
451 
762 
4,070 
20,413 
469,190 
 
 
 
 
468 
243 
556 
1,774 
23,323 
468,890 
 
 
 
 
0.1 
0.1 
0.2 
0.8 
4.1 
94.7 
 
 
 
 
0.1 
0.0 
0.1 
0.4 
4.7 
94.7 
 
 
 
 
127 
87 
262 
1,452 
6,386 
120,237 
 
 
 
 
214 
100 
250 
377 
7,402 
120,208 
 
 
 
 
5,908 
4,180 
13,533 
72,814 
332,152 
5,336,408 
 
 
 
 
10,150 
3,617 
10,681 
13,702 
388,115 
5,338,731 
 
 
 
 
0.1 
0.1 
0.2 
1.3 
5.8 
92.6 
 
 
 
 
0.2 
0.1 
0.2 
0.2 
6.7 
92.6 
 
Maternal 
complications 
(MATLCOMP) 
 
 
Occurrence of maternal complications during most recent 
pregnancy – number of factors 
 
Possible complications include: vaginal bleeding; kidney or 
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Based on 
MORB_DID 
MORB_BLD 
MORB_KID 
MORB_NAU 
MORB_CRV 
MORB5BP 
MORB_PLA 
MORB_LAB 
MORB_PRM 
MORB_TRN 
bladder (urinary tract) infection; severe nausea, vomiting or 
dehydration; incompetent cervix; high blood pressure, 
hypertension; placental problems; labor pains more than 3 wks 
prior to due date; premature rupture of the membranes; 
required blood transfusion. 
 
A.  0 
B. 1 
C. 2 
D. 3 
E. 4 
F. 5 
G. 6 
H. 7 
I. 8 
J. 9 
K. 10 
 
 
 
 
 
 
3,682 
3,470 
2,516 
1,455 
744 
257 
93 
15 
6 
0 
1 
 
 
 
 
 
 
 
178,508 
146,669 
95,382 
46,226 
19,386 
6,637 
1,991 
366 
74 
0 
15 
 
 
 
 
 
 
36.0 
29.6 
19.3 
9.3 
3.9 
1.3 
0.4 
0.1 
0.0 
0.0 
0.0 
 
 
 
 
 
 
39,521 
35,974 
26,171 
15,314 
7,559 
2,898 
843 
206 
30 
13 
22 
 
 
 
 
 
 
2,170,821 
1,707,903 
1,066,182 
518,334 
207,203 
72,238 
16,430 
3,788 
366 
348 
1,383 
 
 
 
 
 
 
37.7 
29.6 
18.5 
9.0 
3.4 
1.3 
0.3 
0.1 
0.0 
0.0 
0.0 
 
Prenatal education 
(PRNTLEDU) 
 
Based on TLK_SMK 
TLK_DRK 
TLK_BELT 
TLK_BC 
TLK_MEDS 
TLK_DRUG 
TLK_BDEF 
TLK_LABR 
TLK_HIVT 
TLK_ABUS 
 
Topics of discussion with a doctor, nurse, or other health care 
worker during any prenatal care visits – number of topics 
 
Possible topics include:  during pregnancy – smoking, drinking 
alcohol, seat belt use, taking medications, illegal drug use, 
genetic or birth defect screenings, procedures if labor starts 
early, HIV testing, and physical abuse. 
 
A.  0 
B. 1 
C. 2 
D. 3 
E. 4 
F. 5 
G. 6 
H. 7 
I. 8 
J. 9 
 
 
 
 
 
 
 
 
 
82 
189 
495 
884 
1,281 
1,310 
1,071 
1,127 
1,445 
1,527 
 
 
 
 
 
 
 
 
 
3,121 
7,787 
20,114 
36,856 
51,396 
57,065 
43,024 
47,459 
57,882 
57,582 
 
 
 
 
 
 
 
 
 
0.6 
1.6 
4.1 
7.4 
10.4 
11.5 
8.7 
9.6 
11.7 
11.6 
 
 
 
 
 
 
 
 
 
888 
1,686 
3,903 
6,963 
10,066 
11,381 
10,888 
12,194 
15,598 
17,739 
 
 
 
 
 
 
 
 
 
38,139 
66,617 
161,150 
303,494 
455,257 
548,173 
486,862 
539,473 
697,525 
811,254 
 
 
 
 
 
 
 
 
 
0.7 
1.2 
2.8 
5.3 
7.9 
9.5 
8.4 
9.4 
12.1 
14.1 
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K. 10 
 
2,828 112,970 22.8 37,245 1,657,052 28.7 
 
Initiation of prenatal 
care 
(PNC_WKS) 
 
How many weeks or months pregnant were you when you had 
your first visit for prenatal care (CDC converted all to weeks)? 
A. Week 4 or earlier 
B. Between weeks 5 and 8 
C. Between weeks 9 and 12 
D. Between weeks 13 and 16 
E. Between weeks 17 and 20 
F. Between weeks 21 and 24 
G. Between weeks 25 and 28 
H. Between weeks 29 and 32 
I. Between weeks 33 and 36 
J. Between weeks 37 and 40 
K. Between weeks 40 and 44 
L. Between weeks 45 and 48 
M. Week 49 or later 
 
 
 
 
 
1,072 
5,096 
4,252 
1,199 
360 
141 
76 
24 
10 
0 
1 
5 
3 
 
 
 
45,757 
210,038 
167,400 
45,372 
15,642 
6,244 
3,025 
1,004 
255 
0 
175 
218 
123 
 
 
 
9.2 
42.4 
33.8 
9.2 
3.2 
1.3 
0.6 
0.2 
0.1 
0.0 
0.0 
0.0 
0.0 
 
 
 
 
16,825 
46,582 
35,314 
13,175 
5,085 
2,512 
1,190 
476 
157 
43 
13 
33 
46 
 
 
 
732,594 
2,498,087 
1,555,624 
567,334 
219,258 
108,223 
51,180 
20,282 
6,581 
1,991 
729 
1,227 
1,884 
 
 
 
12.7 
43.3 
27.0 
9.8 
3.8 
1.9 
0.9 
0.4 
0.1 
0.0 
0.0 
0.0 
0.0 
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Adverse Pregnancy 
Outcomes 
 
Occurrence of adverse pregnancy outcomes  – number of 
outcomes experienced 
 
Possible adverse pregnancy outcomes include: 
- Preterm delivery (less than or equal to 259 day/37 
weeks) 
- Low birth weight (less than or equal to 2,500 grams) 
- Use of the Neonatal Intensive Care Unit (NICU) 
- Length of infant hospital stay (4 days or more) 
- Length of maternal hospital stay (4 days or more) 
- Small for gestational age (computed via algorithm) 
- Infant mortality 
 
A. 0 
B. 1 
C. 2 
D. 3 
E. 4 
F. 5 
G. 6 
H. 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6,023 
1,854 
1,365 
850 
962 
1,089 
96 
0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
327,529 
80,239 
49,999 
18,452 
9,906 
8,507 
623 
0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66.1 
16.2 
10.1 
3.7 
2.0 
1.7 
0.1 
0.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60,589 
21,698 
15,743 
8,338 
9,435 
11,614 
1,111 
23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3,588,517 
1,035,844 
661,688 
233,123 
122,783 
112,143 
10,709 
187 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62.2 
18.0 
11.5 
4.0 
2.1 
1.9 
0.2 
0.0 
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Appendix B:  Frequency Distributions for Post Hoc Variables  
Variable 
(Variable 
Name) 
Survey Items and Response Options Freq. Weighted Freq. % 
 
Physical Abuse 
During 
Pregnancy 
(PAPG5_NO) 
 
CDC Computed – no physical abuse during 
pregnancy 
C.  No 
D. Yes 
 
 
 
4,258 
108,417 
 
 
166,378 
4,870,388 
 
 
3.3 
96.7 
 
Hospitalized 
During 
Pregnancy 
(HSP_PG5) 
 
CDC Computed – hospitalized during 
pregnancy 
C.  No 
D. Yes 
 
 
 
88,059 
24,616 
 
 
4,415,708 
621,058 
 
 
87.7 
12.3 
 
Kessner Index 
(KESSNER) 
 
From birth certificate data – adjust the timing 
and quantity of prenatal care for length of 
gestation 
 
H. Adequate Prenatal Care 
I. Intermediate Prenatal Care 
J. Inadequate Prenatal Care 
K. Unknown Prenatal Care 
 
 
 
 
 
84,500 
23,029 
4,729 
417 
 
 
 
 
 
3,865,436 
971,883 
179,745 
19,701 
 
 
 
 
76.7 
19.3 
3.6 
0.4 
 
# of Prenatal 
Visits 
(PNC_VST_NA
PHSIS) 
 
From birth certificate data 
F.  0-8 visits 
G. 9-11 visits 
H. 12 or more visits 
 
 
 
24,286 
35,339 
53,050 
 
 
813,230 
1,578,142 
2,645,393 
 
 
 
16.1 
31.3 
52.5 
 
Maternal Weight 
Gain During 
Pregnancy 
(MOMLBS) 
 
From birth certificate data  
O. Less than 10 lbs. 
P. 10 to 14 lbs. 
Q. 15 to 19 lbs. 
R. 20 to 24 lbs. 
S. 25 to 29 lbs. 
T. 30 to 34 lbs. 
U. 35 to 39 lbs. 
V. 40 to 44 lbs. 
W. 45 lbs. or more 
 
 
 
7,588 
6,742 
8,947 
16,024 
16,157 
18,489 
12,287 
10,691 
15,750 
 
 
278,491 
245,049 
347,670 
652,875 
719,286 
868,724 
616,316 
526,623 
781,732 
 
 
5.5 
4.9 
6.9 
13.0 
14.3 
17.2 
12.2 
10.5 
15.5 
 
First C-Section 
(DEL_1CS) 
 
From birth certificate data 
C. No 
D. Yes 
 
 
 
86,702 
25,973 
 
 
4,091,941 
944,824 
 
 
81.2 
18.8 
 
Forceps 
Delivery 
(DEL_FORC) 
 
From birth certificate data 
C. No 
D. Yes 
 
 
111,475 
1,200 
 
 
4,981,248 
55,518 
 
 
98.9 
1.1 
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Repeated C-
Section 
(DEL_RCS) 
 
From birth certificate data 
H.  No 
I. Yes 
 
 
99,674 
13,001 
 
 
4,457,254 
579,511 
 
 
88.5 
11.5 
 
Vacuum 
Delivery 
(DEL_VACM) 
 
 
From birth certificate data 
C. No 
D. Yes 
 
 
108,432 
4,243 
 
 
 
4,822,768 
213,997 
 
 
95.7 
4.2 
 
Vaginal Delivery 
(DEL_VAG) 
 
 
From birth certificate data 
F. No  
G. Yes 
 
 
40,339 
72,336 
 
 
1,585,911 
3,450,854 
 
 
31.5 
68.5  
 
Vaginal Delivery 
After C-Section 
(DEL_VCS) 
 
 
From birth certificate data 
E. No 
F. Yes 
 
 
111,422 
1,253 
 
 
4,980,825 
55,940 
 
 
98.9 
1.1 
 
 
Adverse 
Pregnancy 
Outcomes 
 
Occurrence of adverse pregnancy outcomes – 
number of outcomes experienced 
 
Possible adverse pregnancy outcomes include: 
 
- Birth defects  
- Plurality 
- Preterm delivery (less than or equal to 259 
day/37 weeks) 
- Low birth weight (less than or equal to 
2,500 grams) 
- Use of the Neonatal Intensive Care Unit 
(NICU) 
- Length of infant hospital stay (4 days or 
more) 
- Length of maternal hospital stay (4 days or 
more) 
- Small for gestational age (computed via 
algorithm) 
- Infant mortality 
 
E. 0 
F. 1 
G. 2 
H. 3 
I. 4 
J. 5 
K. 6 
L. 7 
M. 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52,542 
19,190 
13,585 
7,169 
7,499 
9,344 
3,048 
274 
24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3,098,411 
925,406 
574,000 
208,971 
105,497 
92,448 
29.368 
2,382 
283 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61.5
18.4 
11.4 
4.1 
2.1 
1.8 
0.6 
0.0 
0.0 
 
 
  
Appendix C:  Correlation Matrix for Post Hoc Analysis Variables 
PROJECT 2  
Post Hoc Analysis 
Correlation Matrix 
 
A
B
U
S
E
 
D
U
R
I
N
G
 
P
R
E
G
N
A
N
C
Y
 
H
O
S
P
I
T
A
L
I
Z
E
D
 
D
U
R
I
N
G
 
P
R
E
G
N
A
N
C
Y
 
K
E
S
S
N
E
R
 
I
N
D
E
X
 
#
 
O
F
 
P
R
E
N
A
T
A
L
 
C
A
R
E
 
V
I
S
I
T
S
 
M
A
T
E
R
N
A
L
 
W
E
I
G
H
T
 
G
A
I
N
 
D
U
R
I
N
G
 
P
R
E
G
N
A
N
C
Y
 
F
I
R
S
T
 
C
E
S
A
R
E
A
N
 
S
E
C
T
I
O
N
 
D
E
L
I
V
E
R
Y
 
F
O
R
C
E
P
S
 
A
S
S
I
S
T
E
D
 
D
E
L
I
V
E
R
Y
 
R
E
P
E
A
T
E
D
 
C
E
S
A
R
E
A
N
 
S
E
C
T
I
O
N
 
D
E
L
I
V
E
R
Y
 
V
A
C
U
U
M
 
A
S
S
I
S
T
E
D
 
D
E
L
I
V
E
R
Y
 
V
A
G
I
N
A
L
 
D
E
L
I
V
E
R
Y
 
V
A
G
I
N
A
L
 
D
E
L
I
V
E
R
Y
 
A
F
T
E
R
 
P
R
E
V
I
O
U
S
 
C
E
S
A
R
E
A
N
 
S
E
C
T
I
O
N
 
D
E
L
I
V
E
R
Y
 
ADVERSE PREGNANCY 
OUTCOMES -0.028 0.338 0.030 -0.102 -0.027 0.330 -0.019 0.106 -0.033 -0.344 -0.021 
INSURED 0.115 -0.040 -0.197 0.139 0.015 0.043 0.019 0.011 0.011 -0.044 -0.001 
MEDICAID -0.093 0.050 0.097 -0.075 -0.037 -0.040 -0.019 0.020 -0.018 0.019 0.008 
INCOME 0.144 -0.066 -0.204 0.147 0.031 0.032 0.019 0.027 0.001 -0.047 0.007 
EDUCATION 0.112 -0.033 -0.188 0.147 0.039 0.040 0.021 0.000 0.012 -0.034 -0.001 
STRESS -0.304 0.104 0.124 -0.076 0.005 -0.003 -0.008 -0.008 -0.006 0.010 -0.011 
ABUSE BEFORE 
PREGNANCY 0.534 -0.055 -0.070 0.044 -0.008 0.012 0.011 0.005 -0.002 -0.014 0.002 
ABUSE DURING 
PREGNANCY 1.000 -0.036 -0.055 0.043 0.005 0.012 0.002 0.002 -0.004 -0.009 -0.009 
PREGNANCY – TRYING 0.092 -0.037 -0.142 0.098 0.002 0.031 0.012 0.010 0.013 -0.033 0.002 
PREGNANCY - 
INTENTION -0.023 -0.010 0.037 -0.035 -0.012 -0.056 -0.017 0.020 -0.015 0.030 0.021 
MATERNAL AGE 0.103 -0.042 -0.136 0.097 -0.062 0.023 -0.004 0.142 -0.027 -0.125 0.044 
HISPANIC ETHNICITY 0.028 0.008 -0.081 0.067 0.033 0.011 0.016 -0.015 0.013 0.003 -0.011 
MATERNAL RACE -0.041 0.009 0.084 -0.065 -0.028 0.004 -0.016 -0.001 -0.009 -0.003 0.004 
PREGNANCY HISTORY -0.021 0.068 0.032 -0.049 -0.129 -0.194 -0.048 0.261 -0.072 -0.031 0.080 
BMI – UNDERWEIGHT -0.016 0.012 0.025 -0.020 0.021 -0.034 0.008 -0.040 0.017 0.055 0.008 
BMI – OVERWEIGHT -0.011 0.041 -0.006 0.017 -0.189 0.086 -0.022 0.122 -0.030 -0.156 0.000 
FOLIC ACID USE 0.083 -0.020 -0.097 0.071 0.023 0.040 0.009 0.003 0.005 -0.036 0.004 
TOBACCO USE 
BEFORE PREGNANCY 0.098 -0.037 -0.052 0.027 -0.071 -0.014 -0.002 0.015 0.005 0.002 0.005 
ALCOHOL FREQUENCY 
BEFORE PREGNANCY 0.036 0.021 0.054 -0.046 -0.074 -0.035 -0.017 0.040 -0.006 -0.001 0.017 
BINGE DRINKING 
BEFORE PREGNANCY 0.049 0.015 0.043 -0.038 -0.076 -0.035 -0.018 0.043 -0.009 -0.003 0.018 
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Project 2 
Post Hoc Analysis 
(continued) 
Correlation Matrix 
TOBACCO USE 
DURING PREGNANCY 0.097 -0.029 -0.065 0.043 0.018 0.019 0.010 -0.009 0.011 -0.009 -0.005 
ALCOHOL FREQUENCY 
DURING PREGNANCY 0.022 0.025 0.001 0.003 0.003 0.011 0.001 0.000 0.009 -0.008 -0.009 
BINGE DRINKING 
DURING PREGNANCY 0.021 0.018 0.009 -0.002 0.005 0.004 -0.003 0.005 0.003 -0.005 -0.011 
MATERNAL 
COMPLICATIONS -0.086 0.398 0.016 -0.017 -0.066 0.060 -0.011 0.031 -0.021 -0.069 -0.007 
HOSPITALIZED 
DURING PREGNANCY -0.036 1.000          
PRENATAL 
EDUCATION -0.003 0.025 0.024 -0.005 -0.005 0.029 -0.008 -0.028 0.005 -0.003 -0.017 
PRENATAL CARE 
INITIATION -0.059 -0.013 0.310 -0.225 -0.022 -0.050 -0.009 -0.020 -0.005 0.053 0.012 
KESSNER INDEX -0.055 0.013 1.000         
# OF PRENATAL CARE 
VISITS 0.043 -0.043 -0.615 1.000        
MATERNAL WEIGHT 
GAIN DURING 
PREGNANCY 
0.005 -0.048 -0.063 0.084 1.000       
FIRST CESAREAN 
SECTION DELIVERY 0.012 0.075 -0.021 0.028 0.076 1.000      
FORCEPS ASSISTED 
DELIVERY 0.002 -0.012 -0.008 0.008 0.019 -0.043 1.000     
REPEATED CESAREAN 
SECTION DELIVERY 0.002 0.013 -0.007 -0.007 -0.047 -0.173 -0.027 1.000    
VACUUM ASSISTED 
DELIVERY -0.004 -0.012 -0.013 0.010 0.018 -0.076 0.006 -0.041 1.000   
VAGINAL DELIVERY -0.009 -0.071 0.021 -0.016 -0.030 -0.709 0.048 -0.532 0.070 1.000  
VAGINAL DELIVERY 
AFTER PREVIOUS 
CESAREAN DELIVERY 
-0.009 -0.004 0.016 -0.017 -0.019 -0.051 0.001 -0.036 0.019 -0.137 1.000 
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